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Homogeneous, structurally defined glycoproteins can be assembled by coupling synthetic 
glycopeptides to synthetic or bacterially-derived protein fragments using the native 
chemical ligation (NCL) reaction.  A limitation of NCL is the requirement for an N-
terminal cysteine residue in one of the peptide fragments.  One method for cysteine-free 
peptide ligation utilizes thiol acyl transfer auxiliaries which effect ligation and can then 
be removed under mild conditions.   
 
We developed new, rapid routes to 1-phenyl-2-mercaptoethyl and 2-mercaptobenzyl 
auxiliaries.  The key steps involved: 1) introduction of a suitably protected thiol to 
auxiliary precursors; 2) direct reductive amination of the auxiliary aldehyde or ketone to 
afford the auxiliary-amine, which can be conjugated to a peptide via the “sub-monomer” 
approach, or the auxiliary-amino acid “cassette” for use in conventional solid phase 
peptide synthesis.  Overall yields are 53-83 %.  A glycopeptide was then assembled via 
auxiliary-mediated ligation at a Gly-Gly junction, which was complete within 48 hours.   
 
Thioester- and auxiliary-peptides were assembled to investigate the scope and limitations 
of auxiliary-mediated ligation for non Gly-Gly junctions.  The 1-phenyl-2-mercaptoethyl 
auxiliary effected ligation at Ala-Gly, Lys-Gly and Gly-Ala junctions in 24-70 % yield, 
whereas the 2-mercaptobenzyl auxiliary effected ligation at a Gly-Ala junction in 42 % 
yield.  Excess thiol was found to inhibit ligation, indicating a change in rate-determining-
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1.  Biological importance of glycoproteins 
 
Protein glycosylation, the modification of the polypeptide backbone with saccharide 
units, (see Figure 1) is one of the most common and important post-translational 
modifications undergone by proteins and is vital for the normal growth and 
development of organisms.  The oligosaccharide groups participate in a large number of 
important biological processes ranging from protein folding and secretion to cell-cell 
recognition and adhesion, and are therefore of fundamental importance in a diverse 











































































































Figure 1: typical N- and O-linked oligosaccharides found on mammalian glycoproteins. 
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In cell-cell communication, saccharides normally have only weak binding affinity for 
their receptor proteins, known as lectins.  When multiple oligosaccharides are displayed 
on a peptide scaffold in glycoproteins however, multiple receptor-oligosaccharide 
interactions occur, resulting in strong overall affinity of glycoproteins for their target 
receptors.  This type of binding is highly specific, as the correct oligosaccharides need 
to be displayed in the correct arrangement for binding to occur.5,6  Making only small 
changes in the displayed oligosaccharides or their spacing can therefore have a large 
effect on the binding specificity. 
 
The oligosaccharide groups also modulate key biophysical properties of glycoproteins 
by forming hydrogen-bonding and hydrophobic interactions with the protein and by 
shielding the polypeptide backbone with a coating of saccharide groups.  They therefore 
play crucial roles in maintaining the correct folding of glycoproteins.  Indeed, even 
when not directly involved in binding and adhesion events as displayed ligands, the 
oligosaccharide groups are often vital for the protein to adopt the conformation required 
for binding.  The oligosaccharide groups also increase protein solubility, maintain 
thermal stability, and shield the polypeptide backbone from proteolysis.7,8 
 
Understanding of the significance of the specific oligosaccharide groups displayed by 
glycoproteins in cell-cell communication, and also as modulators of the biophysical 
properties of proteins, has been hindered by glycoprotein “microheterogeneity”.9  This 
phenomenon is caused by the fact that the oligosaccharide, or “glycan”, groups of 
glycoproteins are built up in the endoplasmic reticulum (ER) and the golgi complex in a 
stepwise process which is not template-driven, nor under direct genetic control.3  As a 
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result, each glycoprotein is expressed as a complex mixture of “glycoforms” with highly 
diverse glycan structures.  Separating specific glycoproteins for biological study from 
these heterogeneous mixtures of closely-related molecules is extremely difficult and 
often yields only very small amounts of material.10  Consequently, the synthesis of 
homogeneously glycosylated glycoproteins has been the focus of much research effort 
over the past decades. 
 
The oligosaccharide, or glycan, groups of glycoproteins can be divided into two main 
classes based on the nature of the covalent linkage to the polypeptide backbone.  O-
linked glycans are attached via an O-glycosidic linkage through the alcohol side-chain 
of the serine or threonine amino acid residues, whereas N-linked glycoproteins are 
attached through the amide side-chain of asparagine (see Figure 1).   
 
More unusual glycosidic linkages are also known.  C-glycosides, where the C2 position 
of the indole side-chain of tryptophan is linked to mannose, and S-glycosides, where the 
thiol side-chain of cysteine is linked to glucose or galactose, have both been isolated 




1.1  N-linked glycosylation 
 
N-linked glycosylation occurs in a diverse range of organisms, from yeasts and fungi to 
mammals.12  The oligosaccharide group is transferred to the protein, and subsequently 
modified, by numerous enzymes in the endoplasmic reticulum and golgi apparatus.  
Modification of asparagine with an oligosaccharide group can occur for any protein 
which contains the amino acid consensus sequence AsnXaaSer/Thr, where Xaa 
represents any amino acid other than proline.   
 
All N-linked glycans contain the basic core pentasaccharide structure Man3GlcNAc2(β-
N)Asn (see Figure 2).  This core structure is elaborated enzymatically to create a huge 
number of different possible glycan structures.3,13
 
N-glycans can be divided into three sub-classes based on the types of subsequent 
elaboration which the pentasaccharide core undergoes.  Complex type N-glycans are 
typified by the absence of mannose beyond the pentasaccharide core and are extended 
by the addition of N-acetylglucosamine and galactose monosaccharides.  High-mannose 
type glycans are extended by the addition of α-linked mannose residues, and hybrid type 
glycans contain elements of both complex and high-mannose types (see Figure 2).8
 
N-linked glycans have many diverse functions.  Intracellularly, they are involved in the 
regulation of protein folding and the degradation of misfolded proteins.  Extracellularly, 






























































































































































































Figure 2: the three main sub-classes of N-linked glycans, with the core pentasaccharide 
highlighted.8
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glycoproteins, either through modulation of protein structure and stability or by acting 
as ligands for a wide range of receptors.   
 
The glycosylphosphatidylinositol (GPI)-anchored glycopeptide CD52 is expressed by 
human lymphocyte cells and is involved in the immune system.  The peptide contains a 
single N-linked glycosylation site, which displays complex type N-glycans, which have 
been found to be necessary for biological activity, for example by acting as ligands for 
sperm-specific antibodies.14,15   
 
The glycoprotein hormone erythropoietin (EPO),16 a blockbuster treatment for anaemia 
which stimulates the production of red blood cells and which also exhibits 
neuroprotective activity, contains three N-glycosylation sites and a single O-
glycosylation site.12  The glycans make up 40 % of the mass of the glycoprotein and are 
vital to its in vivo stability and activity.  EPO lacking fully elaborated N-glycans is 
rapidly cleared from the body and so has essentially no activity.17  The terminal 
saccharides displayed by the oligosaccharide groups are also important.  The removal of 
the terminal sialic acid groups from the N-glycans abolishes erythropoietic activity but 
the resulting asialoEPO retains potent neuroprotective activity in a wide range of 
diseases.8,12  N-glycans are also utilised by a number of viruses to bind to and invade 
host cells.  The HIV-1, hepatitis C and ebola viruses, among others, bind to host cells 
through high-mannose type N-glycans displayed on their envelope glycoproteins.18
 
The biosynthesis of N-linked glycans occurs in the ER and golgi apparatus.  A 
heptasaccharide is initially assembled by cytosolic enzymes on a dolicholpyrophosphate 
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carrier lipid which is bound to the ER membrane.  This is then “flipped” to the lumenal 
face of the membrane, whereupon it is further elaborated into a 14-residue 
oligosaccharide by ER enzymes.  The oligosaccharide is then transferred to a growing 
protein chain at the side chain of an asparagine residue by the action of 
oligosaccharyltransferase, a multi subunit enzyme complex also bound to the ER 
membrane, which recognises the glycosylation sequence AsnXaaSer/Thr.  Two terminal 
glucose units are subsequently trimmed off by ER-resident glucosidase enzymes to give 
a high-mannose type oligosaccharide (Glc1Man9-6GlcNAc2) with a single terminal 




Figure 3: biosynthesis of N-linked oligosaccharides.  ■: GlcNAc; ●: Man; ▲: Glc; 
▲: Fuc; ●, ♦: variable saccharides.3  Reprinted with permission from: Helenius, A.; 
Aebi, M. Science 2001, 291, 2364-2369.  Copyright 2001 AAAS. 
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One of the most important actions of N-glycans is in ensuring the correct folding of the 
protein.  This is accomplished by the calnexin-calreticulin cycle.  Calnexin is bound to 
the membrane of the ER, whereas calreticulin is a soluble protein.3  These 
complementary ER lectins bind to glycoproteins through the remaining terminal glucose 
of the Glc1Man9-6GlcNAc2 oligosaccharide and promote correct folding.  Calnexin and 
calreticulin also form complexes with another folding factor protein, ERp57.  This thiol 
oxoreductase forms disulfide bonds with cysteine residues in the glycoprotein which 
assist folding.19  The duration of glycoprotein to lectin binding can range from minutes 
to hours, and is dependent on how quickly the protein attains its native folded 
conformation.3  The glycoprotein is released from calnexin and calreticulin by the 
removal of the terminal glucose residue from the N-glycan by the glucosidase II 
enzyme.  Correctly folded proteins are then released from the ER.  Misfolded proteins 
are recognised by the ER enzyme uridine diphosphate (UDP)-glucose:glycoprotein 
glucosyltransferase, which binds to the high mannose type N-glycan and recognises 
specific properties of incorrectly folded proteins such as exposed hydrophobic 
regions.3,19,20  The enzyme adds the terminal glucose back to these proteins, allowing 
them to bind again to calnexin or calreticulin. (see Figure 3)   
 
Proteins which cannot be correctly folded are retained in the ER and destroyed by 
endoplasmic reticulum associated degradation (ERAD).  This process is not fully 
understood, as it involves transport to the cytosol by several pathways, including 
trimming by ER-mannosidase I and by interaction with calnexin.  Once the correctly 
folded glycoprotein is released from the ER, it enters the golgi apparatus, where further 
trimming of the oligosaccharide occurs, before further monosaccharide units are added 
 8




































































































Figure 4: some examples of types of O-linked glycans. 
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The modification of a hydroxyl group on the polypeptide backbone of a protein with a 
saccharide or oligosaccharide group occurs in a wide variety of proteins.  O-linked 
glycosylation also occurs via a diverse array of linkages involving different saccharides, 
amino acids and stereochemistries  (see Figure 4).   
 
The most common form of O-linked glycosylation in eukaryotes is mucin type 
glycosylation, characterised by the attachment of N-acetylgalactosamine (GalNAc) via 
an α-glycosidic linkage to the hydroxyl side chain of serine or threonine.  Mucin type 
glycoproteins display dense clusters of oligosaccharide groups attached via this basic 
structure, and hence have highly ordered extended protein conformations.  Mucin type 
glycans can also occur at isolated sites in non-mucin glycoproteins, however.8,12
 
Proteoglycans, found in the extracellular matrix, are O-glycosylated with 
glycosaminoglycans such as heparan sulfate through β-linked xylose residues.  
Intracellular cytosolic and nuclear proteins contain serine and threonine residues 
modified with β-O-N-acetylglucosamine (GlcNAc) monosaccharides which are not 
further substitued by other sugar residues, in contrast to most other peptide-linked 
monosaccharides.  α-O-Linked fucose residues and β-O-linked glucose residues are 
found on epidermal growth factor (EGF)-like sequences on the transmembrane protein 
Notch.4,8,21  α-O-Linked mannose residues are found in yeast cell wall proteins and also 
in glycoproteins secreted by bacteria.4  Amino acid residues other than serine or 
threonine can also be glycosylated.  For example, both vertebrate and invertebrate 
collagens contain galactose residues β-linked to the side chain of hydroxylysine.4,8
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In contrast to N-linked glycosylation, mucin type O-linked glycosylation is initiated in 
the Golgi apparatus with the transfer of a single GalNAc monosaccharide unit to the 
side chain of a serine or threonine residue.  Also unlike N-linked glycosylation, there is 
no consensus sequence for the glycosylation and any serine or threonine residue is a 
potential site for modification, although glycosylation of serine or threonine in some 
sequences is unfavourable. 
 
The GalNAc monosaccharide is added by the family of polypeptide N-acetyl-α-
galactosaminyltransferase (ppGalNAcT) enzymes.  This large family of retaining 
glycosyltransferases use the nucleotide donor UDP-GalNAc to modify proteins and 
appear to be located throughout the Golgi apparatus.23  The properties of proteins which 
are recognised by ppGalNacTs are not well characterised, but appear to include β-turn 
protein conformations and proline-rich domains.  The level of glycosylation also affects 
the ability of ppGalNAcTs to modify protein substrates, with some members of the 
family showing specificity for glycosylated proteins, and thus accounting for the 
prevalence of densely glycosylated mucin domains.22,23  The X-ray crystal structure of 
murine ppGalNAcT-1 has recently been reported,24 giving insights into the mechanism 
of the ppGalNAcT family. 
 
The basic GalNAc(α-O)Ser/Thr “TN antigen” unit is modified in the Golgi apparatus by 
a diverse series of downstream glycosyltransferase enzymes which results in the 
generation of a variety of core glycan structures depending on which specific enzymes 
interact with the glycoprotein (see Figure 5).  These core structures are then elaborated  
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Figure 5: core O-linked glycans. 
 
create diverse complex O-glycans.23  The expression of the key downstream 
glycosyltransferase enzymes is often altered in cancer cells, resulting in the generation 
of glycans which are incompletely or aberrantly elaborated, or prematurely sialyated, 
such as the T-, TN- and sialyl-TN-antigens.  Altered glycan expression can also be 
associated with autoimmune diseases.23,25
 
The density of α-linked GalNAc residues in mucin domains restricts the conformational 
freedom of the polypeptide backbone and results in the adoption of extended rod-like 
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glycoprotein structures which can be hundreds of nanometers in length.8,23  Their dense 
clustering enables the glycans of mucin domains to shield the polypeptide backbone, 
thus enhancing the stability and serum half life of glycoproteins, and allows the 
glycoprotein to exhibit lubricant properties due to the hydration capacity of the 
oligosaccharides, for example in the intestinal lubricant glycoprotein MUC2.23  Mucin 
glycans have also been shown to be important for the adoption of the correct protein 
conformation for signalling properties and binding.  For example, mucin domains are 
necessary for the T-cell surface glycoprotein CD45 to adopt the correct monomeric 
conformation for binding to the protein kinase Lck and the initiation of T-cell 
activation.23
 
Mucin type glycans also function as multivalent ligands for the cell surface receptors 
which initiate cell-cell adhesion interactions.  The most well-studied interactions of this 
type occur in the inflammatory response.  The adhesion and “rolling” of leukocytes at 
sites of inflammation is controlled by the interaction of the selectin family of lectins 
(L(leukocyte)-, P(platelet)- and E(endothelial)-selectin) with sulfated glycans displayed 
by mucin glycoproteins on the surface of endothelial and leukocyte cells, such as PSGL-
1 (P-selectin glycoprotein ligand-1).8,26
 
O-Linked glycans also function as ligands in a variety of other cellular adhesion events 
including those involved in human reproduction and viral and microbial infection.8,23  
Mucin type glycosylation is also found in the “antifreeze glycoproteins”,  mucin-like 
polymers composed of repeating O-glycosylated tripeptide units, which are found in 
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some families of Antarctic fish.  The O-glycans displayed by these glycoproteins inhibit 



































TN-antigen T-antigen Sialyl-TN-antigen  
 
Figure 6: tumour associated antigens. 
 
Glycoproteins expressed on the surface of cancer cells display epitopes known as 
“tumour associated antigens” (see Figure 6).  Many of these antigens are truncated 
forms of mucin type O-glycans, such as the TN- T- and Sialyl-TN antigens, and can be 
specific for different types of cancer.  For example, the TN-antigen is typically found in 
human epithelial tumours, whereas the the sialyl-TN-antigen is characteristic of breast, 
prostate and ovarian cancer.  As these antigens can be recognised by the immune 




2.  Assembly of glycoproteins and glycoprotein mimics 
 
The defined, homogeneous glycoproteins required for biological studies cannot be 
practically produced in sufficient quantities by mammalian cells due the problem of 
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microheterogeneity, whereas recombinant proteins expressed by prokaryotes are not 
glycosylated.  Yeast and fungi do have the ability to glycosylate proteins, but the 
glycans displayed are of non-human type and hence the resulting glycoproteins are 
immunogenic in humans.  These problems have led to the development of several 
different strategies for the production of homogeneous glycoproteins.  These include 
both biological and chemical synthetic techniques and strategies which involve elements 
of both approaches. 
 
 
2.1  Glycoproteins from biological sources 
 
Due to the aforementioned difficulties in the expression of glycoproteins, a large 
amount of research has been focussed on the development of advanced biological 
techniques for the generation of homogeneous glycoproteins.  In “glycoprotein 
remodelling” approaches, the heterogeneous glycans expressed in mammalian 
glycoproteins are selectively trimmed down by enzymatic degradation.  Glycosidase 
and endoglycosidase enzymes have been employed for this purpose, to cleave specific 
glycosidic bonds, or remove large oligosaccharide structures, respectively.  Once the 
glycan has been reduced to a known core structure, often a monosaccharide or 
disaccharide unit, it can be used as the basis for the construction of a new, defined, 
oligosaccharide by enzymatic synthesis.  This approach has been used to generate 
homogeneous glycoforms of proteins including ribonuclease B bearing sialyl Lewis X29 
and high-mannose type30 glycans. 
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Much effort has also been focussed on the “re-engineering” of protein expression 
systems with the goal of producing defined homogeneous glycoproteins by altering their 
native glycosylation machinery.  These techniques involve the incorporation of non-
native glycosyltransferase enzymes into the expression system and the inhibition or 
removal of native enzymes through genetic manipulation.31,32  The processes involved 
in glycan assembly are far from straightforward however, and have proved difficult to 
modify successfully.  Despite these problems, promising advances have been made in 
this area.  Gerngross and co-workers recently achieved the “humanization” of N-linked 
glycosylation in the yeast Pichia pastoris by employing large combinatorial genetic 
libraries and screening hundreds of constructs for activity at each stage of the 
“humanization” process.  The resulting yeast could successfully produce proteins 
displaying largely homogeneous N-linked glycans and illustrates the potential for future 
development in the expression of homogeneous glycoproteins in fungal expression 
systems.33
 
A different approach to the incorporation of glycans during protein biosynthesis is based 
on the use of misacylated tRNAs which can site-specifically incorporate non-natural 
amino acids during translation in response to readthrough of a nonsense codon.  
AUCtRNA is synthetically acylated with the non-natural amino acid, which is then 
incorporated into the protein during expression in E. coli in response to the UAG codon.  
This method has been used to site-specifically incorporate glycosylated amino acids 
such as GlcNAc(α-O)Ser into proteins (see Figure 7).  Other non-natural amino acids 
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Figure 7: incorporation of GlcNAc(α-O)Ser into recombinant protein by misacylated 
tRNA 
 
Recent work in the groups of Wong and Schultz has extended this methodology,34,35 
removing the need for the difficult synthesis of tRNA-amino acid conjugates.  Their 
approach involves the evolution of an orthogonal nonsense supressor tRNA synthetase-
tRNA pair to site-specifically insert an unnatural amino acid during protein 
biosynthesis.  A library of tyrosyl tRNA synthetase active site mutants was evolved to 
generate a mutant tyrosyl tRNA synthetase(TyrRS)-tRNA pair which is capable of 
specifically charging the corresponding Amber-supressor tRNA (mutRNACUA) with the 
desired amino acid.  The Amber stop codon TAG was introduced to the gene of a 
protein of interest and the unnatural amino acid was then site-specifically incorporated 
into the recombinant protein during translation in response to the Amber codon.  tRNA 
synthetase-tRNA pairs have been evolved for the incorporation of GlcNAc(α-O)Ser and 
GalNAc(α-O)Thr in recombinant proteins expressed in E. coli.  When a mutant 
 17
recombinant myoglobin protein, the gene of which was mutated to include the TAG 
codon, was coexpressed with the evolved TyrRS and mutRNACUA genes in E. coli in the 
presence of the correct glycosylated amino acid, the glycosylated amino acid was 
expressed at the encoded site in the recombinant protein as monitored by mass 
spectrometry, although production levels were relatively low.  Incorporation of 
GlcNAc(α-O)Ser was more efficient, as some background tyrosine expression was 
found for GalNAc(α-O)Thr incorporation. 
 
Although these biological methods for glycoprotein generation represent impressive 
achievements and have undoubted potential in the future development of glycoprotein 
assembly, none have found general use due to the inherent drawbacks in their 
approaches. Many of the multiple specific enzymes necessary for glycoprotein 
remodelling are not commercially available or make use of expensive glycosyl 
nucleotide donors.  The humanized yeast expression systems and the mutant tRNA 
synthetase-tRNA pairs are also not yet available, and the largescale biological effort 
involved in the evolution of such systems is beyond the scope of most chemistry 
laboratories.  Chemical synthesis, either in total synthesis approaches or in partnership 
with enzymatic and semi-synthetic techniques, remains the only general method to 







2.2  Synthesis of glycopeptides and glycopeptide mimics 
 
The challenge of glycopeptide synthesis is typically approached using one of two 
different general strategies.  Appropriately protected glycosylated amino acid 
“cassettes” can be synthesised and used in standard stepwise peptide synthesis.  
Alternatively, complex oligosaccharides can be coupled to synthetic peptides through 
natural or unnatural linkages in a convergent approach.  The oligosaccharides can be 
introduced as fully elaborated glycans, or as simpler structures which can then be used 
as the basis for chemical or enzymatic elaboration following synthesis of the 
glycopeptide.  Both strategies involve three main parts: peptide synthesis, 
oligosaccharide synthesis, and the formation of the key glycosidic linkage between the 
saccharide and either a single protected amino acid in the cassette strategy, or a 
polypeptide or protein in the convergent strategy. 
 
 
2.2.1  Peptide Synthesis 
 
Solid phase peptide synthesis (SPPS) is the standard technique for the synthesis of 
polypeptides.36-39  Peptides are built up one residue at a time from the C-terminus by 
suitably protected amino acid building blocks, in a stepwise coupling-deprotection-
coupling process (see Scheme 1).  Following synthesis, the peptide is cleaved from the 
solid support and amino acid side chain protecting groups are removed to generate the 
native peptide.  The vast spectrum of materials, reagents and methods available in 
SPPS, including the large number of solid supports, the wide range of differently labile 
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linkers and protecting groups and numerous coupling protocols makes it an extremely 
flexible and efficient synthetic tool.  The use of automated SPPS is now also widespread 
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=  Solid support with acid-labile linker
R1 - Rn  =  amino acid side chains  
 
Scheme 1: Fmoc solid phase peptide synthesis39
 
Two different protecting group strategies are commonly employed in SPPS.  The Fmoc 
approach utilises amino acid building blocks protected by the N-9-
fluorenylmethoxycarbonyl amine protecting group, which can be removed by 
nucleophilic cleavage with piperidine following coupling, and normally involves acid 
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labile linkers and side chain protection (see Scheme 1).  The alternative older approach 
uses the t-butoxycarbonyl (Boc) amine protecting group, which is removed by acid 
treatment with trifluoroacetic acid (TFA) and employs linkers and side chain protection 
which must be subjected to hydrogen fluoride treatment to effect cleavage. 
 
 
2.2.2  Oligosaccharide Synthesis 
 
The oligosaccharide components of glycopeptides are considerably more challenging to 
synthesise than the peptide components due to their complex, branched structures, 
multiple, similarly reactive hydroxyl groups and the variable stereochemistry of the 
glycosidic linkage.  The synthesis of oligosaccharides therefore requires both 
regiochemical and stereochemical control of the key glycosidation coupling reactions.  
Regiochemical control is normally achieved by the use of orthogonal protecting group 




































X = O, NH




Figure 8: general chemical glycosidation reaction scheme.5
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Many different methods exist for the formation of the glycosidic linkage, but typically a 
glycosyl donor saccharide with a leaving group at the anomeric position is activated, 
normally in the presence of a Lewis acid or heavy metal salt, to form the oxonium 
cation, which then reacts with the selectively exposed hydroxyl group of the glycosyl 
acceptor (see Figure 8).  The stereochemistry of the glycosidic linkage can likewise be 
influenced in several ways, the simplest of which is to exploit the inherent preference 
for the formation of the α-glycoside due to the anomeric effect.  Alternatively, the use of 
a protecting group on the neighbouring C2 substituent of the donor capable of 
neighbouring group participation or “anchimeric assistance” results in formation of the 
1,2-trans glycoside (e.g the β-glycoside in Figure 8).  Other methods of influencing 
anomeric stereochemistry include “intramolecular aglycon delivery” (IAD)40 in which 
the donor and acceptor are tethered together in the correct orientation, or controlling the 
steric surroundings of the anomeric centre to favour the desired conformation.41  
Specific combinations of reagents and reaction conditions which favour a particular 
anomer can also be used.42-44
 
Despite the great advances in carbohydrate chemistry since the report of the first 
practical glycosidation method, the Koenigs-Knorr glycosidation, in 1901,45 
glycosidation reactions are far from trivial and require careful selection of the protecting 
groups on both donor and acceptor as well as the choice of leaving group, reagents and 
reaction conditions for the desired results to be achieved.42,43  The synthesis of 
oligosaccharides is hence extremely labour intensive and time consuming due to the 
many protecting group manipulations and resulting purification steps necessary for the 
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formation of correctly reactive monosaccharide building blocks and their assembly into 
complex oligosaccharide structures.   
 
Oligosaccharide synthesis represents a vast, complex and rapidly evolving area of 
research and therefore a detailed discussion of this field is beyond the scope of this 
report.  Such details can be found in recent reviews.42-44,46,47  In the context of 
glycopeptide synthesis however, it should be noted that oligosaccharides relevant to 
glycoproteins have now become synthetically accessible, through the efforts of several 
different research groups.8,46  In some cases, innovations in carbohydrate chemistry such 
as solid phase and automated carbohydrate synthesis,42,48,49 or reactivity-based one-pot 
methodologies43,50-52 have aided these endeavours. 
 
The use of chemo-enzymatic techniques is also becoming increasingly widespread in 
the synthesis of oligosaccharides.52  The regio- and stereospecificity of enzymatic 
glycosidations, which remove the need for complex protecting group manipulations, and 
the mild reaction conditions under which they occur are obvious advantages over 
traditional chemical glycosidation reactions.  Two major families of enzymes have been 
used to effect glycosidations: glycosyltransferases and glycosidases.  
Glycosyltransferases catalyse the transfer of a monosaccharide from a sugar nucleotide 
donor to saccharide acceptor with excellent stereo- and regiospecificity (see Figure 9), 
whereas the hydrolytic glycosidase class of enzymes can transfer monosaccharide or 

































β 1,3 Gal T
β 1,4 Gal T
 
 
Figure 9: glycosyltransferase catalysed glycosidation reactions.  The regio- and 
stereoisomers formed are dependent on the specific enzyme used.5
 
Another class of enzymes which is increasingly being employed in the synthesis of N-
linked glycopeptides is the endoglycosidases.  In nature, these enzymes recognise 
specific N-linked glycan chains and cleave the glycosidic linkage between the two 
GlcNAc residues in the pentasaccharide core, leaving only a single GlcNAc residue 
conjugated to the peptide backbone.  The use of organic solvents and a large excess of 
glycosyl acceptor (the GlcNAc glycopeptide) causes the enzyme to catalyse a 
transglycosidation reaction which can transfer a large oligosaccharide corresponding to 
the normal glycan substrate to the GlcNAc glycopeptide acceptor (see Scheme 2).8,53   
 
Recent work in this area has extended the scope of the transglycosidation reaction with 
the discovery that sugar oxazolines are effective donor substrates for the 
endoglycosidases.  This improves the efficiency of the reaction and removes the need to 
incorporate the extra GlcNAc residue, wasted as a byproduct in previous procedures, 


























































































































































Scheme 2: synthesis of glycosylated fragment of the nicotinic acetylcholine receptor via 
transglycosidation reaction catalysed by endo-β-N-acetylglucosaminidase Endo-M.7
 
In common with chemical approaches, the use of solid phase enzymatic techniques has 
also been reported in oligosaccharide synthesis, where either the saccharides or enzymes 
can be attached to the solid phase.43  Also noteworthy is the recent work by Kajihara 
and co-workers in the semisynthesis of oligosaccharides.56  This group has developed a 
method for the production of defined complex type N-linked oligosaccharides from egg-
yolk.  The oligosaccharides are obtained as short glycopeptides.  Enzymatic treatment 
with a peptide:N-glycosidase enzyme cleaves the amide linkage between the peptide 
backbone and the oligosaccharide, which can then be used in the synthesis of 
glycopeptides and glycopeptide mimcs. 
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The disadvantages of enzymatic techniques in oligosaccharide synthesis are mainly 
associated with the availability of the enzymes and substrates.  Enzymes for all the 
transformations which carbohydrate chemists might wish to perform are not available, 
and many of those which are are expensive and/or require the use of expensive reagents.  
Those enzymes which have a high tolerance for different substrates, such as the 
glycosidases, also suffer from a corresponding decline in efficiency and regioselectivity.  
In addition to this, some commercially available enzymes are only partially purified and 
can be contaminated with proteases which damage peptide chains.  Nevertheless, 
enzymatic techniques are powerful and useful tools in the assembly of oligosaccharides 
and glycoproteins whose use is likely to grow still further in the future, especially when 
used in combination with chemical synthesis in chemoenzymatic approaches. 
 
 
2.2.3  Formation of the oligosaccharide-peptide linkage 
 
A variety of methods have been used to form the O- and N-glycosidic linkages between 
the peptide and oligosaccharide portions of glycopeptides and a still more diverse range 
of approaches is available for the formation of unnatural saccharide-peptide linkages. 
 
The attachment of O-linked saccharides to peptides is normally accomplished by a 
typical glycosidation reaction, (see Figure 8, page 21) in which the hydroxyl side chain 
of serine or threonine acts as the glycosyl acceptor.  For mucin type O-glycosidation, 
the most common type in nature and correspondingly the most commonly formed in 
synthesis, serine or threonine is glycosylated with N-acetylgalactosamine, or a larger 
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saccharide based upon this basic TN antigen core.  This is normally achieved by the 
glycosidation of the suitably protected amino acid with a 2-azido-galactosyl saccharide 
activated by a Lewis acid, or a soft electrophile or heavy metal salt (see Scheme 3).  
Traditionally, galactosyl bromides have been favoured, although a variety of other 
common leaving groups have also been used.23,25  The 2-azido substituent, introduced to 
favour the formation of the desired α-anomer, can then be reduced to the amine and 















































X = leaving group
R = protecting group/saccharide  
 
Scheme 3:23 synthesis of glycosylated amino acid building blocks for assembly of 
mucin-type O-linked glycopeptides.  a) glycosidation via leaving group activation; b) 
“nitroglycal concatenation” approach. 
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An alternative approach is the “nitroglycal concatenation” method developed by 
Schmidt and co-workers.57  This method is based on the Michael addition of the 
hydroxyl side-chain of the relevant protected amino acid to suitably protected 2-
nitroglycal to give the α-glycoside with high stereoselectivity.  Reduction of the 2-nitro 
group and protecting group manipulation yield the desired GalNAc-Ser/Thr product (see 
Scheme 3). 
 
In both cases the amino acid can be glycosylated with monosaccharides or with larger 
saccharide units.  The glycosylated amino acid can then be further elaborated either 
chemically or enzymatically to produce complex glycan structures.  The completed 
glycosylated amino “cassette” can then be used in standard solid phase peptide 
synthesis.8  It should be noted however that additional complications arise from the use 
of saccharides in SPPS.  The O-glycosidic linkages between monosaccharide units, and 
between saccharide and peptide, are acid labile and hence are not compatible with the 
repeated subjection to acidic conditions necessary for Boc-SPPS.58  With hydroxyl 
groups correctly protected with electron-withdrawing protecting groups, typically acetyl 
or benzoyl esters, however, saccharides are compatible with the short TFA treatment 
used in Fmoc-SPPS to remove amino acid side chain protection.  The use of strong 
bases is also incompatible with glycopeptide synthesis, as strongly basic conditions 
promote the β-elimination of the saccharide group from the serine or threonine side 
chain.  The repeated piperidine treatments used to remove Fmoc protection are 




The strategy used for the assembly of the glycopeptide must also be chosen with care.  
Amino acids glycosylated with large oligosaccharides are often problematic to use in 
peptide coupling reactions, due to the large steric bulk of the glycan unit.  They are also 
challenging and time consuming synthetic targets.43  Chemical elaboration of the 
oligosaccharide following completion of the peptide chain is also very difficult due to 
the problems of monitoring reactions on solid phase and the small scales typically 
involved.  The conceptually most efficient assembly strategy, a convergent coupling of 
the full size oligosaccharide with the completed peptide, has not been achieved for O-
linked glycopeptides.   
 
The most elegant and successful strategies used to date in the synthesis of mucin type 
glycopeptides use chemoenzymatic routes, involving the synthesis of an amino acid 
building block glycosylated with a small- to medium-sized glycan for use in SPPS.  
Following completion of the peptide chain, the oligosaccharide is elaborated 
enzymatically to form the desired glycan structure.53  This approach is illustrated by the 
chemoenzymatic synthesis of a fragment of P-selectin glycoprotein ligand 1 (PSGL-1) 
by Wong and co-workers (see Scheme 4).60  A threonine disaccharide building block 
was used in SPPS to create a monosulfated glycopeptide which was elaborated using 
commercially available enzymes to give the glycopeptide containing the desired 
pentasaccharide structure.  A similar approach has recently been used by Nishimura and 
co-workers for the rapid synthesis of a larger MUC-1 glycopeptide bearing five O-
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Scheme 4: chemoenzymatic synthesis of sulfate PSGL-1 fragment.60
 
N-linked glycans are attached to the polypeptide backbone via an amide linkage to the 
asparagine side-chain, and therefore the methods for forming this linkage are different 
from those used for O-linked glycopeptides.  The most straightforward and widely-used 
approach utilises a standard peptide coupling reaction between the carboxylate side 
chain of aspartic acid and the anomeric aminoglycoside of the appropriate glycan, 
which can be anything from a simple GlcNAc monosaccharide to large oligosaccharides 
based upon the common pentasaccharide core.  The carboxylate coupling partner can be 
either the side chain of the apropriately protected aspartic acid, giving as the product the 
glycosylated amino acid “building block” for SPPS,55,62-65 or a selectively exposed 
aspartate side chain in a preassembled peptide, in a convergent approach.25,43,66-71  The 
aspartatic acid side chain has also been activated by conjugation to a 5-bromo-7-
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nitroindoline group, which rearranges upon treatment with UV light to form an active 
ester.72
 
This peptide coupling reaction can be problematic in two particular respects, however.  
Firstly, the anomerisation of the aminoglycoside has been reported under peptide 
coupling conditions, to give a mixture of products containing the α-isomer as well as the 
desired β-glycoside.73  Secondly, when a saccharide is coupled to an already-formed 
peptide chain, aspartimide formation can take place by intramolecular attack of the 
neighbouring amino group in the peptide chain on the activated carboxylate group.6,74  It 
appears that anomerisation can be suppressed by the correct choice of coupling 
conditions, however.14,74  For example, Danishefsky and co-workers have reported 
excellent results using the “Lansbury aspartylation”69 of fully deprotected glycans.70,74  
The use of an excess of the peptide, whilst not preventing aspartimide formation, 
ensures the presence of sufficient peptide to give the maximum yield of coupled 
product, based upon the typically more valuable saccharide.74  Interestingly, 
aspartamide formation has also been observed in the “building block” approach, via 
intramolecular attack of the amide linkage nitrogen on the activated ester during 
coupling of the building block in SPPS.  Carefully optimised conditions for this 
coupling were subsequently developed to supress the side reaction.65
 
The applicability of both the “building block” and the convergent assembly approaches 
allows greater flexibility in the synthesis of N-linked glycopeptides than is the case for 
their O-linked counterparts.  Both strategies have been successfully employed, but the 
more elegant convergent approach is the most common strategy for the chemical 
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synthesis of N-linked glycopeptides, due to the previously mentioned inhibition of 
peptide coupling yields by large glycan structures.43,64,71  The sensitive glycan is also 
exposed to fewer reactions in this approach and in fact saccharides can be used without 
hyroxyl group protection.  The method is particularly useful for large glycan structures 
as it uses less of the valuable oligosaccharide than the building block approach.  The 
power of the convergent approach has been illustrated by several impressive total 
syntheses of peptides glycosylated with large high-mannose and complex type N-linked 
oligosaccharides, for example fragments of the HIV surface envelope protein gp120, by 
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Scheme 5: total synthesis of glycosylated fragment of gp120.68
 32
The problems detailed above, which can be associated with direct aspartylation of 
aminoglycosides, have led to the development of several alternative methods of forming 
the amide linkage between saccharide and peptide.  Anomeric isothiocyanates of 
appropriately protected GlcNAc and larger saccharides can react with the carboxylate 
side chain of aspartic acid under mild heating conditions to form the desired amide 
linkage.76  The Ritter reaction has also been used.  Anomeric acetonitrilium 
intermediates, formed from the activation of pentenyl glycosides in the presence of 
acetonitrile, will react with the carboxylate side chain to give the amide linkage 
following rearrangement.77  A 2-phthalimido substituent is necessary in this case to 
ensure the β-nitrilium intermediate is formed by neighbouring group participation.  The 
glycosidation of silylated amide side chains of asparagine has been achieved with 
glycosyl sulfoxide donors.78  These methods have seen relatively little use in recent 
years, however.   
 
More recent work has investigated the use of the Staudinger ligation between glycosyl 
azides and phosphinothioester derivatives of aspartic acid to form the β-amide linkage 
with high stereoselectivity.  Yields were moderate, however, for the ligation of even 
relatively simple glycosyl azides.79  Davis and co-workers have also recently reported 
the use of a three component Staudinger ligation between the glycosyl aza-ylide 
intermediate, formed by the reaction of a glycosyl azide with tributylphosphine, and an 
activated aspartate side chain, to form the β-amide linkage.80  Unprotected mono- and 
disaccharides were conjugated to suitably protected asparatic acids and a short model 
peptide in good yield by this technique. 
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Benzyl hydroxamate derivatives of asparagine have also been used as glycosyl 
acceptors in glycosidation reactions with glycosyl fluoride donors, to give the amide-
linked saccharide in good yield and stereoselectivity following reductive removal of the 
benzyloxy group.81  The use of this procedure for more complex systems than 
monosaccharides and single protected amino acid derivatives has yet to be reported, 
however.  Direct glycosidation of the aspartamide side chain with glycosyl β-N-
phenyltrifluoroacetimidate donors has also been reported in good yield and 
stereoselectivity for glycosylation of suitably protected asparagines and asparagine 
dipeptides with simple model monosaccharides.82  In common with their O-linked 
counterparts, N-linked glycopeptides have also been assembled by chemoenzymatic 
routes using either glycosyltransferase83 or endoglycosidase7 enzymes for elaboration of 
the glycan structure following peptide synthesis.8,71
 
A wide range of unnatural peptide-saccharide linkages has also been used in the 
synthesis of glycopeptide mimics.  These have been developed for a number of 
purposes, for example to form linkages more resistant to hydrolysis under physiological 
conditions, but are primarily used to achieve the chemoselective glycosylation of 
peptides. 
 
Chemoselective glycosylation to form glycopeptide mimics has been used as an 
alternative to the synthesis of native glycopeptides, as these reactions typically take 
place under mild conditions in the presence of a variety of other functional groups, and 
are therefore particularly useful for sensitive and heavily functionalised molecules such 
as saccharides and peptides.  In a typical chemoselective glycosylation, the saccharide is 
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modified with a functional group which uniquely recognises and reacts with a 
complementary group on the peptide.  The converse approach, in which the peptide is 
functionalised to react selectively with the anomeric position of the saccharide, has also 
been used.  In most cases these unnatural linkages appear to have little effect on the 























































































Figure 10: chemoselective glycosylations.  Reaction of cysteine with glycosyl α-
haloacetamide (A); reaction of hydroxylamine (B) or hydrazide (C) derivitised peptides 
with unprotected saccharides; and reaction of ketone derivitised peptide with  glycosyl 
hydroxylamine (C). 
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The thiol side chain of cysteine has been used extensively as a handle for the 
chemoselective modification of proteins, as it is capable of reacting with saccharides 
functionalised with several different reaction partners such as α-haloacetamides85 (see 
Figure 10) and bromoethyl saccharides86 to form thioether-linked products, or 
thiosulfonates87 and dithiopyridyl saccharides88 to form disulfide-linked products.   
 
S-linked glycosyl amino acids and dipeptides for use in the synthesis of S-linked 
glycopeptide analogues have also been formed by direct glycosidation of cysteine 
derviatives with glycosyl halides,89,90 or by the coupling of glycosyl thiolates with β-
bromoalanine derivatives.91
 
The chemoselective reaction between a ketone and a hydroxylamine or hydrazine 
derivative has also been extensively used for the chemoselective glycosylation of 
peptides.  Unnatural amino acids containing hydroxylamine92, 93 or hydrazide93 
functionalised side chains can be incorporated into peptides by SPPS.  These can then 
react chemoselectively with the reducing end of unprotected saccharides to give oxime- 
or hydrazide-linked glycopeptide mimics (see Figure 10).  
 
The converse approach has again been used in the case of these reactions, in which the 
ketone is incorporated into the peptide by SPPS.  The peptide can then be chemo- and 
site-selectively modified with functionalised saccharides such as glycosyl 
hydroxylamines (see Figure 10),94,95 thiosemicarbazides95 or hydrazides.95   
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Several other unnatural linkages have been used in the synthesis of glycopeptide 
mimics, although those detailed above represent the most commonly used examples.6,84   
 
One chemoselective reaction which is becoming increasingly popular in the context of 
saccharide linkages is the Huisgen [3 + 2] cylcoaddition96 between an azide and an 
alkyne to form a 1,2,3-triazole-linked species.97,98  The development of this reaction by 
Sharpless and co-workers into a copper-catalysed “click chemistry” reaction has 
enabled it to be used at physiological temperatures and in heavily functionalised 
environments and indeed this approach has been used for the modification of a range of 

















































2.3  Assembly of Glycoproteins 
 
The methods detailed in the previous sections, in particular the advances in 
oligosaccharide synthesis and chemoenzymatic methods for glycan synthesis and 
elaboration, have allowed access to increasingly large and complex glycopeptides and 
several impressive examples of the synthesis of naturally important glycopeptides, such 
as HIV-1 V355 and CD52,15 or glycopeptide mimics have been reported, as previously 
described.  A limitation in glycopeptide synthesis is the size of the polypeptide 
backbone, however.  Only peptides up to approximately 50 amino acid residues in 
length can practically be produced by SPPS.  Beyond this limit, low coupling yields and 
byproduct formation render further peptide elongation by this method impractical.  The 
solution to this problem is peptide ligation: a chemoselective condensation between two 
peptide segments, each assembled by SPPS and either partially or fully deprotected.  
Such reactions typically take place under mild aqueous conditions and allow 




2.3.1  Native Chemical Ligation 
 
The native chemical ligation (NCL) reaction, or native peptide ligation as it is also 
known, developed by Kent and co-workers is one of the most powerful and widely used 
methods for the assembly and modification of peptides and proteins.106  The reaction 
takes place between two peptide coupling partners: one with an N-terminal cysteine 
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residue and the other with a C-terminal α-thioester.  Nucleophilic attack of the cysteine 
side chain thiol leads to a reversible transthioesterification, which is followed by an 
rapid irreversible S to N acyl-shift via a five-membered ring transition state to form the 
native peptide linkage (see Figure 11).  The reaction is entirely chemoselective and is 
carried out at ambient temperatures under aqueous conditions, and is therefore 
































































S to N acyl transfer
peptide thioester N-terminal cysteine peptide
R = H / saccharide  
 
Figure 11: native chemical ligation of unprotected glycopeptide segments. 
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Solubilizing agents such as guanidine hydrochloride or urea do not interfere in the 
reaction and can be used to allow higher peptide concentrations.  The reaction 
progresses most efficiently under slightly basic conditions (pH = 7.0 – 8.0) which 
favour the initial nucleophilic attack without being strong enough to hydrolyse the 
thioester to the corresponding acid.   
 
Addition of an excess of thiol, typically thiophenol or 2-mercaptoethylsulfonic acid 
sodium salt (MESNa) has also been found to increase the efficiency of the reaction by 
helping to prevent oxidation of the cysteine thiol.  The excess thiol also participates in 
reversible transthioesterification with the thioester component.  This has no negative 
impact on the reaction however, as the resulting thioester is also reactive towards the 
cysteine-peptide and the key intermediate thioester formed by the reaction of the two 
peptide coupling partners rearranges too rapidly to be broken down again by exchange 
with free thiol.  In fact thioester exchange with the additional thiol can have a positive 
effect on the reaction by increasing the rate at which the unprofitable intermediate 
thioesters, which can be formed by the reaction of the thioester with internal cysteine 
residues in either peptide, or indeed the cysteine thiol formed at the ligation site 
following rearrangement, are broken down.107  
 
Ligations are typically fast and efficient, although difficulties have sometimes been 
encountered with thioesters containing β-branched C-terminal amino acid residues such 
as isoleucine or valine.106  The mechanism of NCL has recently been further 
investigated by Kent and co-workers.107  In this study, the ability of a range of different 
thiol additives to catalyse the rate-determining transthioesterification step was examined 
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for a model ligation at a Leu-Cys junction.  Aryl thiol additives with pKa > 6, which 
gave a good balance between reactivity for the thiol exchange reaction and the reactivity 
of the resulting thioester, gave the best results.  The thiol exchange reaction was in fact 
found to be the rate-determining step for ligations in the presence of these additives, so 
rapid was the subsequent transthioesterification.  Two thiol additives in particular, 3-
hydroxythiophenol and 4-mercaptophenylacetic acid (MPAA), were very effective 
catalysts for ligation.  In contrast, alkyl and benzyl thioesters, such as those formed 
from the commonly used ligation additives MESNa and benzyl mercaptan, respectively, 
were less reactive and underwent transthioesterification more slowly, although the 
initial thiol exchange reaction was more rapid.  These interesting results should 
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Scheme 8: synthesis of PSA glycoprotein by native chemical ligation.67
 
N-terminal cysteine peptides can be synthesised in a straightforward manner by SPPS.  
The synthesis of C-terminal thioester peptides however, has required the development 
of specialised approaches (see section 2.3.10).  NCL has been used in the assembly of 
numerous proteins and glycoproteins, such as the antimicrobial insect glycoprotein 




Native chemical ligation of two peptide components allows the assembly of proteins 
and glycoproteins of small to medium size.  For larger targets, repeated ligations must 
be used in an iterative approach.  This involves the use of one or more peptide 
fragments which contain both a C-terminal thioester and an N-terminal cysteine residue, 
the latter of which must be selectively masked with a protecting group removable under 
mild conditions compatible with the unprotected peptide.  Following ligation, this 
protecting group is removed to allow the newly formed N-terminal cysteine peptide to 
participate in ligation with a further thioester peptide segment.  The peptide must be 
isolated after each ligation and deprotection step, typically by semi-preparative high 
performance liquid chromatography (HPLC) and lyophilization and so the iterative 
approach can be time-consuming.   
 
To overcome this problem, Kent and co-workers have developed a method for the “one-
pot” total synthesis of proteins.110,111  The approach utilises the 1,3-thiazolidine-4-
carboxo (Thz) group to protect the N-terminal cysteine residue of the N-terminal 
cysteine/C-terminal thioester peptide segment (see Scheme 9).  It is possible to remove 
this protecting group by treatment with methoxylamine hydrochloride at pH ≈ 4.  
Following complete ligation of an N-terminal cysteine peptide and an N-terminal 
Thz/C-terminal thioester peptide, the crude reaction mixture was accordingly treated 
with methoxylamine hydrochloride in this way to unmask the new N-terminal cysteine 
thiol group.  The pH of the reaction mixture was then returned to approximately 7 by 
the careful addition of buffered sodium hydroxide and the second thioester peptide 
segment was added.  The second ligation proceeded smoothly despite the presence of 
methoxylamine, which reacts only very slowly with thioesters at pH 7.  This “one-pot” 
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approach has been successfully applied to the total chemical synthesis of the proteins 
crambin111 and ubiquitin.110  Danishefsky and co-workers have also recently reported 
the synthesis of glycopeptides bearing three oligosaccharides groups by an iterative 

































crambin 17 - 31 crambin 33 - 46+
crambin 17 - 31 crambin 33 - 46
crambin 1 - V15A
crambin 17 - 31 crambin 33 - 46crambin 1 - V15A
1) native chemical ligation
2) MeONH2.HCl pH = 4.0




Scheme 9: “one-pot” total chemical synthesis of crambin.111
 
Kent and co-workers recently improved the speed and efficiency of the iterative 
assembly process still further by the incorporation of a histidine His6 tag at the C-
terminus of the C-terminal peptide segment.114  This allows speedy and simple 
purification of the reaction mixture by Nickel affinity column following each ligation-
deprotection step in an alternative approach to the “one-pot” method.  The utility of this 
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approach was demonstrated by the synthesis of the 17 kDa modular repeat protein TPR, 
involving the iterative ligation of four separate peptide segments. 
 
 








































synthetic peptide  α-thioester
bacterially derived peptide  α-thioester
synthetic or Semi-synthetic protein/protein conjugate  
 
Figure 12: expressed protein ligation. 
 
Despite these advances, most proteins and glycoproteins are still too large (≥30 kDa)114 
to be assembled by total chemical synthesis.  These targets can be reached however, by 
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the use of semi-synthetic techniques.  Protein semi-synthesis involves the fusion of 
synthetic and biologically expressed polypeptide fragments to form proteins.  The 
primary method used for the coupling of synthetic and recombinant peptide fragments 
in protein semi-synthesis is expressed protein ligation (EPL).115-117   
 
This technique, developed by Muir and co-workers, involves a native chemical ligation 
in which either the N-terminal cysteine segment or the C-terminal thioester segment is 
bacterially-derived (see Figure 12).  As the size of recombinant proteins expressed by 
organisms such as E. coli is not limited by the constraints of SPPS, the assembly of 
large proteins containing synthetic segments is possible.  Hence short synthetic 
glycopeptides can be fused to bacterially-derived protein fragments to form large, 
structurally homogeneous glycoproteins.118  This approach has also been used to 
incorporate a wide variety of synthetic tags,119 probes120 and structural motifs121 into 
biologically important proteins. 
 
Recombinant N-terminal cysteine peptide fragments are typically expressed as fusion 
proteins in which the desired peptide sequence is conjugated to a purification tag via a 
specific sequence of amino acid residues which can be recognised and selectively 
cleaved by a commercially available enzyme such as factor Xa protease118 or TEV 
proteases122 to give N-terminal cysteine polypeptides.  Recent work in our group has 
also shown the utility of cyanogen bromide for the cleavage of N-terminal cysteine 
polypeptides from recombinant fusion proteins.123  This alternative approach is 
particularly valuable for fusion proteins which are insoluble under conditions 
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Figure 13: mechanism of intein-mediated protein splicing. 
 
Recombinant polypeptide C-terminal thioesters can be produced as C-terminal fusion 
proteins with modified inteins, which rearrange to generate the thioester in an approach 
developed by Muir and co-workers.115,116  Inteins are naturally occurring protein 
splicing elements which are excised from proteins via a series of intramolecular 
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rearrangements which result in the ligation of the flanking polypeptide sequences, or 
exteins (see Figure 13).  It is possible that the intein domain itself initiates protein 
splicing by twisting the polypeptide backbone into a favourable conformation for the 
rearrangements to occur.117  The fusion of the target polypeptide to a modified intein, 
which can promote only the first N to S acyl shift and cannot be excised, leads to the 
formation of a recombinant thioester which can then be released from the intein by 
intramolecular transthioesterification with a thiol or with an N-terminal cysteine peptide 
in native chemical ligation. 
 
In recent work in our group the power and versatility of the NCL/EPL approach to 
glycoprotein assembly was demonstrated by the formation of structurally homogeneous 
glycoforms of the cellular adhesion glycoprotein GlyCAM-1.118  Synthetic 
glycopeptides and glycopeptide thioesters were ligated to both N-terminal cysteine and 
C-terminal thioester polypeptides expressed in E. coli to produce three full-length, 
homogeneously glycosylated variants of the target protein. 
 
 
2.3.3  Cysteine-free Peptide Ligation 
 
The major limitation of the NCL/EPL approach is its reliance on the presence of the 
relatively uncommon cysteine residue at the ligation junction.  Only about 1.7 % of all 
residues in known proteins are cysteines.53  It is therefore quite probable that a given 
target protein or glycoprotein will either not contain a cysteine residue at all, or that a 
native cysteine will not be present at a site appropriate for use as a ligation junction.   
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Ligation junctions must obviously be sited at points where the ligation coupling partners 
will be available via chemical synthesis or protein expression, and, in the case of 
glycoproteins, cannot be directly adjacent to residues glycosylated with 
oligosaccharides, as the steric bulk of these groups prevents ligation.68   
 
The introduction of non-native cysteine residues at strategic points to accommodate 
ligation can be problematic.  Altering the amino acid sequence can affect the structure 
of the protein.  The unnatural cysteine residue can also cause problems with any 
subsequent ligations.  In the semisynthesis of GlyCAM-1 carried out in our group, for 
example, a non-native cysteine residue was introduced into one of the glycopeptide 
fragments to facilitate its assembly by NCL.  It was found that the subsequent EPL of 
this fragment with a bacterially derived thioester proceeded extremely slowly, unless the 
non-native internal cysteine was capped by treatment with iodoacetamide to form a 
glutamine analogue.  To extend the applicability and generality of the NCL/EPL 
approach and overcome problems such as this, several strategies for cysteine-free 
peptide ligation have been developed, using a range of different approaches. 
 
 
2.3.4  Post Ligation Modification of Cysteine and Selenocysteine 
 
A “desulfurization” approach can be applied to allow the formation of non-cysteine 
containing proteins by NCL.124  In this technique NCL takes place as normal between a 
thioester and an N-terminal cysteine peptide.  The ligation product is then subjected to 
hydrogenation in aqueous acid in the presence of aluminium oxide and palladium, or 
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treated with Raney nickel, to convert the cysteine residue into the much more 
commonly found alanine.   The stereochemistry of the amino acid side chain is 
preserved in the reaction, which proceeded in generally excellent yield for the model 
peptides studied.   
 
This procedure is not particularly general, as it is obviously incompatible with peptides 
or proteins containing native cysteine residues, which are also desulfurized.  Lower 
yields for the reaction were found for peptides containing methionine due to peptide 
damage caused by slow desulfurization of these residues.  Tyrosine phenol side chains 
can also be converted to cyclohexanone under the desulfurization conditions.125
 
N-terminal selenocysteine peptides have been shown to participate in NCL and EPL 
with thioesters in the same manner as their cysteine counterparts, although these 
ligations can give mixtures of products due to the tendency of the selenol side chain to 
react further with a second thioester molecule or with the thiol reagent present in the 
reaction mixture.126,127  Selenocysteine can be reduced to alanine by catalytic 
hydrogenation under similar conditions to cysteine, although the same comments 
regarding damage to the peptide apply.  Alternatively, mild oxidative treatment with 
hydrogen peroxide under aqueous conditions converts the selenol side chain to 






2.3.5  Acyl Transfer Auxiliaries 
 
An interesting and potentially more general approach to cysteine-free peptide ligation is 
the use of thiol acyl transfer auxiliaries which can be appended to the N-terminus of a 
peptide to mimic the action of the cysteine thiol side chain in NCL.  Ideally, the 
auxiliary is cleaved following ligation, resulting  in a “traceless” cysteine-free peptide 
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Figure 14:  thiol auxiliary mediated cysteine-free peptide ligation at an Xxx-Gly 
junction. 
 
Early examples of these auxiliaries were based on the simple modification of the N-
terminal amino acid with an ethanethiol group to give 1 (see Figure 15).128  This 
auxiliary functions in a very similar way to cysteine, with S to N acyl shift taking place 
by an intramolecular rearrangement via a five-membered ring transition state.  Good 
results were obtained for ligation at a model Gly-Gly junction, although the auxiliary 
was not removable following ligation.  The aminoxy-linked analogue 2, designed to 
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allow reductive cleavage by treatment with zinc dust following ligation, showed a 
slower rate of reaction for the Gly-Gly junction and reacted only very slowly at the 













R' = Me, H
R = peptide1 2  
 
Figure 15: early acyl transfer auxiliaries. 
 
The rate-determining-step in these trials was the intramolecular S to N acyl shift 
rearrangement.  This contrasts with cysteine ligation, where this rearrangement step is 
rapid and transthioesterification or thiol exchange is the rate-determining-step.  The 
speed of the rearrangement was severely reduced by steric hindrance caused by the 
presence of even small substituents on the α-carbon of either the C-terminal or N-
terminal amino acid residues on either side of the ligation junction.  Indeed in these 
cases the rearrangement proceeded so slowly that it was even possible to isolate the 
transthioesterified but unrearranged product.  The longer chain of 2 causes the key 
intramolecular rearrangement step to take place via a six-membered rather than five-
membered ring transition state, in addition to introducing undesirable extra flexibility, 
and appeared to be the reason for the poor performance shown by this auxiliary. 
 
Despite these initial problems, auxiliaries based on both these basic scaffolds have been 
developed for use in cysteine-free peptide ligation.  The 2-mercaptobenzyl auxiliaries 
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developed by Dawson and co-workers129 (see Figure 16) undergo rearrangement via a 
six-membered ring transition state.  In this case, however, the six-membered ring is 
constrained or “pre-organised” by the aromatic ring.  The methoxy substituents are 
designed to improve the efficiency of the auxiliary by increasing the electron density of 
the aromatic ring and hence increase the nucleophilicity of the thiol group (5-methoxy 
substituent) and the acid lability of the auxiliary to allow removal following ligation (4- 


































3 :  R = H
4 :  R = OMe













Figure 16: 4,5-dimethoxy-2-mercaptobenzyl (3) and 4,5,6-trimethoxy-2-
mercaptobenzyl (4) auxiliary mediated cysteine-free peptide ligation. 
 
Both 4,5-dimethoxy-2-mercaptobenzyl (Dmb) 3 and 4,5,6-trimethoxy-2-
mercaptobenzyl (Tmb) 4 auxiliaries were successfully used in ligations of model 
peptide segments at Gly-Gly and Lys-Gly junctions in moderate to good yield.  The 
Dmb auxiliary was also used in a successful ligation at the Gly-Ala junction, although 
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reaction in this case was much slower and less efficient.  In contrast to standard 
conditions for NCL, the presence of thiol additives was found to prevent rather than 
facilitate ligation.  This is likely to be due to the excess thiol intercepting the initial 
transthioesterified intermediate before the slow six-membered ring rearrangement step 
can occur.  Ligation causes the benzylamine moiety to become acylated and hence labile 
to acid treatment.  The Tmb auxiliary can be removed by treatment with TFA, but the 
Dmb auxiliary requires the use of HF.   
 
Based on the results of the ligations carried out on model peptide systems, the Tmb 
auxiliary appears to be an efficient acyl-transfer agent which is tolerant of side chains 
on the C-terminal residue of the thioester.  In principle, therefore, the Tmb auxiliary 
should be useful for cysteine-free peptide ligation at Xxx-Gly junctions, where Xxx 
represents any amino acid with a non-sterically bulky side chain.  It may also be 
possible to achieve Gly-Ala ligations using this auxiliary.  The practical difficulties of 
associated with HF treatment make the Dmb auxiliary less useful and also render it 
incompatible with any sensitive modifications present in the peptide or protein, 
including glycosylation or phosphorylation.   
 
In very recent work by Danishefsky and co-workers,113 the Tmb auxiliary was used in 
the assembly of glycopeptides via ligation at Gly-Xxx junctions.  Ligation was achieved 
at a Gly-Ala junction in moderate yield.  More impressively, a successful ligation was 
achieved at the more sterically hindered Gly-Gln junction.  Unsurprisingly, the initial 
attempt at this ligation under standard conditions in phosphate-buffered-saline (PBS) 
solution was unsuccessful.  The addition of DMF cosolvent to the reaction mixture 
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however, resulted in ligation in an impressive 54 % yield for this difficult junction.  A 
double-ligated product, formed by acylation of the auxiliary with a second equivalent of 
thioester following rearrangement, was also formed, but this could be reduced to the 
desired product by treatment with excess thiol.  The yield of ligation at the Gly-Ala 
junction was also improved under these conditions.   
 
In contrast to previous reports129 however, difficulties were encountered during post-
ligation auxiliary removal by treatment with TFA.  In addition to the desired cleaved 
product, formation of a side product of the same mass as the starting material was 
observed.  This was postulated to be the thioester intermediate, arising from a reversal 
of the S – N acyl shift rearrangement initiated by irreversible protonation of the benzylic 
amine.130  To avoid this problem, a two step cleavage protocol was used, involving 
selective methylation of the auxiliary thiol with methyl p-nitrobenzene sulfonate131 prior 
to TFA cleavage.  This procedure would be unsuitable for peptides containing 
unprotected cysteine residues, however. 
 
The Nα-(2-mercaptoethyl) scaffold 1 which was most successful in the initial research 
into cysteine-free ligation has also been used as basis for the development of removable 
acyl transfer auxiliaries.  The Nα-(1-phenyl-2-mercaptoethyl) class of auxiliaries 
developed by Kent and co-workers132 also uses a substituted aromatic ring to introduce 
post-ligation lability to the thiol auxiliary, but the rearrangement step in this case takes 



















































5 :  R1 = H,  R2 = OMe
6 :  R1 = OMe,  R2 = OMe
7 :   R1 = NO2,  R2 = H
R3 = thioester leaving group
 
 
Figure 17: Nα-(1-phenyl-2-mercaptoethyl) auxiliary mediated cysteine-free peptide 
ligation. 
 
The Nα-(1-(4-methoxyphenyl)-2-mercaptoethyl) 5 and Nα-(1-(2,4-dimethoxyphenyl)-2-
mercaptoethyl) 6 auxiliaries were tested in trial ligations with short model peptides for 
several ligation junctions.  Successful ligations were achieved for Gly-Gly, His-Gly and 
Ala-Gly junctions for both auxiliaries and also at a Lys-Gly junction for the less 
substituted 5.  This auxiliary has also been successfully used at a Gly-Ala junction in 
recent studies on the formation of cyclic peptides by cysteine-free ligation.133  In each 
case reaction was slower for the more substituted, larger 6, probably due to the 
sensitivity of the key rearrangement step to steric hindrance as discussed previously.  In 
contrast to the 2-mercaptobenzyl auxiliaries, thiol additives did not prevent ligation in 
these trials.  The dimethoxy-substituted auxiliary 6 is removable by treatment with TFA 
treatment following ligation, whereas removal of 5 requires HF, limiting its 
applicability.  5 has however been used in the total synthesis of the 106-residue protein 
cytochrome b562 via a ligation at a His-Gly junction.134  The Nα-(1-(2,4-
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dimethoxyphenyl)-2-mercaptoethyl) auxiliary 6 would therefore appear to be applicable 
to cysteine-free peptide ligation at Xxx-Gly junctions, where the thioester C-terminal 
amino acid residue Xxx has a non-sterically bulky side-chain.   
 
Recent studies by Dawson and co-workers have examined the use of a photolabile Nα-
(1-(2-nitrophenyl)-2-mercaptoethyl) auxiliary 7.135  This auxiliary was tested at Gly-Gly 
and Ala-Gly junctions using a series of short model peptides.  Efficient ligations were 
achieved for both junctions, although as expected reaction rates for the Ala-Gly junction 
were considerably slower than for the Gly-Gly ligation.  Following ligation, the 
auxiliary was removed by photolysis at 310 nm.  Although these reactions were high 
yielding with minimal formation of side-products, the use of photolytic treatment for 
larger peptides and proteins is potentially problematic, due to the possibility of 
oxidative degradation of sensitive residues such as methionine and tryptophan, and 
other degradative side reactions. 
 
 
2.3.6  “Traceless” Staudinger Ligation 
 
An alternative approach to cysteine-free peptide ligation is based on the “traceless” 
Staudinger ligation developed by Bertozzi and co-workers136,137 and Raines and co-
workers.138,139  In the Staudinger ligation, a chemoselective coupling reaction takes 
place between an azide and a phosphine to form an aza-ylide intermediate140 (see 
Figure 18).  Hydrolysis of the ylide gives the reduced amine.  Alternatively, if an 
appropriate electrophilic moiety is conjugated to the phosphine, the aza-ylide can be 
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trapped by intramolecular nucleophilic attack of the charged nitrogen.  Hydrolysis of the 
resulting cyclic intermediate gives an amide-linked product.  This reaction has been 


































Figure 18: Staudinger ligation to form an amide linkage between R and R’. 
 
The insertion of a cleavable linker between the phosphine and the species to be coupled 
(R in Figure 18 above) results in “traceless” Staudinger ligation with the formation of a 
native amide bond (see Figure 19).  Several ester and thioester structures have been 
tested as linkers but the simple phoshinomethanthioester 8 has proved the most 
effective.136,139  In common with the acyl transfer mediated ligation, the critical factor in 
the Staudinger ligation appears to be the intramolecular rearrangement resulting in 
acylation of the nitrogen atom derived from the azide coupling partner.  In the case of 
phosphinomethanthioester 8 this takes place via a favourable five-membered ring 
transition state which is constrained by the phenyl substituents and in which the 
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nucleophilic aza-ylide nitrogen atom is in close proximity to the thioester carbon.  8 is 
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Figure 19: “traceless” Staudinger ligation to form a native amide linkage between two 
peptide fragments. 
 
Efficient ligations using this technique have been achieved between short model C-
terminal phosphinothioester and N-terminal azide peptide fragments at a range of Xxx-
Gly junctions.  Reaction conditions are mild and typically involve a mixed 
organic/aqueous solvent system.  In common with the auxiliary-mediated ligation, 
thioesters with non-sterically bulky C-terminal residues give the best results.  C-
terminal glycine, alanine and phenylalanine thioesters have all been ligated to N-
terminal azidoglycine peptides in good to moderate yields.139,141  A ligation between a 
short, protected C-terminal glutamic acid thioester and an N-terminal azidoglycine 
peptide has also been reported.143  In another similarity with auxiliary-mediated ligation, 
the Staudinger approach is relatively intolerant of sterically bulky N-terminal residues.  
Low yields have been reported for ligations at Gly-Phe and Ala-Phe junctions, although 
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these still represent an improvement over the results for similar junctions via the 
auxiliary approach.  Unsurprisingly, negligible yields of ligated product were reported 
for the more sterically demanding Gly-Leu and Ala-Leu junctions.142   
 
Recent work has seen the application of this method to protein synthesis and semi-
synthesis.  Raines and co-workers used a combination of the traceless Staudinger 
ligation and EPL to synthesise the 124 residue protein RNase A.143  The C-terminal 
fragment was synthesised as an N-terminal azidoglycine peptide on solid phase.  
Ligation with a protected N-terminal cysteine and C-terminal phosphinothioester 
containing peptide fragment was carried out in reasonable yield on solid phase, despite 
the presence of a sterically bulky glutamic acid side chain at the C-terminus.  Following 
concomitant side chain deprotection and release from the resin, the resulting N-terminal 
cysteine peptide was used in EPL with a bacterially-derived thioester to form the full 
length protein.   
 
Wong and co-workers have recently applied the traceless Staudinger ligation to the 
synthesis of short model glycopeptides, and have shown that the technique is 
compatible with glycosylated peptides, provided the glycosylation site is not adjacent to 
the ligation junction.141  Only β-linked peracetylated Galactose monosaccharides were 
used in these trials however, rather than the natural unprotected α-linked GalNac and 
larger GalNAc derived glycans.  A Staudinger ligation between two peptide fragments 




In the context of applying Staudinger ligation to protein semi-synthesis, bacterially-
derived phosphinothioesters are available by the treatment of recombinant intein fusion 
proteins with a phosphinothiol, in the same manner as described for EPL.144  Wong and 
co-workers have also recently developed methods for the modification of unprotected 
recombinant proteins with N-terminal azidoglucose dipeptides to form recombinant N-
terminal azidoglycine protein fragments.141  Protease catalysed condensation, using the 
enzyme subtilisin Carlsberg, was used to couple an N-terminal azidoglucose dipeptide 
trifluoroethyl ester to an unprotected recombinant peptide.  The resulting N-terminal 
azidoglycine protein fragment was then ligated to a short model C-terminal 
phosphinothioester peptide glycosylated with β-Gal(OAc)4 to give a semi-synthetic 
glycopeptide mimic. 
 
“Traceless” Staudinger ligation may offer an attractive alternative to auxiliary-mediated 
ligation for cysteine-free peptide ligations.  It offers similar tolerance of sterically bulky 
residues and glycosylation around the ligation junction, with some results suggesting 
that the key rearrangement step may in fact be less inhibited by steric bulk than is the 
case for auxiliary-mediated ligation.143  The technique has also been successfully 
applied to protein semi-synthesis.  Another attractive feature is the cleavage of the 
phosphinothiol group under the ligation conditions, instead of by acidic or photolytic 
cleavage in an additional step.  The assembly of native glycopeptides or glycoproteins 
has not been demonstrated however, and as yet only a single native protein has been 
assembled by this approach.  The method is also somewhat less flexible than the 
auxiliary approach, where the auxiliary thiol can be temporarily protected during an 
initial ligation, then unmasked at the appropriate time for use in a subsequent ligation. 
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2.3.7  Peptide Ligation via Decarboxylative Condensation 
 
Very recently, the application of a different chemoselective reaction to peptide ligation 
has been reported by Bode and co-workers.145  The approach is based upon reaction 
between an N-hydroxylamine and the ketone of an α-ketoacid.  This results in the 
formation of  an unstable hemiaminal intermediate which decomposes on mild heating, 







































Figure 20: decarboxylative condensation reaction between an N-alkylhydroxylamine 
and an α-ketoacid. 
 
This decarboxylative condensation was used to form native amide linkages between N-
terminal hydroxylamine-146,147 and C-terminal α-ketoacid-148 peptide fragments.  
Successful couplings were reported between short model peptide fragments under mild 
heating in DMF, aqueous buffers and mixed solvent systems.  Both protected and 
unprotected peptides were used and no further reagents were required.  Couplings were 
complete in 24 hours in generally good yields for all the couplings examined, including 
 62
those involving sterically crowded junctions such as Pro-Ala, Val-Gly and Phe-Ala (see 
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Figure 21: peptide ligation at Phe-Ala junction via decarboxylative condensation. 
 
The approach has also been applied to the synthesis of β-oligopeptides via 
decarboxylative condensation of α-ketoacids with isoxazolidine acetals.149  Although 
only preliminary details of this technique have so far been reported and details of the 
mechanism remain to be elucidated, the mildness of the reagent-free coupling 
conditions and the apparent tolerance for sterically congested junctions make this new 







2.3.8  C-Terminal Activation Methods 
 
A different approach to protein assembly by the coupling of peptide fragments is taken 
in the “thioester method” developed by Hojo and co-workers.150  In this technique, the 
C-terminal thioester of a peptide fragment is transformed into an active ester in the 
presence of a silver (I) salt catalyst, typically by treatment with 3,4-dihydro-3-hydroxy-
4-oxo-1,2,3-benzotriazine (HOOBt) and base in organic solvent.  A standard peptide 
coupling then occurs with the N-terminal primary amine of the second peptide fragment.  
This method has been used to assemble several large peptides and also a model mucin-
type glycopeptide displaying multiple α-GalNAc saccharides.151
 
The method is not fully chemoselective and any lysine or cysteine side chains present in 
either peptide fragment must be protected prior to coupling.  This necessitates extra 
protection/deprotection and purification steps in the peptide assembly process.  Some 
cleavage of the acetamido groups typically used to protect the cysteine side chain, and 
consequent side product formation, has also been reported after prolonged exposure to 
the coupling conditions in slow reactions.150  In contrast to the cysteine-free ligation 
methods previously described however, couplings by the “thioester method” are not 
inhibited by sterically bulky side-chains on the N-terminal amino acid and efficient 
couplings have been reported for a range of Gly-Xxx junctions.  The method has been 
rarely used for the coupling of non-Gly C-terminal thioesters, however, due to 
epimerization of the C-terminal residue under the coupling conditions.150,151  Despite 
these drawbacks, the thioester method may present an attractive complementatry 
strategy to NCL and cysteine-free peptide ligation for the coupling of small synthetic 
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Scheme 10: peptide coupling using the 2-formyl-4-nitrophenyl thioester auxiliary and 
trapping of byproduct with N-methylmaleimide. 
 
In a converse approach to that used in the auxiliary-mediated and Staudinger peptide 
ligations previously discussed, Ito and co-workers incorporated a formyl-substituted 
auxiliary into the C-terminal thioester peptide fragment (see Scheme 10).152  Selective 
reaction with the primary amine at the N-terminus of a second peptide fragment in the 
presence of base was followed by an intramolecular S to N acyl shift rearrangement via 
a constrained six-membered ring transition state similar to that undergone in the case of 
the 2-mercaptobenzyl auxiliary.  The rearrangement gave the desired amide bond and 
the 2-formyl-4-nitrobenzenethiol byproduct, which can be trapped by intramolecular 
aldol cyclization with N-methylmaleimide as shown, providing an additional driving 
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force for the reaction.  The 2-formyl-4-nitrophenyl thioester auxiliary was tested for a 
range of coupling junctions and proved remarkably tolerant of steric bulk on both the N-
terminal and C-terminal amino acid residues.  Couplings between the Fmoc-protected 2-
formyl-4-nitrophenyl thioester of the β-branched valine residue and a range of amino 
acids, including sterically bulky residues such as a second valine residue and tyrosine, 
were achieved in good yields.  The reaction was also shown to be compatible with 
amino acids glycosylated with unprotected saccharides and with the presence of 
aqueous buffer systems. 
 
Unfortunately, despite the range of junctions examined, only the couplings of single 
amino acid residues were studied.  The utility of the method for the coupling of peptide 
fragments has therefore yet to be demonstrated.  The drawbacks of a C-terminal 
thioester activation approach, such as the necessity for protection of lysine and cysteine 
residues, as described for the “thioester method” also apply to this coupling technique. 
 
A novel approach to the synthesis of mucin-type glycopeptide mimics has been used by 
Nishimura and co-workers.153  Glycosylated tripeptides consisting of threonine 
glycosylated with the Core 1 disaccharide or a simple Galβ(1→3)Gal disaccharide 
analogure, flanked on either side by an alanine residue, were initially synthesised.  
Activation of the C-terminal carboxylate group with diphenylphosphoryl azide (DPPA) 
led to a polymerisation reaction forming mucin-like glycopeptide mimics made up of 
chains of 8-15 tripeptide units, the “anti-freeze” properties of which were subsequently 
studied.  The polymerisation conditions were compatible with the presence of 
unprotected saccharides.  The limitations on the size of repeating units which could be 
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used in this method are unclear.  The incompatibility of the polymerisation conditions 
with carboxylate or primary amine side chains also limit the utility of the method in the 
context of preparing natural glycopeptides. 
 
 
2.3.9  Protease-Catalysed Peptide Ligation 
 
Protease enzymes function naturally by hydrolysing peptide bonds.  They can be used 
under thermodynamic and/or kinetic control to catalyse the formation of the peptide 
bond, however.39,53,154  Under thermodynamic control, the reaction conditions are tuned 
to favour formation of the amidolysis rather than hydrolysis product, typically by such 
means as the use of organic solvents to supress ionization of starting materials, or the 
use of an excess of one of the coupling partners.  Under kinetic control, the carboxylate 
acyl donor is typically activated as an ester to favour the formation of the acyl-enzyme 
intermediate.  
 
The subtilisin proteases have been widely used in peptide coupling reactions, and 
engineered subtilisin variants with reduced hydrolytic activity and increased amidolysis 
activity have been produced, some of which are commercially available.155,156  
Subtilisin-catalysed peptide ligation has been used to assemble several polypeptides, 
including N-linked and O-linked glycopeptides.156-158  These ligations demonstrate 
excellent regio- and stereo-specificity and take place in the presence of unprotected 
amino acid side chains and are quite tolerant of different acyl donor and acyl acceptor 
substrates.  The process is particularly useful for the modification or coupling of short 
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peptide or glycopeptide fragments, as demonstated by Wong and co-workers in the 
coupling of an N-terminal azidoglycine dipeptide ester with a short recombinant 
polypeptide.141
 
Despite their relatively broad substrate tolerance, the range of acyl donor and acceptor 
substrates which can be used in subtilisin-catalysed ligation is still inherently limited 
and a screening and optimisation process must often be used to determine the feasibility 
of ligation between particular substrates.  Subtilisin variants with appropriate tolerance 
for the desired substrates will also not necessarily be available.  Despite the reduced 
hydrolytic activity displayed by engineered subtilisin variants, some hydrolysis 
byproducts are generally still formed in these reactions.141,157,158  These side reactions 
are likely to become increasingly problematic with larger peptide fragments, especially 
those containing sequences naturally hydrolysed by the enzyme used.  To prevent self-
condensation, the N-terminus of the acyl donor, and the C-terminus of the acyl acceptor 
must be protected, typically as an Fmoc carbamate and an amide, respectively.  Another 
limitation is the requirement for a large excess of either the acyl acceptor or donor, to 




2.3.10  Synthesis of thioester peptides 
 
With the exception of the protease-catalysed peptide ligation approach described above 
and the recently reported decarboxylative condensation technique (see section 2.3.7), all 
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the methods previously discussed for the ligation of peptide segments involve a C-
terminal thioester as one of the coupling partners.  Recombinant peptide thioester 
fragments can be produced by bacterial expression, but for a truly general and versatile 
assembly approach, access to synthetic thioesters is also necessary.  Thioester peptides 
can be produced by Boc-SPPS, using thioester linkers.159  As previously discussed, the 
HF treatment necessary for cleavage of the peptide from the solid phase is not 
compatible with sensitive modifications present in some peptides, such as glycosylation, 
as well as being practically inconvenient.  The repeated treatments with TFA used to 
remove the Boc amine protecting group can also cause damage to the glycosidic 
linkage.  On the other hand, the thioester group is sensitive to nucleophiles and so is 
incompatible with the repeated piperidine treatments used in Fmoc-SPPS.  A range of 
different approaches have been used to allow the synthesis of thioesters by Fmoc-SPPS, 
from special deprotection protocols to the use of specialised linkers. 
 
The most straightforward approach to the Fmoc-SPPS of thioesters is the use of 
deprotection protocols for the removal of the Fmoc group which do not attack 
thioesters, and therefore allow thioester linkers to be used.  Li and co-workers replaced 
the standard piperidine solution in DMF normally used to remove Fmoc with a solution 
of 1-methylpyrrolidine, in a 1:1 v/v mixture of NMP and DMSO with the presence of 
small amounts of hexamethyleneimine and 1-hydroxybenzotriazole (HOBt).160  Fmoc-
SPPS with this deprotection protocol allowed the direct sythesis of short thioester 
peptides in acceptable yields.  Aminolysis of the thioester was still observed however 
and accounted for a decrease in yield of up to 15 % in model studies.  The hindered 
alkyl thioesters which were found to be the most stable during SPPS in this report were 
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not tested in subsequent ligations, for which they may be poor substrates.107  Despite 
these drawbacks, this deprotection protocol has been used in the synthesis of a partially 
protected, 24-residue peptide alkyl thioester glycosylated with the N-linked core 
pentasaccharide, which was subsequently used in a silver catalysed thioester ligation.64  
Clippingdale and co-workers developed an alternative deprotection protocol using the 
non-nucleophilic base 1,8-diazabicylco[5.4.0]undecane-7 (DBU) in the presence of 
HOBt.161  Acceptable yields of short peptide thioesters were reported using this system.  
Aspartamide formation during peptide synthesis was a significant problem with this 
technique, however. 
 
The most commonly used approaches to peptide thioesters avoid the use of thioester 
linkers.  Instead, the thioester is formed following peptide synthesis.  Peptides 
synthesised on common ester-linker resins, such as Wang or PAM resins, can be treated 
with alkylaluminium thiolate, formed in situ from alkylaluminium chloride and 
ethanethiol, to form thioesters with concomitant cleavage from the solid phase.162  
Subsequent side chain deprotection by TFA treatment afforded unprotected thioester 
peptides in moderate to good yields for the short peptides studied.  Epimerisation of the 
C-terminal residue was a problem with this method, however, as was unwanted thioester 
formation at aspartate and glutamate side chains in the peptide. 
 
In the “backbone amide linker” (BAL) approach, the resin linker is attached at the 
amine nitrogen of the C-terminal amino acid residue instead of at its carboxylate group, 
which is instead protected, typically as an allyl ester.  Following peptide chain 
elongation, the allyl protecting group can be selectively removed and the resulting free 
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C-terminal carboxylate can be coupled to an amino acid thioester under standard peptide 
coupling conditions.  Acid cleavage from the solid phase and concomitant side chain 



































































Peptide A R1, R2 = amino acid side chains





Scheme 11: synthesis of thioester peptides via backbone amide linker approach. 
 
Good yields and minimal racemisation of the penultimate amino acid residue during the 
final amino acid thioester coupling step were reported for a series of short peptide 
thioesters.163  The drawbacks of this strategy derive from the difficulty of the first 
peptide coupling, between the secondary amine of the resin-linked C-terminal residue 
and the next amino acid in the peptide sequence.  The symmetrical anhydrides of the 
appropriate amino acids, in a mixed solvent system, gave the best results in this 
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coupling.  Different amine protection was also required for the second amino acid, as a 
large amount of diketopiperazine formation was observed due to intramolecular attack 
of the N-terminal primary amine at the allyl ester under Fmoc removal conditions.  The 
acid labile N-2-(3,5-dimethoxyphenyl)propyl[2]oxycarbonyl (Ddz) protecting group 
was therefore used, although carefully controlled conditions were necessary for its 
removal to avoid cleavage of the resin linker.   
 
One solution to the problem of diketopiperazine formation is the attachment of the 
linker at the backbone amine of the C-terminal thioester, which is protected as the 
trithioortho ester, rather than the penultimate residue, as reported by Jensen and co-
workers.164  Following completion of the peptide, the thioester is formed concomitantly 
with cleavage from the solid phase and side chain deprotection by treatment with TFA.  
This method is only practical for the synthesis of C-terminal glycine thioesters, 
however, as racemic thioesters will be formed for peptides with chiral C-terminal 
residues.  
 
The use of highly acid labile linkers, such as the carboxy-trityl165,166 or 2-chlorotrityl167 
linkers, allows peptides to be cleaved from the solid phase under mildly acidic 
conditions, such as treatment with acetic acid165,167 or 5 % v/v TFA166 solutions, which 
leave the side-chain protecting groups intact. Activation of the C-terminus of the 
resulting peptide with a smaller excess of the coupling reagents benzotriazole-1-yl-oxy-
tris-pyrrolidinophosphonium hexafluorophosphate (PyBOP)167  or HBTU165,166 than is 
typically used in peptide coupling, and coupling of a thiol, followed by side chain 
deprotection with TFA, affords the corresponding unprotected thioester.  Good yields 
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and low racemisation have been reported for the synthesis of peptide and 
glycopeptide166 thioesters via this route.  The practical incovenience caused by the 
requirement for a final solution phase coupling and subsequent purification step may be 
considered a drawback to this approach, however.  
 
The most general and widely used method for the Fmoc SPPS of thioesters is based on a 
modification of Kenner’s sulfonamide “safety-catch” strategy.168-170  In this approach, 
the C-terminal amino acid residue of the target peptide is coupled to the solid phase via 
an alkanesulfonamide linker, creating an N-acyl sulfonamide linkage.  This linkage is 
acid-stable and is also resistant to basic hydrolysis, as the acyl sulfonamide nitrogen is 
deprotonated under basic conditions and the linkage is thus protected from nucleophilic 
attack.  Following peptide completion, the acyl sulfonamide is activated by substitution 
with an electrophilic reagent such as diazomethane or iodoacetonitrile in the presence of 
base.  Alkylation of the sulfonamide, particularly with an electron-withdrawing 
substituent, renders it susceptible to nucleophilic attack, which cleaves the peptide from 
the linker.  The use of nucleophilic thiols such as thiophenol and benzyl mercaptan in 
this step results in formation of the corresponding S-phenyl or S-benzyl thioesters, 
respectively (see Scheme 12).  Side chain deprotection following this nucleophilic 
cleavage from the resin affords the unprotected peptide thioester.   
 
Peptide thioesters have been synthesised in good yields with low reported C-terminal 
racemization by this method.169  The range of glycopeptides and glycopeptide mimics, 
containing glycans of up to heptasaccharide size, which have also been synthesised 
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Scheme 12: synthesis of peptide thioesters by Fmoc SPPS on alkanesulfonamide 
“safety-catch” resin. 
 
Drawbacks of the approach include inefficient coupling of the first amino acid, although 
this can be overcome by the use of acid fluorides171 or the PyBOP coupling reagent,170 
in the presence of Hünig’s base, in appropriate solvent systems.  The two-step 
activation-cleavage procedure can also be problematic.  Of the electrophilic reagents 
commonly used to activate the sulfonamide, diazomethane and 
trimethylsilyldiazomethane are not always sufficiently activating, resulting in an 
incomplete cleavage reaction.  Alkylation with iodoacetonitrile results in a more 
electron-withdrawing, more activating N-alkyl substituent but in this case the alkylation 
reaction itself can be inefficient.  The proton of the acyl sulfonamide nitrogen atom is 
sufficiently acidic to participate in a Mitsunobu reaction, and this approach has also 
been used for alkylation/activation.172
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One of the main drawbacks of the “safety-catch” method is the difficulty associated 
with monitoring reactions, as the two-step activation and cleavage procedure must be 
used to obtain samples for analysis.  Analysis of reaction progress on safety-catch resins 
is therefore considerably more time-consuming than for standard ester-linker resins.  To 
allow easier monitoring of synthetic progress, particularly the key loading of the first 
amino acid and electrophilic activation steps, Unverzagt and co-workers recently 
applied a “double-linker” concept to the synthesis of a thioester on safety-catch resin.62  
A phenylalanine residue was coupled to amino-PEGA resin derivitised with a Rink 
amide linker.  Subsequent coupling of 3-carboxypropanesulfonamide gave an 
alkanesulfonamide linker which could be cleaved at the phenylalanine residue by 
treatment with TFA to allow easy monitoring of synthetic progress.  The “double-
linker” safety catch resin was used to synthesise a 38 residue peptide thioester 
corresponding to a fragment of RNase B which was glycosylated with an N-linked 
complex-type heptasaccharide, in good yield. 
 
Other recent innovations in safety-catch thioester synthesis have utilised intramolecular 
reactions for the formation of the thioester.  Melnyk and co-workers alkylated several 
model peptides on safety-catch resin with triisopropylsilyl-protected ethanethiol under 
Mitsunobu conditions.173  Fluoride-mediated removal of the triisopropylsilyl protecting 
group led to an intramolecular N to S acyl shift via a favourable five-membered ring 
transition state, in the reverse process to that undergone in native chemical ligation.  The 
peptide thioesters were thus formed on the solid phase.  When a Rink amide-safety 
catch “double-linker” approach similar to that described above was employed, TFA 
cleavage from the resin with concomitant side chain deprotection gave the unprotected 
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peptide thioesters in good yield (see Scheme 13).  Although bulky C-terminal residues 
have been found to inhibit such rearrangements in ligations, efficient thioester formation 
was reported for a thioester with the β-branched valine residue at the C-terminus, 




















































R = Rink amide resin  
 
Scheme 13: thioester synthesis via intramolecular N to S acyl shift. 
 
A similar intramolecular N to S rearrangement approach has been used by Aimoto and 
coworkers.174  In this case the rearrangement was mediated by the 4,5-dimethoxy-2-
mercaptobenzyl auxiliary 3 discussed earlier (see section 2.3.5).  The auxiliary, with its 
thiol masked by the trityl protecting group, was conjugated to Fmoc-alanine and was 
coupled to PAM resin via an intervening alanine spacer.  Following peptide elongation, 
TFA treatment cleaved the peptide side chain and auxiliary thiol protecting groups, 
whilst leaving the PAM linker intact.  The unmasking of the auxiliary thiol initiated an 
N to S acyl shift via a constrained six-membered ring transition state to give the resin-
bound thioester, which could be released from the solid phase by transthioesterification 
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with MESNa.  In common with the use of the auxiliary in cysteine-free ligation, the 
steric bulk of C-terminal residue has a profound influence on the efficiency of the 
rearrangement.  The yield for a model leucine C-terminal thioester was much lower (5 
%) than that of the corresponding glycine thioester (31 %).  Interestingly, poorer results 
were obtained when the auxiliary was conjugated to glycine instead of alanine.  It was 
postulated that the steric bulk of the alanine side chain was actually facilitating the 
reaction by slowing down the reverse S to N acyl shift.  Yields for the thioesters 
synthesised in this methods were generally lower than those of the above safety-catch 
approaches, probably due to slow N to S rearrangement and also to the difficulties 
associated with the use of secondary amino acids (the auxiliary-alanine conjugate, in 
this case) in peptide couplings. 
 
In one of the most interesting recent developments in the field of native chemical 
ligation, Danishefsky and co-workers utilised another intramolecular rearrangement to 
prepare thioesters for NCL in situ from phenolic esters.66,112,175  Model peptides were 
prepared by standard Fmoc SPPS using a resin linker system which allowed cleavage 
from the solid phase whilst leaving side-chain protection intact.  A solution phase 
peptide coupling was then carried out between the protected peptide and phenylalanine 
phenolic ester, equipped with an ortho-disulfide group, to afford the unprotected peptide 
phenolic ester following side chain deprotection.  Unmasking of the ortho-thiol group 
occurred under the reducing conditions used in standard NCL, initiating a dynamic 
equilibrium between the peptide phenolic ester and thioester.  As the thioester was 
intercepted by the N-terminal cysteine peptide fragment or by the thiol additives in the 
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reaction mixture however, the equilibrium altered to fully convert the phenolic ester to 
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Figure 22: in situ thioester formation from peptide phenolic ester 
 
This approach has been used to assemble a range of peptides and glycopeptides 
containing large saccharide structures via NCL.  Yields were generally high, with 
minimal racemisation observed, although the necessity for partially-protected peptides 
and the solution phase coupling of the phenylalanine phenolic ester can be considered 
drawbacks to the method, as previously discussed in relation to the use of highly acid 
labile linkers.   The extension of this technique to the assembly of glycopeptides by 
cysteine-free ligation via the 4,5,6-trimethoxy-2-mercaptobenzyl auxiliary 4 has very 
recently been reported,113 as discussed in section 2.3.5.  A particularly noteworthy 
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aspect of this report is the success of the in situ thioester formation despite the absence 





























































Scheme 14: in situ thioester formation from C-oxy(2-mercapto-1-carboxyamide)-ethyl 
ester and subsequent use in NCL. 
 
A related approach, which avoids the necessity for a solution phase coupling, involves 
the in situ rearrangement of peptide C-oxy(2-mercapto-1-carboxyamide)-ethyl esters.176  
These can be synthesised on Rink amide resins as shown in Scheme 14.  Following 
release from the resin, the cysteine thiol group can be unmasked under standard ligation 
conditions in the presence of excess thiol, allowing an O – S acyl shift to take place and 
resulting in the formation of the thioester.  Significant formation of the peptide acid 
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resulting from hydrolysis of the ester and thioester was reported during cleavage from 
the solid phase and also during the subsequent ligation however, and this problem can 
be considered a major drawback to this method. 
 
 
3.  Project Strategy 
 
One of the general aims of the research in our group is the development of effective and 
general methods for the assembly of glycoproteins.  As discussed previously, 
chemoselective reactions are of particular utility in this field due to the sensitive and 
densely functionalised nature of glycoproteins.  Peptide ligations such as NCL and EPL 
are especially valuable techniques for glycoprotein assembly and have been widely used 
for this purpose.  The requirement for an N-terminal cysteine peptide fragment limits the 
generality and versatility of these methods, however.  We were interested, therefore, in 
investigating the application of cysteine-free peptide ligation to the assembly of 
glycoproteins.   
 
Of the methods previously discussed, post-ligation reduction of cysteine or 
selenocysteine is likely to be inappropriate for the assembly of large proteins due to the 
potential for damage to certain amino acid side chains.  Both the “thioester” and formyl 
auxiliary C-terminal activation approaches are not fully chemoselective, as they require 
partially protected peptide fragments.  This drawback also makes them inapplicable to 
EPL.  Protease-catalysed peptide ligations also require partially protected peptide 
fragments, in addition to their lack of generality and drawbacks for large proteins.   
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At the outset of the project, the Staudinger ligation had only been reported for the 
coupling of short, partially-protected peptide fragments at Xxx-Gly junctions and its use 
had not appeared in the literature subsequent to the papers describing its development.  
The difficulty of producing recombinant N-terminal azidoglycine peptide fragments also 
appeared to limit its utility in EPL.  Furthermore, sequential couplings using this 
method appeared potentially problematic.  We therefore chose to investigate the thiol-
auxiliary approach, which seemed to be the most potentially general and versatile 











5 :  R3 = OMe,  R4 = H
6 :  R3 = OMe,  R4 = OMe
7 :  R3 = H,  R4 = NO2
3 :  R2 = H
4 :  R2 = OMe
R1 = peptide  
Ligation Junction Auxiliary used References 
His-Gly 5, 6 132, 134 
Lys-Gly 3, 4, 5 129, 132  
Gly-Gly All 129 - 135 
Ala-Gly 5, 6, 7 132, 135 
Gly-Ala 3, 4, 5 113, 133 
Gly-Gln 4 113 
 
Table 1: ligation junctions reported for thiol auxiliaries 3 - 7. 
 
Several successful ligations had been reported using both the 2-mercaptobenzyl (3 and 
4) and Nα-(1-phenyl-2-mercaptoethyl) (5 and 6) classes of auxiliary, a number of which 
had gone beyond the use of very small test peptide fragments.129  Indeed an Nα-(1-(4-
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methoxyphenyl)-2-mercaptoethyl) 5 auxiliary-mediated ligation had been successfully 
used in the total synthesis of the protein cytochrome b562.134  These results are 
summarised in Table 1.  It should be noted however, that the reporting of isolated yields 
for both ligations and auxiliary removal is sporadic throughout these reports, especially 
for the ligation of larger peptide fragments.   
 
We aimed to examine the scope and limitations of cysteine-free peptide ligation using 
both classes of auxiliary, including the cleavage reactions, using TFA-cleavable 
auxiliaries 4 and 6.  We planned to gather synthetically relevant results by testing these 
auxiliaries for the ligation of larger peptide fragments than had previously been 
reported.  We were especially interested in investigating ligations at Ser-Gly and Leu-
Gly junctions, as these are present at appropriate sites in the GlyCAM-1 peptide 
sequence to allow assembly by a cysteine-free ligation strategy.118  We also intended to 
test the applicability of these auxiliaries to the ligation of glycopeptide fragments.  
Auxiliaries 3 and 5 were not investigated, as their removal requires treatment with HF, 
which renders them incompatible with glycosylated peptides.  Towards the end of the 
project, the photocleavable Nα-(1-(2-nitrophenyl)-2-mercaptoethyl) 7 auxiliary was also 
reported for ligations at Ala-Gly and Gly-Gly junctions.135
 
The reported syntheses of auxiliaries 4 and 6 and their conjugation to the N-terminus of 
peptides presented some problems for their application to the assembly of 
glycopeptides, however.  In the case of auxiliary 4, the protected 4,5,6-trimethoxy-2-
mercaptobenzylamine 9 was assembled by a prolonged five-step synthesis which 
 82
contained two low yielding steps, one of which was the reductive amination of a 









































































Scheme 15: literature synthesis of 4,5,6-trimethoxy-2-mercaptobenzyl auxiliary 4.129
 
The lengthy “sub-monomer” approach was then used to introduce the auxiliary amine to 
the N-terminus of a model peptide.  Firstly, an α-bromoacetyl-anhydride (prepared from 
the corresponding α-bromo-acid) was coupled to the N-terminus of the model peptide 
on the solid phase.  Displacement by 9 gave the desired auxiliary-peptide conjugate 
after a further three steps.  Comcomitant peptide side chain deprotection and release 
from the solid phase, followed by deprotection of the auxiliary thiol, gave the fully 
unprotected auxiliary-peptide conjugate ready for use in ligation.  The use of the para-
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methylbenzyl protecting group for the thiol necessitated the use of HF treatment for its 
removal and hence this synthesis is incompatible with glycosylated or otherwise 
































Scheme 16: literature synthesis of Nα-(1-(2,4-dimethoxyphenyl)-2-
mercaptoethyl)auxiliary 6.132
 
The initial syntheses of Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) auxiliary 6 was 
reported in very little detail (see Scheme 16).132  In common with the synthesis of 4, 
however, it involved a two-step amination-reduction procedure and also made use of the 
para-methybenzyl thiol protecting group and hence was incompatible with sensitive 
peptides.  The “sub-monomer” approach was also used for formation of the auxiliary-
peptide conjugate.  A more efficient synthesis of Nα-(1-(4-methoxyphenyl)-2-
mercaptoethyl) 5 has recently been reported,133 although this also uses the para-
methybenzyl group and so is again not generally applicable.  The route to the 
nitrophenyl auxiliary 7 used a different approach which utilised the TFA-labile Trityl 
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group to mask the thiol and is therefore more generally applicable, but still involved 




















































R2 = Fmoc, H












Figure 23: synthetic strategy for auxiliary peptides 4 and 6 via direct reductive 
amination. 
 
To overcome these problems and allow the application of these auxiliaries to 
glycopeptide assembly, we aimed to design new short and high yielding synthetic routes 
to 4 and 6.  We envisaged that this objective could be achieved by a direct reductive 
amination of the corresponding aldehyde 10 or ketone 12 with a suitably protected 
amino acid derivative.  Discounting subsequent protecting group manipulation, this 
approach would give the auxiliary-linked amino acid “cassettes” 11 and 13 ready for 
use in standard SPPS in a single step, and also obviate the need for the extra steps of 
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bromoacetylation of the solid phase peptide necessary in the “sub-monomer” approach 
(see Figure 23). 
 
We also planned to utilise suitably labile thiol protecting groups which could be 
removed in the presence of glycosylation, such as the trityl (Trt), para-methoxybenzyl 
(PMB), and ortho-nitrobenzyl (ONB) protecting groups.  The Trt group can be removed 
by treatment with TFA, and can therefore be removed concomitantly with side chain 
deprotection and cleavage of the peptide from the solid phase.  The PMB and ONB 
groups are stable to TFA cleavage, but can be removed by oxidative cleavage by 
mercury acetate in the presence of acetic acid, or by photolysis, respectively.  Hence 
these groups would be appropriate for instances where the thiol group must remain 
masked following cleavage from the solid phase, such as in the synthesis of peptide 
fragments bearing both an N-terminal auxiliary and a C-terminal thioester, as required 
for sequential coupling strategies.  A very similar strategy utilising reductive amination 
and suitably labile protecting groups has since been employed by Danishefsky and co-
workers.113
 
In addition to improving the efficiency and generality of the auxiliary syntheses, we 
were also interested in investigating some of the recent innovations in the synthesis of 
thioesters via the sulfonamide “safety-catch” strategy.  The thioesters for the test 
ligations were therefore synthesised both by the traditional safety-catch protocols and 
also by “double-linker” methodology.62  A number of thioester peptides were also 
formed using the intramolecular N to S acyl shift method previously described.173  The 
utility and efficiency of these different methods were compared. 
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II. Results and Discussion 
 
1.  Synthesis of auxiliary peptides 
 
We chose the O-linked glycoprotein GlyCAM-1 (see Figure 24) as a model system for 
the study of auxiliary-mediated ligations.  In previous work in our group, the assembly 
of GlyCAM-1 by a sequential ligation strategy had been problematic due to the 
presence of a non-native cysteine residue, which was introduced into one of the 
glycopeptide fragments to facilitate its assembly by NCL.118  The subsequent EPL of 
this fragment with a bacterially derived thioester proceeded extremely slowly, unless the 
non-native internal cysteine was capped by treatment with iodoacetamide to form a 
glutamine analogue.  We envisaged that the use of auxiliary-mediated ligation would 
allow us to avoid this problem. 
 
H2N-LPGSKDELQMKTQPTDAIPAAQSTPTSYTSEESTSSKDLSKEPSIFREELISKDNVVIESTKPENQ
EAQDGLRSGSSQ KSSQ LGKI GFVLEETTRPTTSAATTSEENLT TVEEE IE TGAEDIISGASRITKS-CO2H
102 111 11775
A B C D  
 
Figure 24: amino acid sequence of GlyCAM-1, with model junctions for ligation 
studies highlighted. A: model junction for Ser-Gly and Gly-Gly ligation studies; B: 
model junction for Lys-Gly ligation studies; C: model junction for Leu-Gly, Ala-Gly, 
Phe-Gly and Gly-Gly ligation studies; D: model junction for Gly-Ala ligation studies. 
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Four model ligation sites were used to study the effectiveness of auxiliary-mediated 
ligation for a range of ligation junctions as shown in Figure 24.  Successful ligations at 
these junctions would demonstrate the feasibility of the assembly of GlyCAM-1 with 
minor or no changes in sequence via auxiliary-mediated ligation.   
 
Target N-terminal auxiliary peptides and C-terminal thioester peptides were thus 
designed to correspond to the appropriate sequences in GlyCAM-1 and were 
synthesised as described in the following sections. 
 
 
1.1  4,5,6-trimethoxy-2-mercaptobenzyl auxiliary 
 
In the original synthesis of the 4,5,6-trimethoxy-2-mercaptobenzyl auxiliary,129 the 
protected thiol was constructed by displacement of para-methyl benzyl bromide with 
3,4,5-trimethoxy-thiophenol to form the para-methyl benzyl thioether as shown in 
Scheme 17.   This was then subjected to Vilsmeier formylation to form the aldehyde, 
and subsequently converted to 4,5,6-trimethoxy-2-mercaptobenzyl amine 9, which was 
then introduced to the N-terminus of a pre-assembled peptide via the sub-monomer 
approach as previously described.  The 3,4,5-trimethoxy-thiophenol was generated by in 


















































Scheme 17: original synthesis of 4,5,6-trimethoxy-2-mercaptobenzyl auxiliary amine 9. 
 
To improve the generality and efficiency of the route, we planned to substitute the para-
methyl benzyl protecting group with PMB or ONB protection by use of the appropriate 
benzyl halides, and also utilise a direct reductive amination with a suitably protected 
amino acid in the final step.  If successful, this last step would offer two advantages 
over the original synthesis: firstly to give a probable improvement over the original low 
yielding amination procedure, and secondly to form an amino acid “cassette” and thus 
avoid “sub-monomer” conjugation to the peptide.  Trityl protection for the thiol group 




1.1.1  Synthesis of thioethers 
 
The 3,4,5-trimethoxy-thiophenol disulfide 15 was synthesised by the procedure used in 
the original synthesis (see Scheme 18).  3,4,5-trimethoxy-aniline was subjected to 
diazotisation with sodium nitrite and HCl, then treated with an aqueous solution of 
potassium ethyl xanthate to form 14 in 39 % yield.  The initial diazotisation was 
problematic due to the acidic aniline solution solidifying on cooling, although the 
reaction mixture did slowly redissolve as the NaNO2 solution was added.  A low yield 
























14 15  
 
Scheme 18: synthesis of 3,4,5-trimethoxy-thiophenol disulfide 15. 
 
Xanthate 14 was then subjected to base hydrolysis with NaOH at 65 oC to give disulfide 
15 in 88 % yield, in sufficient purity following extraction with ethyl acetate to be used 
directly in the next reaction.  Although the expected product of hydrolysis of 14 was 
3,4,5-trimethoxy-thiophenol, only the disulfide product 15 was observed, indicating 
rapid oxidation of the thiophenol to form the disulfide.   
 
The PMB and ONB protecting groups were introduced in good yield by in situ triphenyl 
phosphine reduction of disulfide 15 to the corresponding 3,4,5-trimethoxy-thiophenol, 
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which subsequently reacted with the benzyl halide of the appropriate protecting group in 
the presence of sodium methoxide to form PMB thioether 16a or ONB thioether 16b 














16a: R = PMB (81 %)
16b: R = ONB (80  %)15  
 
Scheme 19: synthesis of auxiliary-thioethers 16a and 16b. 
 
 
1.1.2  Synthesis of thioethers via Buchwald/Hartwig coupling 
 
Although thioethers 16a and 16b could be successfully synthesised by the route 
described above, we envisaged that a shorter and more efficient synthesis could be 
carried out using a palladium-catalysed coupling between 3,4,5-trimethoxyphenyl 
bromide or triflate (17 or 18, see Table 2, p 96) and the benzyl mercaptan of the 
appropriate protecting group, thus forming the thioether in a single step.   
 
This strategy would take advantage of the methodology for palladium-catalysed 
coupling between aryl triflates or halides and thiols or amines developed by Buchwald 
and co-workers178-180 and Hartwig and co-workers181,182 (see Figure 25).  The 3,4,5-
trimethoxyphenyl bromide and 4-methoxybenzyl mercaptan starting materials for these 
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reactions are commercially available, but it was necessary to synthesise 3,4,5-















HSR + basebase-H+ X-
R = aryl, alkyl, benzyl















Figure 25: catalytic cycle for palladium-catalysed aryl-thiol coupling.177
 
3,4,5-trimethoxyphenyl triflate 18 was synthesised in excellent yield in a 
straightforward manner (see Scheme 20).  Treatment of 3,4,5-trimethoxyphenol with 
triflic anhydride in a 1:1 v/v solution of aqueous potassium phosphate and toluene 

















Scheme 20: synthesis of 3,4,5-trimethoxyphenyl triflate 18. 
 
Alkyl thiols can be prepared by treatment of the corresponding alkyl halide with 
thiourea, followed by hydrolysis.183,184  2-nitrobenzyl bromide was thus treated with 
thiourea in refluxing dioxane, followed by hydrolysis with aqueous NaOH, again under 
reflux (see Scheme 21).  The reaction mixture was subsequently acidified and extracted 
with DCM to afford 2-nitrobenzyl mercaptan 19 in 85 % crude yield.   
 
Unfortunately this product contained an impurity, which was inseparable from the 
product by chromatography.  As palladium-catalysed couplings can be very sensitive to 
















Scheme 21: synthesis of 19 by treatment with thiourea followed by hydrolysis. 
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Treatment of alkyl or benzyl halides with 1-(2-hydroxyethyl)-4,6-diphenylpyridine-2-
thione 20 has been reported by Katritzky and co-workers as a simple procedure for the 
formation of the corresponding thiols under mild and neutral conditions185 (see Scheme 
22).   
 
Addition of alkyl or benzyl halides to a solution of 20 in dry benzene results in 
formation of the pyridinium cation intermediate, which undergoes intramolecular 
nucleophilic displacement to generate the desired thiol and the insoluble pyridinium 
halide salt byproduct, which can be removed by filtration.  Good yields were reported 


















R = alkyl or benzyl group




Scheme 22: thiol formation with 1-(2-hydroxyethyl)-4,6-diphenylpyridine-2-thione 20. 
 
Reagent 20 was synthesised in two steps as shown in Scheme 23.  4,6-diphenyl-2-
pyrone was converted to thione 21 in quantitative yield by treatment with Lawesson’s 
reagent in refluxing toluene.186  21 was then treated with ethanolamine in refluxing 
methanol to afford 20 in good yield.  Treatment of 2-nitrobenzyl bromide with 20 at 
room temperature (see Scheme 22) afforded the desired 2-nitrobenzyl mercaptan 19 in 
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75 % yield following removal of the insoluble pyridinium halide salt by filtration and 




























Scheme 23: synthesis of 1-(2-hydroxyethyl)-4,6-diphenylpyridine-2-thione 20. 
 
With the required starting materials in hand, we applied published conditions187 for 
palladium catalysed aryl C – S  bond formations: heating to reflux in toluene with 
palladium acetate catalyst and the BINAP ligand and sodium t-butyloxide as base, to the 
coupling of triflate 18 and 4-methoxybenzyl mercaptan to form 3,4,5-trimethoxy-(4-
methoxybenzyl)-thioether 16a (Table 2, entry 1).   
 
Disappointingly, negligible product formation was observed under these conditions, 
even after prolonged heating.  When the same reaction was transferred to a microwave 
reactor however, heating to 120 oC at 200 W afforded 16a in 32 % isolated yield after 
only 20 minutes (entry 2).  Following this encouraging result, different bases which had 
been reported to be effective reagents for similar coupling reactions179,187 were used in 
place of NaOtBu (entries 3 – 4).  Triethylamine proved to be the most effective base, 
and a gratifying yield of 74 % was achieved when the reaction with NEt3 was conducted 








17: X = Br
18: X = OTf
16a: R = PMB
16b: R = ONB
RSH, base, BINAP, Pd(OAc)2
Toluene , heating
 
Entrya Substrate Product Base Yield 
(%) 
1 18 16a NaOtBu   < 5 
2 18 16a NaOtBu 32 
3 18 16a 10 % K3PO4 55 
4 18 16a NEt3 61 
5b 18 16a NEt3 74 
6 17 16a NaOtBu 12 
7 17 16a NEt3 24 
8 17 16a 10 % K3PO4 44 
9 18 16b     NEt3 < 5 
10 17 16b 10 % K3PO4 < 5 
 
Table 2: Palladium catalysed aryl – thiol couplings.  a) entry 1: 1.4 eq. thiol, 1.4 eq. 
NaOtBu, 11 mol % Pd(OAc)2, 11 mol % BINAP, 3 eq. LiCl, 80 oC, 24 hours; entries 2-
10: 1.4 eq. thiol, 1.4 eq. base, 11 mol % Pd(OAc)2, 11 mol % BINAP, 120 oC 
microwave heating, 200 W, 20 minutes; b) reaction performed under Ar atmosphere.  
BINAP: 1,1-binaphthalene-2,2-diylbis-(diphenylphosphine) 
 
Commercially available 3,4,5-trimethoxyphenyl bromide 17 proved to be a poorer 
substrate for the coupling reaction than triflate 18 (entries 6 – 8).  The best results for 
coupling of 17 were obtained with aqueous potassium phosphate as the base (entry 8).  
Unfortunately, the best coupling conditions for both 17 and 18 were unsuccessful for 
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their coupling with 2-nitrobenzyl mercaptan 19 to form 3,4,5-trimethoxy-(2-
nitrobenzyl)-thioether 16b (entries 9 – 10).  Electron-deficient thiols such as 19 have 
previously been reported to be poor substrates for these coupling reactions.182
 
Further optimisation studies for the formation of thioether 16a from triflate 18, using a 
range of different solvents, bases and catalysts, were performed using an automated 
parallel microwave reactor and HPLC analysis.  In addition to those reagents previously 
studied, the 1,1-bis-(diisopropylphosphino)-ferrocene (DiPPF)180 and PPh3 ligands, the 
catalyst [(tBu)2P(OH)]2PdCl2 (POPd)188 and Cs2CO3 as base were also investigated   
The trial reactions were carried out under the conditions shown and the results are 
shown in Table 3.  The most significant results are highlighted.   
 
An increase in reaction temperature to 150 oC resulted in a small increase in yield over 
the previous best conditions.  More dramatic results were observed on changing the 
solvent, with DMF and dioxane particularly effective.  DiPPF and triethylamine was 
found to be the most effective ligand-base combination, affording thioether 16a in near-
quantitative yield with dioxane as solvent.  Triethylamine was again the most effective 
base for each of the three catalyst systems used.  The POPd catalyst gave poor yields of 
16a in the presence of NEt3, and no observable product with the other bases.  
Triphenylphosphine was completely ineffective as a ligand in all trials (results not 
tabulated).  These two results confirm the previously reported importance of aromatic 
ligands for these coupling reactions182 and in particular the requirement for bidentate 
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Base Yield (%) 
Pd(OAc)2 BINAP NEt3 76 85 78 36 0 
Pd(OAc)2 BINAP NaOtBu 28 48 58 53 39 
Pd(OAc)2 BINAP K3PO4 3 5 48 36 33 
Pd(OAc)2 BINAP Cs2CO3 0 4 67 0 0 
Pd(OAc)2 DiPPF NEt3 28 90 97 92 28 
Pd(OAc)2 DiPPF NaOtBu 16 0 59 0 47 
Pd(OAc)2 DiPPF K3PO4 10 15 79 18 50 
Pd(OAc)2 DiPPF Cs2CO3 7 25 74 13 51 
POPd - NEt3 4 37 30 33 17 
POPd - NaOtBu 0 0 0 0 0 
POPd - K3PO4 0 0 0 0 0 
POPd - Cs2CO3 0 0 0 0 0 
 
Table 3: HPLC results for coupling optimisation studies. 
 
Use of the best conditions from these trials (DiPPF with NEt3 in dioxane) on a 
preparative scale afforded 16a in a yield of 97 %, identical to that observed by HPLC 
analysis.  Very similar results have subsequently been reported for these couplings 
under microwave conditions.189  Formation of the ONB thioether 16b with the 
optimised conditions for the formation of 16a was not attempted to due to problems 
encountered with the ONB protecting group at a later stage (see Section 1.1.4). 
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1.1.3  Synthesis of auxiliary-amino acid cassettes 
 
Following formation of PMB and ONB thioethers 16a and 16b, the next step was 
preparation of the corresponding auxiliary aldehydes 10a and 10b as precursors for the 
key direct reductive amination.  16a and 16b were thus subjected to Vilsmeier 
formylation.  We were initially concerned that the PMB protecting group might be 
unstable to the HCl byproduct generated by Vilsmeier formylation (see Figure 26) 
































































































Figure 26: mechanism of Vilsmeier formylation. 
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The reaction was therefore initially conducted at a lower temperature (90 oC) for a 
longer duration of 16 hours with PMB thioether 16a.  Unfortunately this procedure 
afforded 4,5,6-trimethoxy-2-(4-methoxybenzylthio)-benzaldehyde 10a in only 49 % 
yield.  Heating at 150 oC as in the original synthesis afforded 10a in an excellent yield 
of 90 %, although longer reaction times for both the formation of the intermediate 
iminium cation and the hydrolysis step were necessary.  Care was required to avoid 
evaporation of the DCM solvent to dryness under the high reaction temperatures, as best 
results were obtained when the minimum volume of solvent was used to ensure a highly 
concentrated reaction.  Saturated sodium bicarbonate solution was used in the 
hydrolysis step to minimise the chance of product degradation due to the HCl 
byproduct.  ONB thioether 16b was a less good substrate for this reaction due to its 
poorer solubility in DCM.  The high concentration necessary for an effective reaction 
was therefore more difficult to achieve.  As a result of these difficulties, ONB aldehyde 


























16a: R1 = PMB
16b: R1 = ONB
DCM, 2 % AcOH
DMF, POCl3
DCM, 0 oC - 140 oC
10a: R1 = PMB (90 %)
10b: R1 = ONB (55 %)
22a: R1 = PMB, R2 = H (93 %)
22b: R1 = ONB, R2 = H (93 %)
22c: R1 = PMB, R2 = Me (96 %)
22d: R1 = PMB, R2 = CH2OtBu (94 %)  
 
Scheme 24: synthesis of t-butyl protected auxiliary-amino acids 22a – 22d. 
 
Auxiliary aldehydes 10a and 10b were then subjected to reductive amination with the t-
butyl esters of glycine, alanine and serine in the presence of sodium 
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triacetoxyborohydride in DCM with 2 % acetic acid added as a catalyst (see Scheme 
24).  The t-butyl protected acids were used to aid subsequent purification.   
 
All of these reactions were practically very straightforward and proceeded rapidly to 
give protected auxiliary-amino acids 22a – 22d in excellent yields after simple 
purification by column chromatography.  This was especially gratifying in comparison 
with the poor yield for the formation of the 4,5,6-trimethoxy-2-mercaptobenzyl amine 9 
via a prolonged two-step procedure at this stage in the original synthesis. 
 
The final step in the synthesis was protecting group manipulation to remove the t-butyl 
ester protection (and the t-butyl ether side chain protecting group for serine) and install 
the Fmoc protecting group to give the auxiliary-amino acid "cassettes" ready for 
conjugation to a peptide by standard SPPS.  We planned to accomplish this by removal 
of the t-butyl protecting groups with aqueous TFA, followed by treatment with Fmoc-
succinimide in the presence of triethylamine in a 1:1 v/v mixture of acetonitrile and 
water to install the Fmoc protecting group.   
 
This apparently straightforward protecting group manipulation proved problematic, 
however.  Although TFA deprotection went to completion in each case as monitored by 
TLC, the Fmoc protection step proceeded very sluggishly, with prolonged reaction 
times and a second addition of reagents necessary.  A column chromatography step was 
also necessary to isolate the Fmoc-protected products in sufficient purity.  The Fmoc-
protected auxiliary-glycine cassettes 11a and 11b were formed in 67 % and 71 % yield 
respectively (see Scheme 25), but Fmoc protection of the more sterically bulky alanine 
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and serine derivatives derived from 22c and 22d was extremely difficult.  The Fmoc-
protected alanine derivative was isolated in only 8 % yield after overnight reaction, and 



















22a: R1 = PMB, R2 = H
22b: R1 = ONB, R2 = H
22c: R1 = PMB, R2 = Me
22d: R1 = PMB, R2 = CH2OtBu
11a: R1 = PMB, R2 = H (67 %)
11b: R1 = ONB, R2 = H (71 %)






Scheme 25: synthesis of Fmoc-protected auxiliary-glycine cassettes 11a and 11b. 
 
The purpose of the Fmoc protecting group was to ensure that byproducts arising from 
the acylation of auxiliary-amino acids with the activated esters of the same species were 
not formed during conjugation to the solid phase peptide.  However, as the steric bulk 
around the secondary amines of alanine and serine appeared to inhibit acylation of these 
auxiliary-amino acids with Fmoc-succinimide, it seemed likely that acylation with the 
activated ester of a second molecule of auxiliary-amino acid would suffer the same 
inhibitory effect, and thus Fmoc protection might not be required at all for these 
compounds.   
 
N-4,5,6 - trimethoxy- 2-(4-methoxybenzylthio)benzyl alanine 11c and N-4,5,6 - 
trimethoxy- 2-(4-methoxybenzylthio)benzyl serine 11d were therefore isolated by 
column chromatography following t-butyl deprotection in 76 % and 71 % yields 
respectively (see Scheme 26).  These somewhat low yields were mainly due to the 
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practical difficulties associated with chromatographic isolation of the polar free acid 



















22c: R1 = PMB, R2 = Me
22d: R1 = PMB, R2 = CH2OtBu
95 % aq. TFA
0 oC
11c: R1 = PMB, R2 = Me (76 %)
11d: R1 = PMB, R2 = CH2OH (71 %)  
 
Scheme 26: synthesis of auxiliary-alanine cassette 11c and auxiliary-serine cassette 
11d. 
 
PMB protected auxiliary-amino acid cassettes 11a, 11c and 11d ready for use in SPPS 
were thus synthesised in four steps in good overall yields (54 % - 64 %) utilising a 
highly efficient novel palladium catalysed aryl – thiol coupling reaction and direct 
reductive amination.   
 
This route therefore represents a considerable improvement over the original synthesis, 
being shorter and higher yielding and compatible with sensitive peptide modifications 
due to the use of the PMB protecting group, and it also avoids the need for “sub-
monomer” peptide conjugation and the associated extra steps.  ONB-protected 
auxiliary-amino acid cassettes such as 11b could also be formed by a longer route.  
Optimisation of the synthesis of ONB-protected auxiliaries was not carried out due to 
problems subsequently encountered during attempted removal of the ONB protecting 
group (see section 1.1.4). 
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1.1.4  Synthesis of auxiliary-peptides 
  
Peptides corresponding to fragments of the glycoprotein GlyCAM-1 were synthesised 
on NovaSyn®TGT resin preloaded with serine with a loading of 0.22 mmol/g (see 











































































































=  Fmoc-Ser Novasyn TGT resin
R1 - Rn  =  amino acid side chains
Ra = PMB, ONB
Rb = H, Me
Rc = H, Fmoc
HOBt / HBTU
DIPEA,  DMF




x = 3 to n-1




Scheme 27: Fmoc SPPS of auxiliary peptides. 
 
Synthesis was conducted on a 0.05 mmol scale by manual Fmoc SPPS, using 10 
equivalents of each Fmoc amino acid per coupling and HBTU/HOBt coupling reagents 
 104
in the presence of Hünigs base.  Fmoc protecting group removal was carried out with 20 
% v/v piperidine in DMF.  Synthesis was monitored by the Kaiser ninhydrin test190 and 
LC-MS analysis of samples of the peptide.   
 
Auxiliary-amino acid cassettes 11a – 11c were coupled to peptides A - C, 
corresponding to fragments of GlyCAM-1, using five equivalents of amino acid and 
coupling reagents (see Scheme 28).  These couplings went to completion as monitored 
by LC-MS.  This result was especially significant in the case of auxiliary-alanine 
cassette 11c as the reported formation of an N-terminal alanine peptide bearing the 
4,5,6-trimethoxy-2-mercaptobenzyl auxiliary by the sub-monomer approach occurred in 
only 50 % yield.129  No evidence of coupling of auxiliary dipeptides or other byproducts 
resulting from acylation of the secondary amine of 11c was detected, confirming that 
Fmoc protection was not necessary for the auxiliary-alanine cassette.   
 
Following coupling of auxiliary-glycine cassettes 11a and 11b to peptides A and B, the 
Fmoc protecting groups were removed from the resulting solid phase peptides by 
treatment with 20 % v/v piperidine in DMF as before (see Scheme 28).  The resulting 
peptides were then cleaved from the resin with concomitant side chain deprotection by 
treatment with 95 % v/v TFA, with 2.5 % v/v ethanedithiol (EDT) as a scavenger 
reagent.  Following coupling of auxiliary-alanine cassette 11c to peptide C, the resulting 
peptide could be cleaved directly from the solid phase, as the Fmoc deprotection step 
was not necessary in this case. 
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Each of the crude peptides was then purified by semi-preparative reverse-phase HPLC 
to afford peptides 23a - 23c bearing the PMB-protected auxiliary, and peptide 23d 












































































HOBt/HBTU,  DIPEA, DMF
1)
2) 20 % piperidine, DMF
3) 95 % TFA, 2.5 % EDT, 2.5 % H2O
11a
HOBt/HBTU,  DIPEA, DMF
1)
2) 20 % piperidine, DMF
3) 95 % TFA, 2.5 % EDT, 2.5 % H2O
11a
HOBt/HBTU,  DIPEA, DMF
1)
2) 95 % TFA, 2.5 % EDT, 2.5 % H2O
HOBt/HBTU,  DIPEA, DMF
1)
2) 20 % piperidine, DMF
3) 95 % TFA, 2.5 % EDT, 2.5 % H2O
11c
11b
peptide A: GlyCAM-1 101-132 = SQTVEEELGKIIEGFVTGAEDIISGASRITKS
peptide B: GlyCAM-1 110-132 = KIIEGFVTGAEDIISGASRITKS
peptide C: GlyCAM-1 116-132 = VTGAEDIISGASRITKS  
 
Scheme 28: synthesis of PMB-protected auxiliary peptides 23a - 23c and ONB-
protected auxiliary peptide 23d. 
 
The semi-preparative HPLC trace for the purification of PMB-protected auxiliary-
glycine peptide 23b and the electrospray (ESI) mass spectrum for the isolated product 
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are shown in Figure 27.  The fragment ion peak due to cleavage of the auxiliary at the 
benzylic position appears to be characteristic of the auxiliary species and was generally 














Figure 27: isolation of auxiliary-glycine peptide 23b.  A: 254 nm UV
purification; B: ESI positive ion mass spectrum of purified 23b (calculate
Da, observed: 1392.0 Da [MH2]2+, 1225.8 Da [M-AuxH2]2+) showi





 trace of HPLC 
d mass = 2782.2 
ng characteristic 
peptide B = 
The PMB protecting group was removed from peptides 23a – 23c by treatment with 
excess mercury(II)acetate in 10 % v/v aqueous acetic acid.  The reaction mixture was 
quenched by the addtion of solid dithiothreitol (DTT) to a final concentration of 5 % 
w/v and shaking for one hour, after which the thick white precipitate was removed and 
the resulting solution was purified by semi-preparative HPLC to afford peptides 24a - 


























































peptide A: GlyCAM-1 101-132 = SQTVEEELGKIIEGFVTGAEDIISGASRITKS
peptide B: GlyCAM-1 110-132 = KIIEGFVTGAEDIISGASRITKS
peptide C: GlyCAM-1 116-132 = VTGAEDIISGASRITKS  
 
Scheme 29: Removal of PMB protecting group: a) 10 % v/v AcOH, Hg(OAc)2, 
followed by 5 % w/v DTT. 
 
A direct relationship was observed between the size of the peptide and the time taken 
for completion of the reaction.  Deprotection of the shorter peptide 23c was complete 
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when quenched after one hour, whereas overnight reaction was required for the 
deprotection of the larger peptide 23a (see Scheme 29).  The HPLC trace for the 
purification of auxiliary-peptide 4b and the ESI mass spectrum for the isolated product 


















Figure 28: isolation of auxiliary-glycine peptide 24b.  A: 254 nm UV trace of HPLC 
purification; B: ESI positive ion mass spectrum of purified 24b (calculated mass =  
2662.02 Da, observed: 1331.8 Da [MH2]2+, 1225.8 Da [M-AuxH2]2+, 888.4 Da [MH3]3+, 
817.6 Da [M-AuxH3]3+).  peptide B = KIIEGFVTGAEDIISGASRITKS. 
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Deprotection of ONB-protected auxiliary-glycine peptide 23d was attempted by UV 
photolysis under published conditions for the removal of this protecting group from 
cysteine.192  A degassed solution of the peptide in 1:1 v/v acetonitrile/PBS buffer (pH 
6.0), containing L-(–)-ascorbic acid as an antioxidant and semicarbazide hydrochloride 
as a carbonyl scavenger, was subjected to photolysis at 365 nm for two hours (see 
Scheme 30).  Unfortunately, no evidence of the deprotected product was observed by 
mass spectrometry.  Instead only the ONB protected starting material 23d was observed, 
along with multiple similar signals assumed to be due to peptide degradation.  










hυ (365 nm), additives




peptide B = KIIEGFVTGAEDIISGASRITKS  
 
Scheme 30: attempted photolytic removal of ONB protecting group from auxiliary-
glycine peptide 23d. 
 
In summary, although the failure of the photolytic ONB deprotection represented a 
setback, 4,5,6-trimethoxy-2-mercaptobenzyl auxiliary-peptides could be efficiently 
assembled using PMB-protected building blocks, which could be rapidly synthesised in 
high yield via: 1) palladium catalysed aryl – thiol coupling; 2) Vilsmeier formylation; 3) 
direct reductive amination with amino acid t-butyl ester; 4) protecting group 
manipulation.  PMB-protected auxiliary-glycine and auxiliary-alanine building blocks 
were efficiently incorporated into peptides using standard SPPS.  Following cleavage 
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from the solid phase, removal of the PMB protecting group with mercury acetate in 
acetic acid afforded the auxiliary-peptides 24a – 24c ready for use in cysteine-free 
peptide ligation.  Results for the ligation and auxiliary removal studies conducted with 
these substrates are presented in section 3. 
 
 
1.2  Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) auxiliary 
 
Peptides bearing the Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) auxiliary 6 were 
constructed according to the strategy shown in Figure 29.  The ketones 12a and 12b, 
containing the protected thiol group, were formed by displacement of the commercially 





















13a: R1= PMB, R2 = H
13b: R1= Trt, R2 = H
13c: R1= Trt, R2 = Me
6a-6d: R3 = peptide
 
 
Figure 29: synthetic strategy for Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) 
auxiliary peptides 
 
Direct reductive amination with the appropriate amino acid afforded the auxiliary-amino 
acid cassettes 13a - 13c, which were incorporated into peptides by standard SPPS.  It 
was possible to use unprotected amino acids for the reductive amination and hence 
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avoid a further deprotection step.  Alternatively, the ketone could be converted to the 
primary amine by treatment with ammonium bicarbonate to form the Nα-(1-(2,4-
dimethoxyphenyl)-2-mercaptoethyl amine for conjugation to a peptide via the 
submonomer approach.  Following SPPS, the thiol protecting group was removed to 
afford the desired peptides 6a – 6d. 
 
 
1.2.1  Synthesis of auxiliary-amino acid cassettes and amines 
 
The original route for the synthesis of Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)-
peptides132 was reported in very little detail (see Scheme 31).  It involved displacement 
of 2-bromo-2,4-dimethoxyacetophenone with para-methylbenzyl mercaptan to form 2-
keto-2-(2,4-dimethoxyphenyl) (S-paramethylbenzyl) ethanethiol, followed by a two step 
amination-reduction procedure to afford the auxiliary benzylamine 2-amino-2-(2,4-
dimethoxyphenyl) (S-paramethylbenzyl) ethanethiol, which was conjugated to a peptide 













DIPEA 2)  Reduction
 
 
Scheme 31: original synthesis of Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl amine. 
 
The more recently published route to Nα-(1-(2-nitrophenyl)-2-mercaptoethyl)-
peptides135 involves a multistep synthesis of the trityl-protected auxiliary-benzylamine, 
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which is again used for submonomer conjugation to a peptide.  We envisaged that a 
more efficient synthesis would involve introduction of the protected thiol by 
displacement of 2-bromo-2,4-dimethoxyacetophenone as in the original synthesis, with 
the replacement of the para-methylbenzyl group with PMB or trityl protection to allow 
the use of deprotection conditions compatible with glycosylated peptides.  A single-step 
direct reductive amination with the appropriate amino acid would then afford the 
auxiliary-amino acid cassette 13 for incorporation into a peptide by standard SPPS, as 
for the 4,5,6-trimethoxy-2-mercaptobenzyl auxiliary 4. 
 
PMB- and trityl-protected ketones 2-keto-2-(2,4-dimethoxyphenyl) (S-
paramethoxybenzyl) ethanethiol 12a and 2-keto-2-(2,4-dimethoxyphenyl) (S-trityl) 
ethanethiol 12b were formed in excellent yield by straightforward displacement of 
commercially available 2-bromo-2,4-dimethoxyacetophenone with the appropriate thiol 
reagent (see Scheme 25).  The ONB protecting group was not investigated due to the 
problems experienced with its removal (see section 1.1.4).   
 
Disappointingly, the conditions which had afforded the 4,5,6-trimethoxy-2-
mercaptobenzyl-amino acids 22a – 22d in high yield were unsuccessful for the less 
reactive acetophenones 12a and 12b (see Scheme 32).  No reaction was observed on 
stirring for four hours at room temperature.  Increasing the reaction temperature 
afforded a mixture of the starting ketone and the 2-(4-methoxybenzyl)-2,4-
dimethoxyacetophenyl alcohol 25 arising from ketone reduction by sodium 
triacetoxyborohydride.  The large difference in reactivity between benzaldehydes and 
the acetophenones was illustrated by the successful reductive amination of the related 
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2,4-dimethoxybenzaldehyde under identical conditions to afford N-2,4-



































DCM, 2 % AcOH
rt - reflux
12     +
DCM, 2 % AcOH
26 (94 %)
12a: R = PMB (98 %)




Scheme 32: formation of ketones 12a and 12b and attempted reductive amination. 
 
A range of different reductive amination conditions were attempted for the formation of 
the auxiliary-amino acid cassette (see Scheme 33).  A two-step procedure involving 
Lewis-acid catalysed amination followed by reduction with the stronger reducing agent 
sodium borohydride resulted in formation of alcohol 25 only.  The use of higher 
temperatures and microwave heating in the presence of either an acid or base catalyst 
was also unsuccessful, as only the starting ketone 12a was observed by TLC and MS 
analysis in both cases.  Conversion of the ketone to the corresponding oxime with 
methoxylamine as a precursor of the auxiliary-benzylamine, as in the original synthesis, 
was also unsuccessful, as were attempts to form the primary benzylamine via two-step 
amination-reduction and microwave-assisted amination, which resulted in formation of 
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alchol 25, and no reaction, respectively.  Similar difficulties with the reductive 





























1) H2NOH,  NEt3,  DCM









Scheme 33: unsuccessful reductive aminations.  PPTS: pyridinium para-
toluenesulfonate. 
 
The difficulties encountered with the reductive amination of the 12a prompted us to 
consider alternative methods for the introduction of the amino acid.  We therefore 
examined the possibility of formation of the auxiliary-amino acid cassette via 
displacement of the benzyl halide or sulfonate.  12a was first reduced to racemic alcohol 
25 in high yield by treatment with sodium borohydride.  This was then converted into 2-
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chloro-2-(2,4-dimethoxyphenyl) (S-paramethoxybenzyl) ethanethiol by reaction with 
thionyl chloride in DCM (see Scheme 34).  As the product was unstable to 
chromatography, the crude product obtained following work up was treated directly 
with glycine t-butyl ester in the presence of Hünigs base.  No product could be isolated 
from this reaction, however.  It is likely that decomposition of the unstable benzyl 
















12a 25 (89 %)
MeOH






Scheme 34: formation of 2-chloro-2-(2,4-dimethoxyphenyl) (S-paramethoxybenzyl) 
ethanethiol and attempted displacement. 
 
Unfortunately 2-bromo-2-(2,4-dimethoxyphenyl) (S-paramethoxybenzyl) ethanethiol, 
prepared by treatment of 25 with either hydrobromic acid in acetic acid, or with carbon 
tertrabromide in the presence of triphenylphosphine, as shown in Scheme 35, was 
similarly unstable.  Although alcohol 25 was fully consumed in the initial reactions, 
isolation of the product in sufficient purity for NMR identification was problematic, and 
mass spectrometry of the crude product was also inconclusive.  No product formation 
was observed on treatment of the crude reaction mixtures with glycine t-butyl ester as 
above.  Similar problems with such benzyl halides have been previously reported.193   
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We also attempted the conversion of alcohol 25 to the corresponding benzyl triflate, by 
treatment with triflic anhydride and pyridine, and to the benzyl tosylate, by treatment 
with tosyl chloride and pyridine, but these reactions were also unsuccessful as the 




























DCM,  0 oC - RT
TsCl,  pyridine










could not be isolated
could not be isolated
 
 
Scheme 35: formation of 2-bromo-2-(2,4-dimethoxyphenyl) (S-paramethoxybenzyl) 
ethanethiol and benzyl sulfonates and attempted displacements. 
 
The low stability of these benzyl halides and sulfonates is likely to be due to favourable 
elimation of the halide or sulfonate group, due to stabilisation of the resulting 
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carbocation by the phenyl ring methoxy substituents, or possibly by intramolecular 
nucleophilic attack of the sulfur atom to form a three-membered ring sulfonium cation 
and subsequent elimination of the PMB group to form the 2,4-dimethoxyphenyl 
thiirane. 
 
A further possible route to the desired auxiliary-amino acids was also investigated.  
Benzophenone Schiff base derivatives of amino acids, such as 27, can be formed via 
transimination by simply adding benzophenone imine to the appropriate amino acid 
derivative (see Scheme 36).194  We envisaged that conversion of ketone 12a to the 
corresponding imine 28, followed by addition of glycine t-butyl ester, might therefore 
result in the formation of imine intermediate 29, which could then be reduced to the 
desired product. 
 
As a trial of this approach, benzophenone glycine t-butyl ester 27 was formed as shown 
in a crude yield of 80 %.  Although TLC analysis indicated complete reaction and 27 
was detected by mass spectrometry of the crude product following work up, only a 
small amount (2 %) of the product was isolated by column chromatography.  The major 
product isolated from the column was in fact benzophenone, arising from 
decomposition of the imine product during chromatography.   
 
Despite this problem, we envisaged that this approach could still be successful if 
chromatographic purification was avoided until the final step.  Ketone 12a was thus 
treated with ammonia in the presence of titanium tetrachloride.  TLC and mass 
spectrometry analysis of the crude product of this reaction following work up were 
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inconclusive.  Upon addition of glycine t-butyl ester to a solution of the crude product 
however, evolution of gas was observed, consistent with imine formation in the first 
step.  TLC analysis of the reaction was again inconclusive, but the transiminated 
product 29 was detected by mass spectrometry of the crude product following work up.  
Treatment of the crude product with sodium borohydride however, afforded only 
alcohol 25.  This suggests that, although formation of imine intermediate 29 appeared to 
occur to some extent, it had rapidly broken down to regenerate ketone 12a, despite the 
























































80 % crude yield
 
 
Scheme 36: transimination strategy. 
 
At this stage we decided to revisit our original reductive amination approach, as both 
the intermediate benzyl halides for the displacement approach and the benzylimine for 
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the transimination approach appeared too unstable to be practically useful.  Successful 
conditions for this transformation were eventually developed, based upon a method used 
for similar substrates by Williams and co-workers.195   
 
Treatment of ketones 12a and 12b with ammonium acetate and sodium 
cyanoborohydride in refluxing methanol for 24 – 48 hours afforded the Nα-(1-(2,4-
dimethoxyphenyl)-2-mercaptoethyl) amines 30a and 30b, which can be used for the 




















12a: R1 = PMB
12b: R1 = Trt
30a: R1 = PMB (79 %)





Scheme 37: formation of Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) amines 30a 
and 30b. 
 
PMB-protected benzylamine 30a could be easily isolated by acidification of the reaction 
mixture and washing with Et2O to remove unreacted 12a.  Adjustment of the pH of the 
aqueous fraction to pH ≈ 10 with powdered potassium hydroxide, followed by 
extraction with DCM, afforded 30a in good yield and purity.  This acid-base extraction 
procedure was not possible for 30b due to the acid-lability of the trityl protecting group, 
and therefore it was necessary to purify this product by column chromatography.  The 
difficult isolation of the product from a close-running impurity contributed to the lower 
yield of 30b.   
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These encouraging results prompted us to attempt formation of our preferred target 
auxiliary-amino acid cassettes under the same conditions.  Gratifyingly, unprotected 
glycine and alanine were sufficiently soluble under the reaction conditions for 
successful reductive amination to occur in 77 – 55 % yield to afford auxiliary amino 

























12a: R1 = PMB
12b: R1 = Trt
13a: R1 = PMB, R2 = H (77 %)
13b: R1 = Trt, R2 = H (58 %)





Scheme 38: synthesis of auxiliary-amino acid cassettes 13a – 13c. 
 
Slightly longer reaction times were required than for amination with ammonium acetate.  
The addition of a small amount of DCM to the reaction mixture was found to aid 
formation of trityl-protected cassettes 13b and 13c by increasing the solubility of the 
starting ketone 12b, although a lower yield for these products relative to the PMB 
species was observed as seen for amine 30b.  The use of unprotected amino acids 
enabled formation of cassettes 13a – 13c in a single step, without the further 
deprotection step required for the 4,5,6-trimethoxy-2-mercaptobenzyl auxiliaries.  The 
high polarity of 13a – 13c did cause some difficulties during chromatographic 
purification however, which led to a slight decrease in yield in each case.  Auxiliary-
alanine cassette 13c was isolated as a 3:2 mixture of diastereomers.   
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Based upon the discovery that Fmoc protection was not necessary for the amino group 
of the 4,5,6-trimethoxy-2-mercaptobenzyl auxiliary-alanine cassette 11c, we reasoned 
that Fmoc protection would also not be required for glycine cassettes 13a and 13b, 
where the amino group is similarly adjacent to a tertiary carbon centre, and alanine 
cassette 13c, where the amine group lies between two tertiary carbons.   
 
PMB and trityl protected auxiliary-amino acid cassettes 13a – 13c ready for use in SPPS 
were thus synthesised in only two steps in good overall yields (53 % - 75 %) utilising 
direct reductive amination of initially unreactive ketones 12a and 12b with the 
unprotected amino acid.  This synthesis again represents a considerable improvement 
over the original route, being shorter and higher yielding and compatible with sensitive 
peptide modifications due to the use of the PMB and trityl protecting groups.  Auxiliary 
benzylamines 30a and 30b for use in sub-monomer strategies could also be formed in 
good yield by this route. 
 
A similar strategy for the assembly of the Nα-(1-(4-methoxyphenyl)-2-mercaptoethyl) 
auxiliary 5 via reductive amination of the corresponding ketone with an amino acid to 
form an auxiliary-amino acid cassette has since been used by Botti and co-workers.133  
This synthesis utilised the para-methylbenzyl protecting group however, and involved a 
less straightforward two-step amination reduction procedure.  Use of amino acid ethyl 
esters for the reductive amination also necessitated a further deprotection step.  This 
group also noted the difficulty of Fmoc protection of the auxiliary-amino acid cassette 
and the possibility of successful coupling of the unprotected cassette, although careful 
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control of the reaction appeared to be necessary to avoid side reactions under the 
coupling conditions used. 
 
 
1.2.1  Synthesis of auxiliary-peptides 
 
Peptides 31a – 31c and glycopeptide 31d bearing the Nα-(1-(2,4-dimethoxyphenyl)-2-
mercaptoethyl) auxiliary were synthesised on NovaSyn®TGT resin preloaded with 
serine as described for auxiliary 4.  Synthesis was conducted on a 0.05 mmol scale by 
manual Fmoc SPPS, using 10 equivalents of each Fmoc amino acid per coupling and 
HBTU/HOBt coupling reagents in the presence of Hünigs base.  Fmoc removal was 
carried out with 20 % v/v piperidine in DMF.  Glycopeptide 31d was prepared using the 
Fmoc-Ser[(OAc)3GalNAc]-OH cassette, prepared and incorporated as described in 
reference 196.  Synthesis was monitored by the Kaiser ninhydrin test190 and LC-MS 
analysis of samples of the peptide.   
 
Auxiliary-amino acid cassettes 13a – 13c were coupled to peptides A - C and 
glycopeptide D, corresponding to fragments of GlyCAM-1, using five equivalents of 
amino acid and coupling reagents (see Scheme 39).  The couplings of both auxiliary-
glycine cassettes 13a and 13b and auxiliary-alanine cassette 13c went to completion as 
monitored by LC-MS, with no evidence of coupling of auxiliary dipeptides or other 
byproducts resulting from acylation of the secondary amine of 13a – 13c.  This result is 
in contrast with the suggestion by Botti and co-workers that this coupling step must be 
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HOBt/HBTU,  DIPEA, DMF
1)
HOBt/HBTU,  DIPEA, DMF
1)
13b
HOBt/HBTU,  DIPEA, DMF
1)
2) 95 % TFA, 2.5 % EDT, 2.5 % H2O
13c
13a
peptide A: GlyCAM-1 101-132 = SQTVEEELGKIIEGFVTGAEDIISGASRITKS
peptide B: GlyCAM-1 110-132 = KIIEGFVTGAEDIISGASRITKS
peptide C: GlyCAM-1 116-132 = VTGAEDIISGASRITKS
peptide D: GlyCAM-1 76-83 = SSQLEET(GalNAc(OAc)3)S
2) 95 % TFA, 2.5 % EDT, 2.5 % H2O
2) 95 % TFA, 2.5 % EDT, 2.5 % H2O
HOBt/HBTU,  DIPEA, DMF
1)
13b






Scheme 39: synthesis of auxiliary peptides 31a - 31c and PMB-protected auxiliary 
glycopeptide 31d. 
 
Following coupling of cassettes 13a - 13c, the resulting peptides were cleaved from the 
resin with concomitant side chain deprotection by treatment with 95 % v/v TFA, with 
2.5 % v/v ethanedithiol (EDT) as a scavenger reagent.  The trityl thiol protecting group 
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was also cleaved in this step (see Scheme 39).  The crude peptides were then purified 
by semi-preparative reverse-phase HPLC to afford auxiliary-peptides 31a – 31c in 10 % 
- 13 % overall yield as shown and PMB-protected auxiliary-glycopeptide 31d.  The ESI 














Figure 30: ESI positive ion mass spectrum of purified 31b, showing characteristic 
fragmentation of auxiliary at the benzylic position (calculated mass = 2646.0 Da, 
observed: 1323.9 Da [MH2]2+, 1225.9 Da [M-AuxH2]2+, 883.2 Da [MH3]3+, 817.7 Da [M-
AuxH3]3+).  peptide B = KIIEGFVTGAEDIISGASRITKS. 
 
Removal of the PMB protecting group from glycopeptide 31d was initially attempted 
under the conditions which had been successful for deprotection of 4,5,6-trimethoxy-2-
mercaptobenzyl-peptides 23a – 23c (see Scheme 40).  Treatment of 31d with 
mercury(II)acetate in aqueous acetic acid, followed by the addition of DTT, had little 
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effect in this case however and only a minimal amount of the deprotected product was 
formed (black trace, Figure 31).  The use of neat TFA at 0 oC instead of aqueous acetic 
acid however, led to almost complete deprotection within 10 minutes as shown by the 

























































































10 % AcOH, Hg(OAc)2





Scheme 40: removal of PMB protection from auxiliary-glycine glycopeptide 31d. 
 
In summary, Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)-peptides could be 
efficiently assembled using either trityl- or PMB-protected building blocks, which could 
be synthesised in good yield in only two steps.  Fmoc protection was not required for 
alanine or glycine building blocks.   The trityl group was cleaved concomitantly with 
release from the solid phase to afford auxiliary-peptides 31a – 31c ready for use in 
cysteine-free peptide ligation.  Adapted deprotection conditions for the removal of the 
PMB protecting group were applied to glycopeptide 31d to afford auxiliary-
































Figure 31: deprotection of auxiliary glycopeptide 31d.  A: HPLC purification UV 
traces for PMB deprotection of 31d.  Black trace: 10 % v/v AcOH, Hg(OAc)2, 0 oC – 
RT, 1 hour, then 5 % w/v DTT, 1 hour; blue trace: neat TFA, Hg(OAc)2, 0 oC, 10 
minutes, then 10 % v/v TFA, 5 % w/v DTT, 1 hour.  B: ESI positive ion mass spectrum 
of purified 32 (calculated mass = 1462.5, observed: 1462.7 [M]+, 1266.9 [M-Aux]+).  A 
fragment peak (937.3) due to loss of auxiliary and peracetylated GalNAc is also seen. 
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2.  Synthesis of thioester peptides 
 
Following the successful synthesis of the auxiliaries and their efficient incorporation 
into peptides, short thioester peptides were required to test the auxiliary-mediated 
ligation reaction for a range of ligation junctions.  The sulfonamide “safety-catch” 
method was chosen for the synthesis of the thioester peptides due to previous 
experience of this approach in our group.85,118,196  The adoption of this approach also 
allowed us to investigate some of the recent innovations in this area, specifically the use 
of the “double-linker” methodology62 and the formation of thioesters via intramolecular 
N to S acyl shift173 (see introduction, section 2.3.10). 
 
 
2.1  Sulfonamide safety catch peptides: initial coupling with DIPCDI 
 
The target thioester peptides had the sequences GLRG, AEEEA, AEEEF and AALTK.  
These were based on fragments of GlyCAM-1 and were designed to allow a range of 
ligation junctions to be examined.  The initial synthesis of the C-terminal alanine, 
phenylalanine and lysine peptides was conducted on a 0.05 mmol scale on 4-
sulfamylbutyryl safety catch resin with a loading of 1.1 mmol/g.  Coupling of the C-
terminal amino acid was carried out in DCM/DMF (4:1 v/v) with 
diisopropylcarbodiimide (DIPCDI) and 1-methyl imidazole (NMI), using four 
equivalents of each reagent and the appropriate Fmoc-protected amino acid. (see 
Scheme 41)  This coupling was repeated as the initial coupling can be inefficient for 
safety catch resins.170,171   
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Elaboration of the peptide was then conducted by standard SPPS using HOBt/HBTU 
coupling with five equivalents of each Fmoc-amino acid exactly as described for the 
synthesis of the auxiliary-peptides.  In each case coupling of the N-terminal residue was 
carried out with the Boc-protected amino acid in order to avoid the requirement for an 





















































R = Me, Ph, (CH2)4NHBoc
33a: peptide = AEEEA (<1 %)
33b: peptide = AEEEF (5 %)
33c: peptide = AALTK (7 %) DIPCDI    =
NMI    =
 
 
Scheme 41: synthesis of peptide thioesters 33a – 33c with initial coupling with 
DIPCDI. 
 
Following completion of the solid phase peptides, activation of the sulfonamide group 
was carried out with excess iodoacetonitrile in the presence of Hünigs base for 24 hours 
with the exclusion of light.  Thioester formation with concomitant release from the resin 
was then carried out by treatment with excess benzyl mercaptan and catalytic sodium 
thiophenoxide for a further 18 – 24 hours.108  The resin was then removed by filtration 
and the filtrate was concentrated and treated with 95 % v/v TFA, 2.5 % v/v EDT to 
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remove the side chain and N-terminal protecting groups.  The crude products were then 
purified by semi-preparative HPLC.   
 
Unfortunately HPLC purification afforded the target thioesters 33a – 33c in extremely 
low yields (< 1 % for alanine thioester 33a, see Scheme 41).  The crude products 
appeared to be relatively pure with no significant side products present, but product 
recovery was very low.   
 
Due to the previously discussed problems of monitoring synthesis on sulfonamide 
safety catch resins (see introduction, section 2.3.10) it was difficult to determine at 
which stage the synthesis had failed.  The two most likely problem steps were the initial 
loading of the C-terminal amino acid and the final activation and cleavage step, as the 
remaining SPPS couplings and deprotections had gone to completion as monitored by 
the Kaiser ninhydrin test. 
 
 
2.2  Sulfonamide safety catch peptides: initial coupling with acid fluoride 
 
The very poor yields obtained for the peptide thioesters by the above approach led us to 
investigate the acid fluoride method for the coupling of the C-terminal amino acid.171  
Protected glycine, alanine and lysine were therefore treated with cyanuric fluoride in the 
presence of pyridine as shown in Scheme 42 to afford the acid fluoride products 34a – 
34c in quantitative or near-quantitative yield after work up, in sufficient purity to be 
















-10 oC - RT
34a: R = H (99 %)
34b: R = Me (99 %)










































Scheme 42: synthesis of acid fluorides 34a – 34c. 
 
Fmoc-protected glycine and alanine acid fluorides 34a and 34b were coupled to 4-
sulfamylbutyryl safety catch resin in the presence of Hünigs base for two hours (see 
Scheme 43).  UV Fmoc analysis of the resulting peptidyl resins showed a loading of 76 
% for glycine and 74 % for alanine with respect to the given value for the resin loading.  
SPPS and the activation and cleavage and deprotection steps were then carried out as 
before to afford C-terminal alanine thioester 33a and C-terminal glycine thioester 33d. 
 
Despite the efficient initial couplings however, C-terminal alanine thioester 33a was 
again obtained in a low yield of 2 %.  Although this represents an improvement over the 
previous yield obtained for 33a via the DIPCDI coupling method, and sufficient 
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material for further studies was obtained, the low yield still represents a disappointing 
result.  Glycine thioester 33d was also obtained in a low yield of 7 %.  These results 
suggested that the activation and cleavage reactions were the problem steps.  No 
significant side products were seen during HPLC purification as before, suggesting that 
the activation and cleavage reactions were clean but inefficient, and that the majority of 















































R = H, Me
33a: peptide = AEEEA (2 %)
33d: peptide = GLRG (7 %)
76 % (R = H)
74 % (R = Me)
 
 




2.3  “Double linker” sulfonamide safety catch peptides 
 
Examination of the activation and cleavage reactions for sulfonamide safety catch 
peptides is difficult due to the fact that samples for analysis must be prepared by the 
same two step procedure.  To solve this problem, we sought to apply the recently-
developed “double-linker” strategy62 (see introduction, section 2.3.10) to allow easier 
analysis of these reactions via facile acidic cleavage of the peptide from the resin. 
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Alkane sulfonamide resin 35 was therefore prepared on Rink amide resin as shown in 
Scheme 44.  Fmoc protected phenylalanine was coupled to Rink amide resin (loading 
0.62 mmol/g) as a spacer, under standard HOBt/HBTU coupling conditions.  The 
phenylalanine also functions as an aid to purification and characterisation by increasing 
the size, hydrophobicity and UV activity of the acid-cleaved peptide.  Following Fmoc 
deprotection, 3-carboxypropanesulfonamide was added by HOBt/DIPCDI coupling, 
using three equivalents of each reagent, to form the double-linker sulfonamide resin 35.  
SPPS and the activation and cleavage reactions can thus be easily monitored by acidic 

















































1)  20 % piperidine
2)
HOBt / HBTU,  DIPEA
2)
HOBt / DIPCDI






Scheme 44: synthesis of double-linker sulfonamide resin 35. 
 
The C-terminal amino acid residue of each of the thioester peptides AEEEA, AALTK 
and GLRG, was coupled to the sulfonamide resin 35 on a 0.1 mmol scale as the Fmoc-
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protected acid fluoride in the presence of Hunigs base as before (see Scheme 45).  UV 
Fmoc analysis showed a loading of 76 % for glycine and a loading of 55 % and 58 % 
for alanine and lysine respectively.  Although these values are relatively low, they 
represent a loading sufficient to obtain the material required for ligation studies.  These 
low loadings also indicate that acylation of the sulfonamide is difficult and hence side 
products arising from acylation of the remaining free sulfonamide by activated esters 
later in SPPS should not be formed to any significant degree. 
 
Following completion of the peptides, thioester formation was carried out in one of two 
ways: by activation with iodoacetonitrile followed by cleavage with benzyl mercaptan 
to afford the benzyl thioester 33 (route A, Scheme 45), or activation by Mitsunobu 
alkylation with 2-hydroxy-(S-triisopropylsilyl)-ethanethiol 36, followed by deprotection 
and spontaneous intramolecular N – S acyl shift173 (route B).  In this second case the 
resin-bound alkyl thioester was subsequently released by TFA cleavage of the Rink 
amide linker to afford free thioester peptide 37. 
 
Following synthesis of the C-terminal alanine peptide (sequence AEEEA) on resin 35, 
the peptide was cleaved from the resin as the benzyl thioester (33a) by activation with 
iodoacetonitrile followed by cleavage with benzyl mercaptan and subsequent TFA 
deprotection (route A, Scheme 45), as previously carried out for peptides synthesised on 











































































R = H, Me, (CH2)4NHBoc
76 % (R = H)
54 % (R = Me)




1) ICH2CN,  DIPEA
2) BnSH, NaSPh





1) TBAF / AcOH




33a: peptide = AEEEA (7 %)
36
O
37a: peptide = AEEEA (11 %)
37b: peptide = GLRG (12 %)





Scheme 45: synthesis of thioester peptides on double-linker resin 35, via standard 
activation/cleavage to form benzyl thioesters (route A) or intramolecular formation of 
alkyl thioesters (route B). 
 
Thioester 33a was the only product observed by LC-MS of the crude reaction mixture 
(see Figure 32), but a low yield of 4 % was again obtained for 33a following HPLC 
purification.  In this case however, use of the double-linker approach allowed the 
examination of the remaining resin-bound species by treatment of a sample of the resin 












Figure 32: LC-MS analysis of crude reaction mixture for formation of thioester 33a.  A: 
total ion count (TIC) chromatogram; B: ESI spectrum of 33a peak (calculated mass = 































































Figure 33: LC-MS analysis of resin-bound products.  A: TIC trace showing alkylated 
sulfonamide peptides; B: ESI positive ion mass spectrum of minor peak (calculated 
mass = 881.9 Da, observed: 882.4 Da [M]+); C: ESI positive ion mass spectrum of 
major peak (calculated mass = 899.9 Da, observed: 900.4 Da [M]+). 
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LC-MS of the resulting crude product showed two major peaks due to products arising 
from incomplete reaction with benzyl mercaptan (see Figure 33).  The smaller of these 
was the iodoacetonitrile-alkylated peptide.  The larger peak corresponded to the peptide 
alkylated with acetamide (CH2CONH2) which is presumably formed by hydrolysis of 
the nitrile group under the aqueous resin cleavage conditions.  Only a trace of non-
alkylated peptide was present, and no shorter peptide side products arising from 
acylation of the free sulfonamide remaining from the initial acid fluoride coupling were 
observed.  The alkylation step had therefore been efficient and the problem step in the 
thioester synthesis appeared to be the reaction of the activated peptide with benzyl 
mercaptan.  The remaining resin was therefore resubjected to treatment with benzyl 
mercaptan and a further 3 % yield of thioester 33a was isolated following HPLC 
purification.   
 
Although the analysis of the activation/cleavage procedure allowed an improvement in 
the yield of thioester formation, resubjection of the release step was necessary and the 
amount of product recovered was still low.  We therefore investigated the formation of 
thioesters via intramolecular N – S acyl shift,173 (route B, Scheme 45) as in this 
approach all peptide products are cleaved from the resin by the final treatment with 
TFA. 
 
2-Hydroxy-(S-triisopropylsilyl)-ethanethiol 36 was prepared as shown in Scheme 46.  
The potassium salt of triisopropylsilyl (TIPS) thiolate was prepared by the addition of 
TIPS thiol to potassium hydride in pentane at 0 oC, and recrystallised from toluene to 
afford the salt as a white solid, which was used without further purification.  
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Displacement with bromoethanol by its addition to a suspension of the salt in THF 









0 oC - RT 36 (86 %)  
 
Scheme 46: preparation of 36. 
 
C-terminal alanine peptide AEEEA was again prepared on double-linker resin 35, as in 
previous studies, and subjected to Mitsunobu alkylation with 36 with 
diethylazodicarboxylate (DEAD) and triphenylphosphine in THF (see Scheme 47).   
 
Subsequent TFA treatment of a sample of the resin and MS analysis showed several 
peaks, one of which corresponded to the alkylated sulfonamide with fragmentation of 
the TIPS protecting group.  The major peak corresponded to the non-alkylated starting 
material, however.  Although the formation of complex mixtures of products arising 
from TFA cleavage of the alkylated peptide at this stage has been reported,173 the 
presence of the starting peptide as the major peak suggested that alkylation was 
incomplete.  The resin was thus resubjected to the Mitsunobu alkylation conditions and 
then taken on to the next step without further analysis. 
 
The resulting peptide resin was treated with a solution of tetrabutylammonium fluoride 
(TBAF) and acetic acid in THF to remove the TIPS protecting group.  The peptide was 
then cleaved from the resin with 95 % v/v TFA, 2.5 % v/v EDT and purified by HPLC.  
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The authors of the paper describing this approach state that intramolecular N – S acyl 
shift to form the thioester occurs spontaneously upon removal of the TIPS group, but 
this rearrangement may actually occur during the TFA cleavage step.  A species 
corresponding to the mass of the target thioester 37a was isolated in 11 % yield, or 20 % 
with respect to the measured loading for the C-terminal alanine residue (see Scheme 
47), along with a small amount of the non-alkylated peptide (not isolated).  As the mass 
of the target thioester is identical to that of the deprotected but unrearranged acyl 








































































R = H, Me, (CH2)4NHBoc
76 % (R = H)
54 % (R = Me)










37a: peptide = AEEEA (11 %)
37b: peptide = GLRG (12 %)
37c: peptide = AALTK (18 %)
Rink amide
linker
1) TBAF / AcOH
2) 95 % TFA
 
 
Scheme 47: synthesis of alkyl thioester peptides 37a - 37c on double-linker resin 37, via 
intramolecular thioester formation. 
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In previous studies, treatment of the products of NCL with nucleophiles 106,197 such as 
hydrazine108,113 has been used to confirm that the rearrangement from the thioester to 
the amide has occurred, as the thioester reacts to form the hydrazide, whereas the 
rearranged amide product is unreactive.  A sample of the isolated product was thus 
treated with 2 % v/v hydrazine hydrate in sodium phosphate buffer at pH = 8.  LC-MS 
analysis of the reaction after three hours showed complete consumption of the starting 
material.  Unfortunately the hydrazide product was not seen, presumably due to a very 
short retention time for this species.  Instead a single major peak was observed 
corresponding to the mass of the thiol 38 released from the thioester product upon 
reaction (see Figure 34).   
 
Treatment of a second sample of the isolated product with excess benzyl mercaptan led 
to formation of the benzyl thioester 33a in under two hours.  Thiol 38 was again 
observed, along with peaks corresponding to the oxidised disulfide.  These results are 
consistent with the presence of thioester 37a, but it is also possible that similar results 
might be observed from nucleophilic attack of benzyl mercaptan on the alkylated (and 
thus activated) but unrearranged acyl sulfonamide product.   
 
Although such rapid reaction of the unrearranged acyl sulfonamide would be surprising 
given the slow nucleophilic cleavage observed for the activated sulfonamide resin, a 
further test was required to conclusively identify the isolated product as thioester 37a.   
 
As the unrearranged sulfonamide would not be reactive in cysteine ligation, a sample of 
the product was treated with an excess of an N-terminal cysteine peptide with the 
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sequence H-Cys-(GlyCAM-1 103-132)-OH as shown in Figure 34.  After 24 hours, 
almost all of the starting material had been consumed, with formation of the expected 
ligation product.  Thiol 38 was also observed.  After 48 hours LC-MS indicated 
complete consumption of the starting material, which was thus identified as thioester 
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37a test reactions
products
conditions products observed by LC-MS
2 % v/v hydrazine hydrate,
10 mM Na phosphate buffer pH = 8
3 hours
benzyl mercaptan,
10 mM Na phosphate buffer pH = 8
2 hours
A E E E A
38
33a
+   38
20 mM TCEP, 2 % MESNa
10 mM Na phosphate buffer pH = 8
48 hours
A E E E A
+   38
GlyCAM-1 103-132 = TVEEELGKIIEGFVTGAEDIISGASRITKS  
 
































Figure 35: LC-MS analysis of thioester confirmation reaction with Cys-peptide. A: 
reaction at time = 0 hours, showing peaks for test product (assumed to be 37a) and Cys-
peptide; B: reaction at time = 48 hours, showing peaks for thiol 38, ligation product and 



























Figure 36: ESI positive ion mass spectra of ligation products from LC-MS 35B above.  
A: mass spectrum of peak for thiol 38 (calculated mass = 373.5 Da, observed: 396.4 Da 
[MNa]+, 769.7 Da [2MNa]+); B: ESI positive ion mass spectrum of peak for ligation 
product (calculated mass = 3783.2 Da, observed: 1892.4 Da [MH2]2+, 1262.3 Da 
[MH3]3+), also showing signals for remaining Cys-peptide starting material (calculated 
mass = 3253.7 Da, observed: 1627.4 Da [MH2]2+, 1085.6 Da [MH3]3+).  peptide = 
TVEEELGKIIEGFVTGAEDIISGASRITKS. 
 
The intramolecular rearrangement approach was therefore found to be the most efficient 
method for the synthesis of the C-terminal alanine thioester, and C-terminal glycine 
thioester GLRG (37b) and C-terminal lysine thioester AALTK (37c) were subsequently 
synthesised by the same approach.  In each case more than 50 % alkylation was 
achieved by subjection to the Mitsunobu conditions (see Figure 37).  As this conversion 
provided sufficient material for ligation studies, the step was not repeated.  The thiol 
deprotection and TFA cleavage steps were carried out exactly as before to afford 
thioesters 37b and 37c in 12 % and 18 % isolated yield respectively, after HPLC 























Figure 37: LC-MS analysis of crude reaction mixture for cleavage of C-terminal lysine 
thioester 37c from the resin.  A: TIC trace of crude reaction mixture, showing peaks for 
37c and for non-alkylated acyl sulfonamide (SM); B: ESI positive ion mass spectrum of 
37c peak (calculated mass = 858.1 Da, observed: 858.6 Da [M]+). 
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3.  Ligation studies 
 
The auxiliary-peptides and short thioesters described in the previous sections were used 
to examine the scope and limitations of auxiliary-mediated ligations by conducting test 
ligations with auxiliaries 4 and 6 at a range of Xxx-Gly junctions and also at the Gly-
Ala junction.  Initial studies were conducted using the most straightforward junction, 
Gly-Gly.  The compatibility of the ligation and auxiliary removal conditions with 
glycosylated peptides was also investigated at this stage.  Studies of ligations at more 
sterically demanding junctions were then conducted. 
 
 
3.1  Ligation at Gly-Gly junctions 
 
3.1.1  Ligation results 
 
C-terminal glycine alkyl thioester 37b was ligated with N-terminal auxiliary peptides 
24b and 31b under typical denaturing NCL conditions, at pH = 8.0 with TCEP as the 
reducing agent and MESNa thiol additive as shown (Scheme 48).  Both the thioester 
and auxiliary peptides were used in approximately 3 mM concentration.  Reaction 
progress was monitored by LC-MS. 
 
Ligation of Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)-peptide 31b with 37b was 
virtually complete within 48 hours, and no further reaction was observed after 54 hours.  
Two different peaks corresponding to the mass of the product 39b were observed by 
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LC-MS, corresponding to the two diastereomers of the product.134,135  HPLC 





















































200 mM Na phosphate, pH 8.0
20 mM TCEP, 2 % MESNa
6M guanidine hydrochloride
60 hours
200 mM Na phosphate, pH 8.0








peptide B: GlyCAM-1 110-132 = KIIEGFVTGAEDIISGASRITKS  
 
Scheme 48: Gly-Gly ligations with auxiliary-peptides 24b and 31b. 
 
Ligation of 4,5,6-trimethoxy-2-mercaptobenzyl peptide 24b proceeded slightly more 
slowly, and the reaction took 60 hours to reach completion.  In this case unreacted 24b 
eluted very close to the product 39a from both LC-MS and HPLC columns, 
complicating analysis and purification somewhat.   
 
Ligation product 39a was isolated in 64 % yield by HPLC, containing traces of starting 
auxiliary-peptide 24b (see Figure 38).  In both ligations alkyl thioester 37b was only 







Figure 38:  ESI positive ion mass spectrum of ligation product 39a (calculated mass = 
3045.5 Da, observed: 1523.6 Da [MH2]2+, 1016.1 Da [MH3]3+) containing traces of 


































Figure 39:  ESI positive ion mass spectrum of ligation product 39b (calculated mass =  








3.1.2  Auxiliary removal 
 
Following successful formation and isolation of ligation products 39a and 39b, these 
peptides were treated with 95 % v/v TFA, 2.5 % v/v EDT for three hours to remove the 

























































peptide B: GlyCAM-1 110-132 = KIIEGFVTGAEDIISGASRITKS  
 
Scheme 49: auxiliary removal from ligation products 39a and 39b. 
 
The Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) auxiliary 6 was efficiently removed 
from peptide 39b under these conditions, to afford the desired native peptide 40 in 
quantitative yield following HPLC purification (see Figure 40).  The successful 
auxiliary cleavage reaction confirmed that the key rearrangement of the thioester 
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intermediate to the amide-linked ligation product had taken place, as the unacylated 












Figure 40: ESI positive ion mass spectrum of peptide 40 (calculated mass =  2833.2 Da, 
observed: 1417.4 Da [MH2]2+, 945.6 Da [MH3]3+).  peptide B = 
KIIEGFVTGAEDIISGASRITKS. 
 
When the same conditions were applied to the removal of the 4,5,6-trimethoxy-2-
mercaptobenzyl auxiliary 4 from peptide 39a however, a mixture of the desired cleaved 
product 40 and a species with the same mass as the starting peptide 39a was formed.  
The peaks corresponding to this species were not reduced by prolonged exposure to 
TFA.  Due to the formation of this TFA-stable species, the target peptide 40 was 
isolated in a lower yield of 58 % in this case. 
 
Danishefsky and co-workers have since noted a similar effect113 during TFA cleavage of 
these auxiliaries and have postulated that a reversal of the S – N acyl shift which occurs 
during ligation takes place to form thioester 41, caused by irreversible protonation of the 
benzylamine.  This problem could be avoided by methylation of the auxiliary thiol with 
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methyl p-nitrobenzene sulfonate prior to TFA treatment.  As the TFA-stable byproduct 
was not isolated in our case however, it was not possible to confirm that thioester 41 
had been formed.   
 
Auxiliaries 4 and 6 were thus successfully used for traceless cysteine-free ligation at the 
Gly-Gly junction by ligation and subsequent TFA cleavage of the auxiliary.  Auxiliary 6 
was the more efficient of the two, both in ligation and in its removal, affording native 
peptide 40 in 71 % yield over the two steps, whereas removal of auxiliary 4 appears to 
have been complicated by the formation of a TFA-stable by-product. 
 
 
3.1.2  Glycopeptide ligation 
 
Following the successful ligations carried out for the Gly-Gly junction above, the more 
effective auxiliary 6 was used to assemble a glycopeptide fragment via ligation at the 
same junction in order to test the compatibility of the ligation and auxiliary removal 
conditions with glycosylated peptides. 
 
Auxiliary-glycopeptide 32 was ligated to C-terminal glycine benzyl thioester 33d under 
the same conditions as the for the previous Gly-Gly ligations, as shown in Scheme 50.  
The ligation was followed by LC-MS and was complete after 48 hours.  The ligated 







































200 mM Na phosphate pH 8.0
20 mM TCEP, 2 % MESNa
6 M guanidine hydrochloride
48 hours
3 hours
2 % hydrazine hydrate



































Figure 41: ESI positive ion mass spectrum from LC-MS analysis of glycopeptide 
ligation at time = 48 hours, showing glycopeptide product 42, with characteristic signals 
due to fragmentation of auxiliary and the glycosidic linkage (calculated mass = 1845.9 
Da, observed: 1845.9 Da [M]+,  1650.1 Da [M-aux]+, 1517.3 Da [M-aux-
(OAc)3GalNAc]+, 923.8 Da [MH2]2+). 
 
Ligation product 42 was treated with 95 % v/v TFA for three hours to remove the 
auxiliary exactly as before and the resulting crude product was purified by HPLC to 








hydrazine hydrate to remove the acetyl ester protecting groups from the saccharide to 
afford the fully deprotected native glycopeptide 44 as shown in Figure 43.  This step 
also provided an additional confirmation of the formation of the stable amide-linked 






















Figure 42: LC-MS analysis of HPLC purified glycopeptide 43.  A: TIC trace for 
purified 43 following auxiliary removal with TFA; B: ESI positive ion spectrum of 43, 
again showing characteristic fragmentation of glycosidic linkage (calculated mass = 

























Figure 43: LC-MS analysis of HPLC purified deprotected glycopeptide 44.  A: TIC trace 
for purified 44 following acetyl ester removal with hydrazine; B: ESI positive ion mass 
spectrum of 44, again showing characteristic fragmentation of glycosidic linkage 
(calculated mass = 1523.6 Da, observed: 1524.0 Da [M]+, 1320.8 Da [M-
(OAc)3GalNAc]+,  762.6  Da [MH2]2+). 
 
No decomposition of the glycopeptide was observed during PMB deprotection of the 
auxiliary-glycopeptide or during the ligation, auxiliary removal and hydrazine 
deprotection steps, all of which proceeded cleanly and efficiently as monitored by LC-
MS, thus confirming the compatibility of this auxiliary-mediated ligation approach with 
the assembly of glycopeptides.   
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3.2  Ligation at junctions other than Gly-Gly 
 
3.2.1  Initial studies  
 
Following the success of the initial Gly-Gly ligation studies for the assembly of both 
peptides and glycopeptides, ligation studies were extended to a range of Xxx-Gly 
junctions.  Peptides bearing the more effective Nα-(1-(2,4-dimethoxyphenyl)-2-
mercaptoethyl) auxiliary 6 were thus ligated with short thioester peptides containing 
alanine and lysine as the C-terminal residue, as ligation at these junctions had been 
previously reported.129,132,135  Studies were also conducted on the Ser-Gly, Leu-Gly and 
Phe-Gly junctions and the Gly-Ala junction.  The first two of these were of particular 
interest as they are present at appropriate sites in the sequence of GlyCAM-1 for its 
assembly via auxiliary-mediated ligation with no changes in amino acid sequence. 
 
Ligations were conducted under the same conditions as for the Gly-Gly ligations and 
monitored by LC-MS as before.  Ligations of auxiliary-glycine peptides 31a and 31b 
with C-terminal alanine, phenylalanine, lysine and leucine benzyl thioesters 33a – 33c 
and 33e were all unsuccessful, however (see Scheme 51).   
 
Minor peaks corresponding to the mass of the ligated products were observed by LC-
MS in the early stages of each ligation, but did not increase as the reaction progressed, 
therefore these signals were most likely due to the transthioesterified but unrearranged 
product.  The findings in previous studies that the S – N acyl shift rearrangement is the 
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200 mM Na phosphate, pH 8.0
20 mM TCEP, 2 % MESNa
6M guanidine hydrochloride
48 hours
200 mM Na phosphate, pH 8.0





33a: peptide = AEEEA
33b: peptide = AEEEF
33c: peptide = AALTK
33d: peptide = GLRG
33e: peptide = AEEEL
33f: peptide = GLRS
No ligation product
32
200 mM Na phosphate, pH 8.0









200 mM Na phosphate, pH 8.0








200 mM Na phosphate, pH 8.0






peptide A = SQTVEEELGKIIEGFVTGAEDIISGASRITKS
peptide B = KIIEGFVTGAEDIISGASRITKS
peptide C = VTGAEDIISGASRITKS  
 
Scheme 51: unsuccessful Xxx-Gly and Gly-Ala ligations. 
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No further reaction was observed by LC-MS after 48 hours in each case.  Ligation of 
auxiliary-glycopeptide 32 with C-terminal serine thioester 33f was similarly 
unsuccessful.  Ligation of the 4,5,6-trimethoxy-2-mercaptobenzyl-glycine peptide 24b 
with C-terminal leucine thioester 33e (see Figure 44) also failed, as did ligation at the 
Gly-Ala junction using Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)-alanine peptide 


















Figure 44: LC-MS TIC trace for ligation of auxiliary-peptide 24b and C-terminal 
leucine thioester 33e at time = 16 hours, showing only starting peptide 24b and 
conversion of 33e to MESNa alkyl thioester.  peptide B = 
KIIEGFVTGAEDIISGASRITKS. 
 
Although the steric bulk of the amino acid residues at the ligation junction is known to 
have a large effect on the speed of the critical S – N acyl shift rearrangement in 
auxiliary-mediated ligations, the lack of any product formation for these non-Gly-Gly 
ligations was disappointing, especially for those junctions for which successful ligations 
had previously been reported.  This was particularly true for the Ala-Gly junction, 
which is the least sterically-crowded non-Gly-Gly junction. 
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The original reports on the use of Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) 
auxiliary 6132,134 utilised very similar conditions to those used in our case: denaturing 
ligation buffer at basic pH, with reducing agent and thiol additives, although in this case 
the auxiliary was conjugated to only a short six-residue peptide.  The authors of the 
paper describing the use of 4,5,6-trimethoxy-2-mercaptobenzyl auxiliary 4129 however, 
noted an inhibitory effect of thiol additives on ligations, although no explanation for this 
effect was offered.   
 
In each ligation reaction we had observed a rapid thiol exchange reaction between the 
benzyl or alkyl thioester and the MESNa catalyst to form the MESNa thioester.  We 
therefore reasoned that the transthioesterified but unrearranged product would also be 
subject to similar rapid thiol exchange to regenerate the MESNa thioester and the 
starting auxiliary-peptide, and that the steric bulk around the non-Gly-Gly ligation 
junctions was slowing the critical rearrangement step to such an extent that the 
transthioesterified product was broken down before the rearrangement could occur.  
This underlines the dramatic effect that the steric bulk of the ligation junction has on the 
rearrangement step, rendering the ligation at the Ala-Gly junction ineffective in the 
presence of thiol, whereas no such problems were observed for the Gly-Gly junction.   
 
 
3.2.2  Thiol-free ligations 
 
A series of test ligations was conducted under the same conditions as previously 
described, but without the addition of MESNa.  Following the observation of the 
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dramatic effect of steric bulk at the ligation junction, studies were concentrated on the 
less sterically-demanding Ala-Gly, Gly-Ala and Lys-Gly junctions.  To determine the 
feasibility of ligation without the thiol catalyst, the Gly-Gly ligations with both 















































































peptide B: GlyCAM-1 110-132 = KIIEGFVTGAEDIISGASRITKS
 
 
Scheme 52: thiol-free ligations at the Gly-Gly junction. 
 
Auxiliary-peptides 24b and 31b were thus ligated with alkyl thioester 37b as before, but 
with no thiol additive (see Scheme 52).  In both cases the ligations were more difficult 
to follow by LC-MS, as the spectra were frequently complicated by the presence of 
additional signals.  Some of these corresponded to further thioester species, for example 
the double-ligated product 45 arising from acylation of the auxiliary thiol of the ligated 
product with a second molecule of the thioester (see Figure 46).  Reaction progress was 
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also difficult to monitor due to the overlapping signals of the auxiliary-peptides and the 
ligated products in the LC-MS chromatograms.   
 
To avoid possible undesired side reactions,107 the reaction time was limited to 72 hours, 
after which time the reaction appeared to be finished as no further consumption of the 
thioester was observed.  Two distinct peaks were again observed for the diastereomers 
of auxiliary-peptide 31b and the resulting ligated product 39b.  This effect was also 
observed in subsequent ligations with Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) 
auxiliary 6.   
 
To aid purification and break down any undesired thioester products, such as 45, 
MESNa was added and the reaction mixture was shaken for a further six hours prior to 
HPLC purification.  Ligated products 39a and 39b were isolated in 54 % and 67 % yield 
respectively.  This corresponds to a slightly lower yield than for the ligations in the 













Figure 45: ESI positive ion mass spectrum of ligation product 39a (calculated mass = 
3045.5 Da, observed: 1524.0 Da [MH2]2+, 1016.2 Da [MH3]3+), showing trace of 


















Figure 46: ESI positive ion mass spectrum of mixture of ligated product 39b 
(calculated mass =  3029.5 Da, observed: 1010.7 Da [MH3]3+, 945.7 Da [M-auxH3]3+) 
and double-ligated product 45 (calculated mass =  3413.5 Da, observed: 1706.9 Da 
[M]2+, 1138.7 Da [MH3]3+) from LC-MS analysis of ligation reaction mixture at time = 
72 hours, prior to addition of MESNa.  peptide B = KIIEGFVTGAEDIISGASRITKS. 
 
The thiol free ligation conditions were then applied to the previously unsuccessful Ala-
Gly ligations.  Auxiliary-glycine peptides 24b and 31b were ligated to C-terminal 
alanine thioester 37a for 72 hours in the absence of thiol, then for six hours with 
MESNa, and were followed by LC-MS as before (see Scheme 53). 
 
Disappointingly, no product was observed after 72 hours ligation between 37a and the 
4,5,6-trimethoxy-2-mercaptobenzyl auxiliary peptide 24b.  Although thioester 37a 
appeared to be consumed, no peaks corresponding to the ligated product were observed 
by LC-MS.  Instead only peaks corresponding to the starting auxiliary-peptide were 
seen.  Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) auxiliary 6 performed much 
better in this case, however.  Ligated product 46 was isolated in 70 % yield by HPLC 
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from ligation between 31b and 37a for 72 hours, followed by addition of MESNa as 
before (see Figure 47).  In contrast to the Gly-Gly ligation, the double-ligated product 




































































peptide B: GlyCAM-1 110-132 = KIIEGFVTGAEDIISGASRITKS
 
 






Figure 47: ESI positive ion mass spectrum of ligated product 46 (calculated mass = 
3175.5 Da, observed: 1588.7 Da [MH2]2+, 1059.6 Da [MH3]3+). 
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Ligated product 46 was then treated with 95 % v/v TFA, 2.5 % v/v EDT to remove the 
auxiliary group (see Scheme 53).  As seen for peptide 39b, the reaction was complete 
within three hours as monitored by LC-MS and the native peptide product 47 was 












Figure 48: ESI positive ion mass spectrum of 47 (calculated mass =  2979.3 Da, 
observed: 1490.5 Da [MH2]2+, 994.3 Da [MH3]3+).  peptide B = 
KIIEGFVTGAEDIISGASRITKS. 
 
As for the Ala-Gly ligation, 4,5,6-trimethoxy-2-mercaptobenzyl auxiliary 4 was 
unsuccessful at the Lys-Gly junction (see Scheme 54).  No ligated product was 
observed by LC-MS after reaction of auxiliary peptide 24a and C-terminal lysine 
thioester 37c for 72 hours.   
 
Ligation of Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) auxiliary-peptide 31a with 
37c for 72 hours however, resulted in a mixture of starting material 31a, plus a smaller 
amount of ligated product 48.  Following treatement with MESNa, it was possible to 
isolate 48 by HPLC, although in a lower yield of 24 %.  The auxiliary group was then 




































































peptide A: GlyCAM-1 101-132 = SQTVEEELGKIIEGFVTGAEDIISGASRITKS
 
 







Figure 49: ESI positive ion mass spectrum of 49 (calculated mass = 3907.3 Da, 
observed: 1954.6 Da [MH2]2+, 1303.6 Da [MH3]3+, 977.9 Da [MH4]4+). 
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During the course of these studies, the assembly of peptides and cyclic peptides via 
ligation at a Gly-Ala junction using the HF-labile Nα-(1-(4-methoxyphenyl)-2-
mercaptoethyl) auxiliary 5 was reported.133  Ligation at this junction had also been 
reported with 4,5-dimethoxy-2-mercaptobenzyl auxiliary 3,129 which also requires HF 
treatment for its removal.  We were therefore interested in investigating whether the 
corresponding TFA-labile auxiliaries 6 and 4 would also be successful for ligations at 
this junction under the thiol-free conditions, as an attempted ligation at this junction 




































































peptide C: GlyCAM-1 116-132 = VTGAEDIISGASRITKS  
 
Scheme 55: thiol-free Gly-Ala ligations. 
 
Auxiliary-alanine peptides 24c and 31c were thus ligated with glycine thioester 37b for 
72 hours, followed by MESNa addition for six hours, as before (see Scheme 55).  
Ligation was successful with both auxiliary-peptides, but in both cases analysis and 
purification were complicated by the presence of unreacted starting auxiliary-peptide, 
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which eluted very close to the ligated product.  Products 50a and 50b were isolated in 
42 % and 48 % yield respectively, containing traces of the corresponding starting 




Figure 50: ESI positive ion mass spectrum of 50a (calculated mass = 2371.7 Da, 
























Figure 51: ESI positive ion mass spectrum of 50b (calculated mass = 2355.7 Da, 
observed: 1178.8 Da [MH2]2+, 786.6 Da [MH3]3+).  peptide C = 
VTGAEDIISGASRITKS. 
 
Ligated products 50a and 50b were then treated with 95 % v/v TFA for three hours to 
remove the auxiliary groups (see Scheme 56).  As previously seen, auxiliary 6 was 
removed from 50b in quantitative yield by this procedure, whereas formation of an acid-
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stable side product presumed to be the rearranged thioester 52 was observed during 
removal of auxiliary 4 from 50a.  Native peptide product 51 was therefore isolated in a 

































































Scheme 56: auxiliary removal from ligated products 50a and 50b. 
 
The auxiliary-peptide starting materials 24c and 31c, traces of which were present in the 
ligated products 50a and 50b, again proved difficult to remove during HPLC 
purification and traces of these starting materials were again detected in the native 
















Figure 52: ESI positive ion mass spectra of peptide product 51 (calculated mass = 
2159.4 Da, observed: 1080.6 [MH2]2+, 720.8 [MH3]3+) from LC-MS analysis of crude 
reaction mixture, showing traces of auxiliary-peptide starting material 4c.  
 
 
3.3  Ligation summary 
 
Auxiliary-mediated ligations were thus successfully carried out at the Gly-Gly, Ala-Gly, 
Lys-Gly and Gly-Ala junctions under thiol-free conditions (see Table 4).  The 
previously reported large effect of steric bulk at the ligation junction was observed for 
the non-Gly-Gly ligations.  In these cases the rate-determining S – N acyl shift 
rearrangement was slowed to such an extent that ligation was unsuccessful in the 
presence of thiol additives, as the transthioesterified product was broken down by thiol 
exchange before rearrangement could occur.   
 
For the most straightforward Gly-Gly ligation, better results were obtained in the 
presence of the MESNa thiol catalyst, as the formation of additional undesired thioester 













   Isolated yield (%)  
Ligation junction 
 
Auxiliary + MESNa - MESNa 
Auxiliary Removal
            (%) 
Gly-Gly 4 64 54 58 
Gly-Gly 6 71 67 100 
Ala-Gly 4 0 0 n/a 
Ala-Gly 6 0 70 100 
Gly-Ala 4 0 42 60 
Gly-Ala 6 0 48 100 
Lys-Gly 4 0 0 n/a 
Lys-Gly 6 0 24 100 
 
Table 4: ligation summary. 
 
Ligations using Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) auxiliary 6 were more 
successful for each ligation junction studied than those performed with the 4,5,6-
trimethoxy-2-mercaptobenzyl auxiliary 4.  Ligation with auxiliary 6 at the Ala-Gly 
junction gave the best results obtained for thiol-free ligation, affording the ligated 
product in 70 % yield.  An acceptable yield of 48 % was recorded for the converse Gly-
Ala junction and it was also possible to achieve ligation at the Lys-Gly junction, albeit 
in a lower yield of 24 %.  Auxiliary 6 could also be removed in quantitative yield in 
straightforward fashion from all of the ligation junctions studied, under conditions 
compatible with glycosylated peptides.   
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In contrast auxiliary 4 was unsuccessful in ligations at the Xxx-Gly junctions studied, 
although ligation at the Gly-Ala junction was successful in 42 % yield.  Lower yields 
were also recorded for the removal of this auxiliary, due to the presumed rearrangement 






1.  Conclusions 
 
Rapid and facile routes to both the 4,5,6-trimethoxy-2-mercaptobenzyl 4 and Nα-(1-
(2,4-dimethoxyphenyl)-2-mercaptoethyl) 6 TFA-cleavable auxiliaries have been 
developed, based on two main steps:  firstly introduction of a protected thiol via either 
S-alkylation with the appropriate alkyl halide (for auxiliary 6), or a palladium-catalysed 
S-arylation with aryl triflate (for auxiliary 4), followed by direct reductive amination of 
the resulting aldehyde or ketone with an amino acid derviative.   
 
PMB protected 4,5,6-trimethoxy-2-mercaptobenzyl auxiliary-amino acid “cassettes” 
11a, 11c and 11d ready for use in SPPS were synthesised in four steps in good overall 
yields (54 % - 64 %) utilising a highly efficient microwave-assisted palladium catalysed 
aryl – thiol coupling reaction and a direct reductive amination with t-butyl protected 
amino acids.  PMB and trityl protected Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) 
auxiliary-amino acid cassettes 13a – 13c were synthesised in only two steps, again in 
good overall yields (53 % - 75 %) utilising direct reductive amination of initially 
unreactive ketones 12a and 12b with the unprotected amino acid under optimised 
conditions.  Both of these syntheses represent considerable improvements over the 
previously published routes for such auxiliaries, being shorter and higher yielding and 
compatible with sensitive peptide modifications such as in glycoproteins, which are of 
particular interest to our group, due to the use of the PMB and trityl protecting groups.   
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The auxiliary-amino acid cassettes 11 and 13 were used directly in standard SPPS to 
efficiently introduce the auxiliaries to the N-termini of peptides, thus avoiding the extra 
steps and potentially problematic reactions involved in the previously employed 
“submonomer” conjugation approach.  Fmoc protection of the auxiliary cassette was 
only necessary for 4,5,6-trimethoxy-2-mercaptobenzyl-glycine 11a.  It is noteworthy, 
however, that the auxiliary benzylamines 30a and 30b required for submonomer 
introduction of auxiliary 6 could also be formed in good yield by the above route, 
demonstrating the versatility of our approach.  Following SPPS, the trityl and PMB 
protecting groups employed to mask the auxiliary thiol moeity were both efficiently 
removed under conditions compatible with glycosylated peptides, with trityl 
deprotection occurring concomitantly with release of the peptide from the resin.  Very 
similar strategies for the assembly, protection and conjugation to peptides of these 
auxiliaries have since been used by other groups. 
 
A “Double-linker” sulfonamide safety-catch strategy was applied for the study of the 
synthesis of the peptide thioester coupling partners.  Mitsunobu alkylation, followed by 
intramolecular N to S acyl shift, was found to be the most effective method for the 
formation of the target thioester peptides, although repetetitive subjection of the 
activated sulfonamide resin to benzyl mercaptan cleavage may give comparable results. 
 
Auxiliary-mediated ligations were successfully carried out at Gly-Gly ligation junctions 
in the presence of the MESNa thiol catalyst, to afford peptide and glycopeptide ligation 
products.  The corresponding native peptide products were then obtained by 
straightforward removal of the auxiliary with TFA.  Auxiliary 6 was removed in 
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quantitative yield by this procedure, but lower yields were recorded for the removal of 
auxiliary 4.  This effect may be due to the rearrangement of the ligated product back to 
the TFA-stable thioester, which has subsequently been proposed by Danishefsky and 
co-workers.113  Removal of the acetyl ester protecting groups of the saccharide in 
glycopeptide product 43 was accomplished by treatment with hydrazine hydrate to 
afford fully deprotected native glycopeptide 44.  No decomposition of the glycopeptide 
was observed during the ligation, auxiliary removal and hydrazine deprotection steps, 
all of which proceeded cleanly and efficiently as monitored by LC-MS, thus confirming 
the compatibility of this auxiliary-mediated ligation approach with the assembly of 
glycopeptides. 
 
Ligations at junctions other than Gly-Gly failed in the presence of MESNa.  In these 
cases the rate-determining S – N acyl shift rearrangement was slowed to such an extent 
by steric crowding at the ligation junction that ligation was unsuccessful in the presence 
of thiol additives, as the transthioesterified product was broken down by thiol exchange 
before rearrangement could occur. 
 
Thiol-free ligation conditions were thus used for subsequent ligations and were 
successfully applied to ligations at the Gly-Gly, Ala-Gly, Lys-Gly and Gly-Ala 
junctions.  For the most straightforward Gly-Gly ligation, better results were obtained in 
the presence of MESNa, as the formation of additional undesired thioester products 
occurred under thiol-free conditions. 
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Ligations using Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) auxiliary 6 were more 
successful for each ligation junction studied than those performed with the 4,5,6-
trimethoxy-2-mercaptobenzyl auxiliary 4.  Ligation with auxiliary 6 at the Ala-Gly 
junction gave the best results obtained for thiol-free ligation, affording the ligated 
product in 70 % yield.  In contrast auxiliary 4 was unsuccessful in ligations at the Xxx-
Gly junctions studied, although ligation at the Gly-Ala junction was successful in 42 % 
yield.   
 
In summary, new, effective routes for the synthesis of auxiliaries 4 and 6 and their 
incorporation into peptides were developed and small-to-medium-sized peptides bearing 
the auxiliaries successfully participated in cysteine-free ligations at a range of ligation 
junctions.  Introduction, deprotection and removal of the auxiliaries were also shown to 
be compatible with peptide glycosylation. 
 
 
2.  Future work 
 
Future developments in this area will involve the application of sequential cysteine-free 
ligations to the assembly of large, complex glycopeptides and indeed impressive studies 
towards this goal have very recently been reported.113  This report also details successful 
ligation at unfavourable Gly-Xxx junctions with the 4,5,6-trimethoxy-2-mercaptobenzyl 
auxiliary 4 under adapted ligation conditions utilising DMF cosolvent.  The application 
of similar conditions seems likely to improve the efficiency of these ligations and 
extend the range of junctions at which ligation is possible.  Model studies will be 
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required to determine which junctions are feasible for ligation with auxiliaries 4 and 6 
under these conditions.   
 
More efficient cleavage of auxiliary 4 was also described in the above report, via 
methylation of the auxiliary thiol to avoid the undesired reverse rearrangement to the 
thioester.  The use of a reversible masking step, for example formation of the S-tert-
butylthio- or 3-nitro-2-pyridinesulfenyl disulfides, would enable this procedure to be 
applied to cysteine-containing peptides. 
 
The unique reactivity of the auxiliaries raises the possibility of their use in sequential 
ligation strategies without the need for protection of the thiol moiety.  Existing 
sequential ligation strategies depend on temporary protection of N-terminal cysteine 
residues, which must be removed prior to subsequent ligation (see Scheme 9, page 44).  
As the auxiliaries are unreactive for non-Gly-Gly ligations in the presence of thiol 
additives, N-terminal auxiliary peptides could be assembled via a standard cysteine-
ligation without the need for protection of the auxiliary thiol, which could then 
participate in a subsequent ligation under thiol-free conditions.  
 
Very recent studies by Kent and co-workers have examined thioester reactivity in 
relation to rate of reaction for cysteine ligations.107  Phenyl thioesters such as the 3-
hydroxythiophenol thioester, similar to that formed by Danishefsky’s in situ thioester 
formation approach, or the 4-(carboxymethyl)thiophenol thioester, were found to be 
more reactive than alkyl or benzyl thioesters.  Although the rate-determining step for 
cysteine-free ligation is the S – N acyl transfer rearrangement rather than the thiol 
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exchange step, faster formation of the transthioesterified product by use of these more 
reactive thioesters is likely to improve the efficiency of the ligation.  Such thioesters are 
readily available via the use of the appropriate thiol in the cleavage step in the 
sulfonamide safety catch approach, or via a thiol exchange reaction with less reactive 









All reagents and solvents were purchased from Aldrich and Fisher and used as supplied 
unless otherwise stated.  Anhydrous solvents were purchased from Aldrich and used as 
supplied.  Analytical TLC was carried out on Merck aluminium-backed plates coated 
with silica gel.  Plates were visualized using UV light and p-anisaldehyde or 2,4-
dinitrophenylhydrazine dip.  Flash chromatography was carried out on silica gel 60 Å 
particle size 35 – 70 micron. 
 
1H spectra were recorded at 250 MHz and 13C NMR spectra at 63 MHz on a Bruker 
250SY instrument.  Mass spectra were obtained on a Micromass Platform II series 
electrospray MS and a Micromass Platform II mass spectrometer connected to a Waters 
Alliance HPLC system.  LC-MS was performed using a Phenomenex Luna C18 LC-MS 
column (2.1×50 mm) and a gradient of 5-95 % acetonitrile containing 0.1% TFA over 25 
minutes (flow rate of 0.2 ml/min). Semi-preparative HPLC was performed using a 
Phenomenex LUNA C18 column and a gradient of 10-90 % acetonitrile containing 0.1 % 
TFA over 50 minutes (flow rate of 3.0 ml/min).   
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3,4,5-trimethoxyaniline (2.50 g, 13.7 mmol) was dissolved in acetic acid (8.0 ml).  10 % 
aqueous HCl (10.0 ml) was added and the reaction mixture was cooled to 0 oC.  A 
solution of sodium nitrite (1.32 g, 19.2 mmol) in H2O (5.0 ml) was added dropwise over 1 
hour.  Stirring was continued for a further 20 minutes at 0 oC.  The reaction mixture was 
then added to a solution of potassium ethyl xanthate (4.38 g, 27.4 mmol) in H2O (12.0 
ml) at 65 oC.  The reaction mixture was stirred at 65 oC for 20 minutes, then allowed to 
cool to room temperature.  The reaction mixture was extracted with EtOAc (3 x 40.0 ml) 
and the combined organic extracts were washed with saturated NaCl solution (40.0 ml), 
dried over MgSO4 and concentrated in vacuo.  The crude residue was purified by column 
chromatography over silica (EtOAc/petroleum ether bp 40-60 oC, 10:90) to give the 
product 14 as a yellow oil (1.552 g, 5.38 mmol, 39 %).  1H-NMR (250 MHz, CDCl3): δ = 
6.81 (2H, s, CHAr x 2), 4.69 (2H, q, J = 7.1 Hz, xanthate OCH2), 3.95 (3H, s, OMe), 3.93 
(6H, s, OMe x 2), 1.41 (3H, t, J = 7.1 Hz, xanthate CH3).  13C-NMR (62.8 MHz, CDCl3): 
δ = 213.0 (qC, thiocarbonyl), 153.2 (qC x 2), 139.5 (qC), 122.1 (CHAr x 2), 70.1 (xanthate 
CH2), 60.8 (CH3, OMe), 56.2 (CH3, OMe x 2), 13.5 (CH3, xanthate CH3).  LRMS (ESI): 
found 310.8.  C12H16O4S2Na [MNa]+ requires 311.04.  1H and 13C spectroscopic data in 
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Xanthate 14 (1.5 g, 5.21 mmol) was dissolved in EtOH (20.0 ml).  Aqueous NaOH 
solution (3 M, 20.0 ml) was added and the reaction mixture was stirred at 65 oC for 1 
hour.  The reaction mixture was allowed to cool, then acidified to pH 5 with 10 % v/v 
aqueous HCl and extracted with EtOAc (3 x 40.0 ml).  The combined organic extracts 
were washed with saturated NaCl solution (40.0 ml), dried over MgSO4 and concentrated 
in vacuo to afford 15 as a yellow oil (900 mg, 2.26 mmol, 88 % crude) which was used 
without further purification.  LRMS (ESI): found 421.0.  C18H22O6S2Na [MNa]+ requires 
421.08.  Not characterised in literature (reference 129). 
 
 













16a: R = PMB (81 %)
16b: R = ONB (80  %)15  
 
Disulfide 15 (860 mg, 2.16 mmol) was dissolved in a 1:1 v/v solution of THF/MeOH 
(50.0 ml).  NaOMe (640 mg, 11.9 mmol) was added and the reaction mixture was stirred 
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for 5 minutes.  Either para-methoxybenzyl chloride or ortho-nitrobenzy bromide (4.80 
mmol) was added, followed by triphenylphosphine (1.16 g, 4.43 mmol) and stirring was 
continued for 15 minutes, after which the reaction mixture was concentrated in vacuo and 
purified by column chromatography over silica to give the products as white solids. 
3,4,5-trimethoxyphenyl-(4-methoxybenzyl)-thioether 16a: column eluent 
EtOAc/petroleum ether bp 40-60 oC, 20:80 (1.117 g, 3.49 mmol, 81 %). Colourless solid, 
m.p. 64-65 oC.  1H-NMR (250 MHz, CDCl3): δ = 7.07 (2H, d, J = 8.7 Hz, PMB CHAr x 
2), 6.70 (2H, d, J = 8.7 Hz, PMB CHAr x 2), 6.40 (2H, s, Tmp CHAr x 2), 3.92 (2H, s, 
PMB CH2), 3.70 (3H, s, OMe), 3.67 (3H, s, OMe), 3.66 (6H, s, OMe x 2).  13C-NMR 
(62.8 MHz, CDCl3): δ = 158.6 (qC), 153.0 (qC x 2), 137.1, 130.5 (qC x 2), 129.9 (CHAr x 
2), 129.6 (qC), 113.7 (CHAr x 2),, 108.3 (CHAr x 2), 60.7 (CH3), 55.9 (CH3 x 2), 55.1 
(CH3), 39.6 (CH2).  HRMS (FAB): found 320.1075.  C17H20O4S [M]+ requires 320.1082. 
3,4,5-trimethoxyphenyl-(2-nitrobenzyl)-thioether 16b: column eluent 
EtOAc/petroleum ether bp 40-60 oC, 10:90 - 20:80 (1.155 g, 3.45 mmol, 80 %).  1H-NMR 
(250 MHz, CDCl3): δ = 7.84 (1H, dd, J1 = 7.5 Hz, J2 = 1.8 Hz, ONB CHAr), 7.28 (2H, td, 
J1 = 7.5 Hz, J2 = 1.8 Hz, ONB CHAr x 2), 7.07 (1H, dd, J1 = 7.5 Hz, J2 = 1.8 Hz, ONB 
CHAr), 6.32 (2H, s, Tmb CHAr x 2), 4.25 (2H, s, ONB CH2), 3.67 (3H, s, OMe), 3.60 (6H, 
s, OMe x 2).  13C-NMR (62.8 MHz, CDCl3): δ = 158.0 (qC x 2), 149.0, 138.9, 137.5, (qC 
x 3), 133.3, 131.4 (CHAr x 2), 131.3 (qC), 128.1, 124.9, 120.6, 105.3 (CHAr x 4), 62.3, 






















3,4,5-Trimethoxyphenol (2.00 g, 11.0 mmol) was dissolved in toluene (15.0 ml) and 30 % 
aqueous K3PO4 solution (15.0 ml) was added.  The reaction mixture was cooled to 0 oC 
and trifluoromethansulfonic anhydride (2.20 ml, 13.0 mmol) was added slowly dropwise 
with stirring to maintain a reaction temperature of < 10 oC.  The reaction mixture was 
allowed to warm to room temperature and stirred for a further 1 hour, then extracted with 
toluene (2 x 10.0 ml).  The combined organic extracts were washed with water (30.0 ml), 
dried over MgSO4 and concentrated in vacuo to give 18 as a pale yellow solid (3.23 g, 92 
%) which was used without further purification.  m.p. 62-63 oC.  IR (nujol) νmax  1420  
cm-1.  1H-NMR (250 MHz, CDCl3): δ = 6.58 (2H, s, CHAr x 2), 3.95 (6H, s, OMe x 2), 
3.93 (3H, s, OMe).  13C-NMR (62.8 MHz, CDCl3): δ = 153.6 (qC x 2), 145.1, 128.9, 
128.1 (qC x 3), 99.9 (CHAr x 2), 60.9 (CH3), 56.3 (CH3 x 2).  19F-NMR (235.3 MHz, 


























4,6-diphenyl-2-pyrone (1.00 g, 4.03 mmol) and Lawesson’s reagent (3.26 g, 8.06 mmol) 
were suspended in anhydrous toluene (10.0 ml) under Ar.  The reaction mixture was 
heated to reflux under a drying tube overnight.  The reaction mixture was allowed to cool 
and then concentrated in vacuo and purified by column chromatography over silica 
(EtOAc/petroleum ether bp 40-60 oC, 20:80) to afford 21 as a red solid (1.06 g, 4.01 
mmol, 100 %).  1H-NMR (250 MHz, CDCl3): δ = 8.00 (1H, m, CHAr), 7.71 (2H, m, CHAr 
x 2), 7.53-7.47 (7H, m, CHAr x 6 + CH), 7.20 (1H, d, J = 1.7 Hz, CH).  13C-NMR (62.8 
MHz, CDCl3): δ = 196.8, 165.2, 148.3, 135.2 (qC x 4), 131.3 (CH), 130.6 (qC), 131.0, 
129.3 (CH x 2), 129.0 (CH x 2), 126.8 (CH x 2), 125.9 (CH x 2), 125.4 (CH), 104.9 (CH 



















21 (1.05 g, 3.98 mmol) was dissolved in MeOH (60.0 ml).  Ethanolamine (290 µl, 4.80 
mmol) was added and the reaction mixture was heated to reflux for 7 hours.  After this 
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time TLC analysis indicated incomplete reaction, so a further portion of ethanolamine 
(145 µl, 2.40 mmol) was added and heating was resumed for a further 5 hours.  The 
reaction mixture was allowed to cool and concentrated in vacuo to give an orange solid, 
which was triturated with H2O.  The crude residue was then purified by column 
chromatography over silica (EtOAc/petroleum ether bp 40-60 oC, 30:70) to afford 20 as a 
yellow foam (871 mg, 2.84 mmol, 71 %).  m.p 113-114 oC.  IR (nujol) νmax  3285, 1051 
cm-1.  1H-NMR (250 MHz, CDCl3): δ = 8.07 (1H, d, J = 2.2 Hz, CH), 7.62 (2H, m, CHAr 
x 2), 7.51 (3H, m, CHAr x 3), 7.45 (3H, m, CHAr x 3), 7.40 (2H, m, CHAr x 2), 6.38 (1H, 
d, J = 2.2 Hz, CH), 4.81 (2H, t, J = 5.5 Hz, CH2), 3.91 (2H, t, J = 5.5 Hz, CH2).  13C-NMR 
(62.8 MHz, CDCl3): δ = 181.1, 153.0, 145.2, 135.7, 135.2 (qC x 5), 131.5, 130.0, 129.7 
(CH x 3), 129.1 (CH x 2), 128.8 (CH x 2), 128.5 (CH x 2), 126.9 (CH), 115.6 (CH x 2), 





















20 (1.00 g, 3.26 mmol) was dissolved in anhydrous benzene (40.0 ml) and 2-nitrobenzyl 
bromide (700 mg, 3.24 mmol) was added.  The reaction mixture was stirred under argon 
at room temperature for 24 hours, after which time a yellow precipitate of the pyridinium 
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bromide salt had formed.  The precipitate was filtered off and washed with benzene (2 x 
20.0 ml).  The combined filtrates were concentrated in vacuo and purified by column 
chromatography over silica (EtOAc/petroleum ether bp 40-60 oC, 10:90 – 30:70) to afford 
19 as a clear liquid (410 mg, 2.43 mmol, 75 %).  1H-NMR (250 MHz, CDCl3): δ = 8.02 
(1H, m, CHAr), 7.57 (1H, m, CHAr), 7.45 (1H, m, CHAr), 7.35 (1H, m, CHAr), 4.02 (2H, d, 
J = 8.4 Hz, CH2), 2.14 (1H, t, J = 8.3 Hz, SH).  13C-NMR (62.8 MHz, CDCl3): δ = 136.8 
(qC), 132.9 (CHAr), 132.7 (qC), 131.4, 128.1, 125.4 (CHAr x 3), 26.3 (CH2).  LRMS 
(ESI): found 168.1.  C7H6NO2S [M-1]- requires 168.01. 
 
 








17: X = Br
18: X = OTf
16a: R = PMB
16b: R = ONB




200 mg of bromide 17 or triflate 18 was placed in a microwave tube and 11 mol % 
palladium diacetate and 11 mol % (R)-(+)-BINAP were added.  The tube was sealed with 
a metal cap with septum, then toluene (5.0 ml or 2.5 ml in biphasic reactions), thiol (1.4 
eq.) and base (1.4 eq. or 2.5 ml 10 % K3PO4) were added under argon.  The tube was 
placed in a CEM Discover microwave operated with ChemDriver software and heated at 
120 oC at a microwave power of 200 W for 20 minutes.  The reaction mixture was diluted 
with ethyl acetate (25.0 ml) and washed with brine (15.0 ml), then dried over magnesium 
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sulfate, filtered and evaporated under vacuum.  The crude products were purified by 
column chromatography over silica.  3,4,5-trimethoxy-(4-methoxybenzyl)-thioether 
16a was isolated in the yields detailed in Table 2 by the above procedure, identical to 16a 
produced by displacement of PMB chloride with disulfide 15 by TLC, NMR and MS.  
3,4,5-trimethoxy-(2-nitrobenzyl)-thioether 16b could not be isolated. 
 
 









1.5 eq PMBSH, 2 eq base






Triflate 18 (50 mg, 0.16 mmol) was placed in a microwave tube and 6 mol % catalyst, 8 
mol % ligand, base (0.32 mmol) and 4-methoxybenzyl mercaptan (35 µl, 0.24 mmol) 
were added.  The tube was sealed with a metal cap with septum, then the solvent (2.5 ml) 
was added under argon.  The tube was placed in a CEM Discover microwave operated 
with ChemDriver software and heated at 150 oC at a microwave power of 200 W for 20 
minutes.  100 µl of the reaction mixture was diluted with MeOH (10.0 ml) and the 
resulting solution was filtered and analysed by HPLC against an standard sample of 16a.  
Analytical  HPLC was performed using a Phenomenex Luna C18 LC-MS column (250×5 
mm) and a gradient of 10-90 % acetonitrile containing 0.1 % TFA over 45 minutes (flow 
rate of 0.1 ml/min) with UV detection at 254 nm.   
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Triflate 18 (200 mg, 0.64 mmol) was placed in a microwave tube and DiPPF (20 mg, 0.05 
mmol, 8 mol %), Pd(OAc)2 (8 mg, 0.04 mmol, 6 mol %), NEt3 (170 µl, 1.20 mmol) and 
4-methoxybenzyl mercaptan (125 µl, 0.89 mmol) were added.  The tube was sealed with 
a metal cap with septum, then anhydrous dioxane (5.0 ml) was added under argon.  The 
tube was placed in a CEM Discover microwave operated with ChemDriver software and 
heated at 150 oC at a microwave power of 200 W for 20 minutes.  The reaction mixture 
was diluted with ethyl acetate (25.0 ml) and washed with brine (15.0 ml), then dried over 
magnesium sulfate, filtered and evaporated under vacuum.  The crude products were 
purified by column chromatography over silica (EtOAc/petroleum ether bp 40-60 oC, 
















16a: R1 = PMB
16b: R1 = ONB
DMF, POCl3
DCM, 0 oC - 140 oC
10a: R1 = PMB (90 %)
10b: R1 = ONB (55 %)  
 
Thioether 16a or 16b (2.70 mmol) was dissolved in anhydrous DCM (5.0 ml) and added 
to a flame-dried flask fitted with a condenser under an argon atmosphere.  Anhydrous 
DMF (0.21 ml, 2.70 mmol) was added and the reaction mixture was cooled to 0 oC.  
Phosphorous oxychloride (0.29 ml, 3.10 mmol) was added slowly dropwise over 10 
minutes.  The reaction was allowed to warm to room temperature, then heated to 150 oC 
for 5 hours.  The reaction was allowed to cool, saturated sodium bicarbonate solution 
(20.0 ml) was added dropwise and the reaction was stirred at room temperature for 3 
hours.  The reaction mixture was then extracted with DCM (3 x 20.0 ml).  The combined 
organic extracts were washed with brine (30.0 ml), dried over magnesium sulfate and 
evaporated under vacuum to give a brown solid, which was purified by column 
chromatography over silica to give the products 10a or 10b. 
4,5,6-trimethoxy-2-(4-methoxybenzylthio)-benzaldehyde 10a: column eluent EtOAc/ 
petroleum ether bp 40-60 oC, 20:80 (white solid, 841 mg, 2.42 mmol, 90 %).  1H-NMR 
(250 MHz, CDCl3): δ = 10.26 (1H, s, aldehyde), 7.27 (2H, d, J = 8.6 Hz, PMB CHAr x 2), 
6.77 (2H, d, J = 8.6 Hz, PMB CHAr x 2), 6.51 (1H, s, Tmb CHAr), 4.02 (2H, s, PMB CH2), 
3.90 (3H, s, OMe), 3.76 (3H, s, OMe), 3.74 (3H, s, OMe), 3.71 (3H, s, OMe).  13C-NMR 
(62.8 MHz, CDCl3): δ = 188.8 (qC, aldehyde), 158.8, 158.1, 157.9, 139.6, 138.1 (qC x 5), 
129.7 (CHAr), 127.7, 119.9 (qC x 2), 113.9 (CHAr x 2), 104.4 (CHAr x 2), 62.2, 60.9, 55.9, 
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55.1 (CH3 x 4, OMe x 4), 36.5 (CH2).  m/z (ESI): 371.0 [MNa]+, C18H20O5SNa requires 
M 371.09. 
4,5,6-trimethoxy-2-(2-nitrobenzylthio)-benzaldehyde 10b: column eluent EtOAc/ 
petroleum ether bp 40-60 oC, 20:80-30:70 (yellow solid, 539 mg, 1.48 mmol, 55 %).  1H-
NMR (250 MHz, CDCl3): δ = 10.25 (1H, s, aldehyde), 7.75 (1H, d, J = 7.5 Hz, ONB 
CHAr), 7.61 (1H, d, J = 7.6 Hz, ONB CHAr), 7.47 (1H, t, J = 7.5 Hz, ONB CHAr), 7.37 
(1H, t, J  = 7.6 Hz, ONB CHAr), 6.38 (1H, s, Tmb CHAr), 4.42 (2H, s, ONB CH2), 3.90 
(3H, s, OMe), 3.56 (3H, s, OMe), 3.36 (3H, s, OMe).  13C-NMR (62.8 MHz, CDCl3): δ = 
188.9 (qC, aldehyde), 158.0 (qC x 2), 149.0, 138.9, 137.5, (qC x 3), 133.3, 131.4 (CHAr x 
2), 131.3 (qC), 128.1, 124.9 (CHAr x 2), 120.6 (qC), 105.3 (CHAr), 62.3, 60.9, 55.9 (CH3 x 
3), 33.7 (CH2).  LRMS (ESI): found 364.1.  C17H18NO6S [MH]+ requires 364.09. 
 
 













DCM, 2 % AcOH
10a: R1 = PMB (90 %)










22a: R1 = PMB, R2 = H (93 %)
22b: R1 = ONB, R2 = H (93 %)
22c: R1 = PMB, R2 = Me (96 %)
22d: R1 = PMB, R2 = CH2OtBu (94 %)  
 
Benzaldehyde 10a or 10b (500 mg) was dissolved in DCM (40.0 ml) and acetic acid 
(0.80 ml, 2 %).  The appropriate t-butyl protected amino acid (1.2 eq.) was added, 
followed by sodium triacetoxyborohydride (2.0 eq.).  The reaction mixture was stirred at 
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room temperature for one hour, then neutralised with saturated sodium bicarbonate 
solution (50.0 ml).  The reaction mixture was extracted with DCM (3 x 40.0 ml), washed 
with brine (50.0 ml), then dried over MgSO4 and concentrated in vacuo to a yellow oil.  
The crude products were purified by column chromatography over silica to afford the 
pure products as white foams in yields of 93-96 %. 
N-4,5,6-trimethoxy-2-(4-methoxybenzylthio)benzylglycinet-butyl ester 22a: column 
eluent EtOAc/ petroleum ether bp 40-60 oC, 50:50 (93 %).  1H-NMR (250 MHz, CDCl3): 
δ = 7.08 (2H, d, J = 9.0 Hz, PMB CHAr x 2), 6.74 (2H, d, J = 9.0 Hz, PMB CHAr x 2), 
6.58 (1H, s, Tmb, CHAr), 3.93 (2H, s, PMB CH2), 3.83 (3H, s, OMe), 3.80 (3H, s, OMe), 
3.78 (2H, s, Tmb CH2), 3.73 (3H, s, OMe), 3.69 (3H, s, OMe), 3.21 (2H, s, Cα-H2), 2.29 
(1H, bs, NH), 1.39 (9H, s, tBu).  13C-NMR (62.8 MHz, CDCl3): δ = 171.4, 158.6, 152.1, 
152.3, 141.9, 130.3 (qC x 6), 129.9 (CHAr x 2), 129.2, 127.6 (qC x 2), 113.7 (CHAr x 2), 
111.8 (CHAr), 80.7 (qC, tBu), 61.1, 60.6, 55.8, 55.1 (CH3 x 4, OMe x 4), 50.7, 44.8, 40.0 
(CH2 x 3), 27.9 (CH3 x 3, tBu).  LRMS (ESI): found 463.8.  C24H34NO6S [MH]+ requires 
M 464.21. 
N-4,5,6-trimethoxy-2-(2-nitrobenzylthio)benzylglycinet-butyl ester 22b: column 
eluent EtOAc/ petroleum ether bp 40-60 oC, 40:60 (93 %).  1H-NMR (250 MHz, CDCl3): 
δ = 7.89 (1H, dd, J1 = 7.5 Hz, J2 = 1.8 Hz, ONB CHAr), 7.36 (2H, td, J1 = 7.5 Hz, J2 = 1.8 
Hz, ONB CHAr x 2), 7.14 (1H, dd, J1 = 7.5 Hz, J2 = 1.8 Hz, ONB CHAr), 6.49 (1H, s, Tmb 
CHAr), 4.32 (2H, s, ONB CH2), 3.84 (3H, s, OMe), 3.81 (3H, s, OMe), 3.76 (2H, s, Tmb, 
CH2), 3.65 (3H, s, OMe), 3.22 (2H, s, Cα-H2), 2.76 (1H, s, NH), 1.39 (9H, s, OtBu).  13C-
NMR (62.8 MHz, CDCl3): δ = 171.3, 152.6, 152.3 148.5, 142.5, 133.4 (qC x 6), 132.7, 
132.2 (CHAr x 2), 129.1, 128.1 (qC x 2), 128.0, 124.9, 113.8 (CHAr x 3), 80.7 (qC, tBu), 
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61.1, 60.6, 55.8 (CH3 x 3, OMe x 3), 50.6, 45.1, 37.9 (CH2 x 3), 27.9 (CH3 x 3, tBu).  
LRMS (ESI): found 479.2.  C23H31N2O7S [MH]+ requires M 479.19. 
N-4,5,6-trimethoxy-2-(4-methoxybenzylthio)benzyl-L-alaninet-butyl ester 22c: 
column eluent EtOAc/ petroleum ether bp 40-60 oC, 50:50 (96 %).  1H-NMR (250 MHz, 
CDCl3): δ = 6.91 (2H, d, J = 8.6 Hz, PMB CHAr x 2), 6.69 (2H, d, J = 8.6 Hz, PMB CHAr 
x 2), 6.64 (1H, s, Tmb CHAr), 4.04 (2H, s, PMB CH2), 3.89 (3H, s, OMe), 3.76 (4H, s + 
m, OMe + Cα-H), 3.69 (3H, s, OMe), 3.69 (3H, s, OMe), 3.66 (1H, d, J = 3.1 Hz, 
benzylic CHa), 3.60 (1H, d, J = 3.1 Hz, benzylic CHb), 1.47 (3H, d, J = 5.4 Hz, Cα-Me), 
1.33 (9H, s, tBu).  13C-NMR (62.8 MHz, CDCl3): δ = 167.9, 160.8, 157.4, 154.8, 141.5, 
130.6 (qC x 6), 129.9 (CHAr x 2), 129.1, 118.2 (qC x 2), 113.7 (CHAr x 2), 113.4 (CHAr), 
84.8 (qC, tBu), 61.1, 60.7 (CH3 x 2, OMe x 2), 55.9 (CH), 55.5, 55.0 (CH3 x 2, OMe x 2), 
44.1, 40.9 (CH2 x 2), 29.5 (CH3 x 3, tBu), 15.1 (CH3 Cα-Me).  LRMS (ESI): found 478.1.  
C25H36NO6S [MH]+ requires M 478.23. 
N-4,5,6-trimethoxy-2-(4-methoxybenzylthio)benzyl-L-serine(O-t-butyl)t-butyl ester 
22d: column eluent EtOAc/ petroleum ether bp 40-60 oC, 30:70 (94 %).  1H-NMR (250 
MHz, CDCl3): δ = 7.05 (2H, d, J = 9.0 Hz, PMB CHAr x 2), 6.71 (2H, d, J = 9.0 Hz, PMB 
CHAr x 2), 6.53 (1H, s, Tmb CHAr), 3.91 (2H, s, PMB CH2), 3.81 (1H, d, J = 1.9 Hz, 
benzylic CHa), 3.80 (3H, s, OMe), 3.77 (s, OMe), 3.74 (1H, d, J = 1.9 Hz, benzylic CHb), 
3.70 (3H, s, OMe), 3.64 (3H, s, OMe), 3.40 (2H, m, Cα-CH2), 3.25 (1H, t, J = 5.9 Hz, Cα-
H), 2.16 (1H, bs, NH), 1.38 (9H, s, tBu), 1.06 (9H, s, tBu).  13C-NMR (62.8 MHz, 
CDCl3): δ = 172.6, 158.6, 152.6, 152.1, 141.6 (qC x 5), 130.1 (CHAr x 2), 130.0, 129.5, 
128.5 (qC x 3), 113.6 (CHAr x 2), 112.3 (CHAr), 80.4, 72.7 (qC x 2, tBu x 2), 63.2 (CH2), 
61.9 (CH), 60.6, 60.2, 55.8, 55.1 (CH3 x 4, OMe x 4), 44.3, 40.1 (CH2 x 2), 28.0 (CH3 x 
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22a: R1 = PMB, R2 = H
22b: R1 = ONB, R2 = H
22c: R1 = PMB, R2 = Me
22d: R1 = PMB, R2 = CH2OtBu
95 % aq. TFA
0 oC
11c: R1 = PMB, R2 = Me (76 %)
11d: R1 = PMB, R2 = CH2OH (71 %)
 
 
95 % TFA v/v , 5 % H2O v/v (5.0 ml) was slowly added to the t-butyl protected auxiliary-
amino acid (200 mg) at 0 oC.  The reaction mixture was stirred for 3 - 4 hours at 0 oC 
until the reaction was complete by TLC analysis.  The reaction mixture was then 
evaporated under vacuum and azeotroped with toluene.  The crude auxiliary-alanine and 
serine acids 11c and 11d were then purified by column chromatography over silica. 
N-4,5,6 - trimethoxy- 2-(4-methoxybenzylthio)benzyl alanine 11c: column eluent 
EtOAc/ petroleum ether bp 40-60 oC, 70:30-100:0 (yellow foam, 76 %).  1H-NMR (250 
MHz, CDCl3): δ = 8.38 (1H, bs, CO2H), 6.96 (2H, d, J = 8.6 Hz, PMB CHAr x 2), 6.68 
(2H, d, J = 8.5 Hz, PMB CHAr x 2), 6.49 (1H, s, Tmb CHAr), 4.14 (1H, d, J = 5.8 Hz, Tmb 
CH), 4.10 (1H, d, J = 5.8 Hz, Tmb CH), 3.85 (3H, s, OMe), 3.83 (2H, s, PMB CH2), 3.72 
(3H, s, OMe), 3.68 (3H, s, OMe), 3.62 (3H, s, OMe), 3.25 (1H, q, J = 7.0 Hz, Cα-H), 1.42 
(3H, d, J = 7.0 Hz, Cα-Me).  13C-NMR (62.8 MHz, CDCl3): δ = 173.4, 158.8, 154.0, 
152.6, 141.4, 130.8 (qC x 6), 130.0 (CHAr x 2), 129.0, 119.4 (qC x 2), 113.7 (CHAr x 2), 
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113.0 (CHAr), 61.2, 60.7, 55.8 (CH3 x 3), 55.3 (CH), 55.1 (CH3), 41.9, 40.5 (CH2 x 2), 
14.5 (CH3).  LRMS (ESI): found 421.9.  C21H28NO6S [MH]+ requires M 422.16. 
N-4,5,6 - trimethoxy- 2-(4-methoxybenzylthio)benzyl serine 11d: column eluent 
DCM/MeOH, 95:5-80:20 (white foam, 71 %).  1H-NMR (250 MHz, CDCl3): δ = 8.82-
7.45 (1H, bs, CO2H), 6.90 (2H, d, J = 8.5 Hz, PMB CHAr x 2), 6.68 (2H, d, J = 8.5 Hz, 
PMB CHAr x 2), 6.52 (1H, s, Tmb CHAr), 4.98 (1H, bs, NH), 4.08 (2H, AB quartet, Tmb 
CH x 2), 3.88-3.75 (5H, s, OMe + PMB CH2), 3.71 (3H, s, OMe), 3.65 (3H, s, OMe), 
3.61 (3H, s, OMe), 3.36 (3H, m, Cα-CH2 + OH), 1.18 (1H, d, J = 8.0 Hz, Cα-H).  13C-
NMR (62.8 MHz, CDCl3): δ = 172.0, 158.8, 154.4, 152.5, 141.4, 130.7 (qC x 6), 130.0 
(CHAr x 2), 129.0, 118.6 (qC x 2), 113.7 (CHAr x 2), 113.4 (CHAr), 61.1 (CH), 60.7, 55.7, 
55.0, 50.5 (CH3 x 4), 43.0, 40.5, 29.6 (CH2 x 3).  LRMS (ESI): found 438.1. C21H28NO7S 
[MH]+ requires M 438.16. 
 
 


















22a: R = PMB
22b: R = ONB
11a: R = PMB (67 %)
11b: R = ONB (71 %)





The t-butyl protected auxiliary-glycine ester 22a or 22b was subjected to TFA 
deprotection exactly as described above for formation of 11c and 11d.  Following 
azeotropic evaporation, the crude residue was dissolved in H2O (5.0 ml).  NEt3 (1.0 eq. 
based on 22) was added.  9-fluorenylmethoxycarbonyl-N-hydroxysuccinimide (1.0 eq.) 
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was dissolved in acetonitrile (5.0 ml) and added with stirring.  The reaction mixture was 
stirred at room temperature for 3 hours, maintaining a pH of 8.5 - 9.0 by the addition of 
further NEt3 as necessary.  The reaction mixture was neutralized with 1.5 M HCl and 
extracted with DCM (3 x 20.0 ml).  The combined organic extracts were washed with 1.5 
M HCl (30.0 ml) and brine (30.0 ml), dried over MgSO4, filtered and concentrated in 
vacuo to give the crude products as yellow oils, which were purified by column 
chromatography over silica to afford the products 11a and 11b.  
N-9-fluorenylmethoxycarbonyl-N-4,5,6-trimethoxy-2-(4-methoxybenzylthio)benzyl-
glycine 11a: column eluent EtOAc/petroleum ether bp 40-60 oC, 90:10 (white foam, 67 
%) m.p 72-74 oC.  IR (nujol) νmax  3018, 1718, 1699 cm-1.  1H-NMR (250 MHz, CDCl3): 
δ = 7.54 (4H, m, Fmoc), 7.23 (4H, m, Fmoc), 7.00 (2H, d, J = 7.7 Hz, PMB CHAr x 2), 
6.66 (2H, d, J = 7.7 Hz, PMB CHAr x 2), 6.53 (1H, d, J = 2.7 Hz, Tmb CHAr), 4.65 (2H, 
AB quartet, Tmb CH x 2), 4.39 (2H, d, J = 6.6 Hz, Fmoc CH2), 4.18 (1H, m, Fmoc CH), 
3.84 (2H, s, PMB CH2), 3.73 (3H, s, OMe), 3.69 - 3.60 (11H, s x 4, OMe x 3 + CH2).  
13C-NMR (62.8 MHz, CDCl3): δ = 174.7 (qC x2), 171.1 (qC), 158.7 (qC x2), 153.2 (qC 
x2), 143.9 (qC x2), 141.1 (qC x 4), 129.8 (CHAr x 2), 127.5 (CHAr x 2), 126.9 (CHAr x 2), 
125.1, 124.8 (CHAr x 2), 119.9 (CHAr x 2), 113.7 (CHAr x 2), 68.1, 67.5 (CH2 x 2), 60.6, 
60.3, 55.8, 55.1 (CH3 x 4), 60.3 (CH2), 47.1 (CH), 43.1, 39.5 (CH2 x 2).  HRMS (FAB):  
found 629.2088.  C35H35NO8S [M]+ requires 629.2084. 
N-9-fluorenylmethoxycarbonyl-N-4,5,6-trimethoxy-2-(2-nitrobenzylthio)benzyl-
glycine 11b: column eluent EtOAc/petroleum ether bp 40-60 oC, 90:10 (yellow gummy 
solid, 71 %).  IR (nujol) νmax  3018, 1716, 1697, 1526, 1352 cm-1.  1H-NMR (250 MHz, 
CDCl3): δ = 7.80 (1H, dd, J1 = 7.9 Hz, J2 = 1.6 Hz, ONB CHAr), 7.66 (2H, m, Fmoc CHAr 
x 2), 7.51 (2H, m, Fmoc CHAr x 2), 7.36-7.11 (7H, m, Fmoc CHAr x 4 + ONB CHAr x 3), 
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6.46 (1H, s, Tmb CHAr), 4.58 (2H, AB quartet, Tmb CH x 2), 4.40 (2H, d, J = 5.6 Hz, 
Fmoc CH2), 4.11-4.28 (3H, m + s, Fmoc CH + ONB CH2), 3.75 (3H, s, OMe), 3.67 (3H, 
s, OMe), 3.61 (2H, s, CH2), 3.63 (3H, s, OMe).  13C-NMR (62.8 MHz, CDCl3): δ = 174.3 
(qC x 2), 171.1, 153.3, 148.5, 143.8 (qC x 4), 141.2 (qC x 4), 133.0 (qC), 132.9 (CHAr x 
2), 132.1 (CHAr), 129.5 (qC), 128.1 (CHAr x 2), 127.5 (CHAr x 2), 126.9 (CHAr x 2), 125.1 
(qC), 119.8 (CHAr x 2), 60.7 (CH3 x 2), 60.3 (CH2 x 2), 55.8 (CH3), 47.1 (CH2), 43.4 
















12a: R = PMB (98 %)
12b: R = Trt (96 %)  
 
2-bromo-2,4-dimethoxyacetophenone (250 mg, 0.97 mmol) was dissolved in DMF (5.0 
ml).  Diisopropylethylamine (202 µl, 1.16 mmol) was added, followed by para-
methoxybenzyl thiol or trityl thiol (1.16 mmol).  The reaction mixture was stirred at room 
temperature for 2 hours, then evaporated to dryness in vacuo.  The crude residue was 
dissolved in ethyl acetate (100 ml) and washed with brine (50.0 ml).  The aqueous extract 
was extracted with ethyl acetate (50.0 ml) and the combined organic extracts were dried 
over MgSO4, filtered and evaporated under vacuum to give yellow solids, which were 
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purified by column chromatography over silica to give the products 12a and 12b as white 
or yellow solids.   
2-keto-2-(2,4-dimethoxyphenyl) (S-paramethoxybenzyl) ethanethiol 12a: column 
eluent EtOAc/petroleum ether bp 40-60 oC, 20:80 (white solid, 98 %).  m.p. 69-71 oC.   
1H-NMR (250 MHz, CDCl3): δ = 8.03 (1H, d, J = 8.8 Hz, Dmb CHAr), 7.38 (2H, d, J = 
8.0 Hz, PMB CHAr x 2), 6.95 (2H, d, J = 8.7 Hz, PMB CHAr x 2), 6.68 (1H, dd, J = 8.8 
Hz, J = 2.3 Hz, Dmb CHAr), 6.58 (1H, d, J = 2.3 Hz, Dmb CHAr), 3.98 (6H, s x 2, OMe x 
2), 3.91 (3H, s, OMe), 3.83 (2H, s, CH2), 3.78 (2H, s, CH2).  13C-NMR (62.8 MHz, 
CDCl3): δ = 193.9, 164.7, 160.6, 158.5 (qC x 4), 133.3 (CHAr), 130.2 (CHAr x 2), 129.8, 
119.0 (qC x 2), 113.7 (CHAr x 2), 105.4, 98.2  (CH x 3), 55.4 (CH3 x 2), 55.1 (CH3), 40.9, 
35.0 (CH3 x 2).  HRMS (FAB): found 355.0973.  C18H20O4SNa [MNa]+ requires 
355.0980. 
2-keto-2-(2,4-dimethoxyphenyl) (S-trityl) ethanethiol 12b: column eluent 
EtOAc/petroleum ether bp 40-60 oC, 10:90-30:70 (pale yellow solid, 96 %).  Decomposes 
at 121 oC.  1H-NMR (250 MHz, CDCl3): δ = 7.60 (1H, d, J = 8.6 Hz, Dmb CHAr), 7.32 
(6H, m, Trt), 7.12 (9H, m, Trt), 6.36 (1H, dd, J = 8.6 Hz, J = 2.3 Hz, Dmb CHAr), 6.19 
(1H, d, J = 2.3 Hz, Dmb CHAr), 3.69 (3H, s, OMe), 3.51 (5H, s, OMe + CH2).  13C-NMR 
(62.8 MHz, CDCl3): δ = 193.9, 164.1, 160.1 (qC x 4), 144.1 (qC x 3), 132.5 (CHAr), 
129.0 (CHAr x 6), 127.3 (CHAr x 6), 125.9 (CHAr x 3), 118.9 (qC), 104.6, 97.4 (CHAr x 2), 
65.4 (qC), 54.9, 54.6 (CH3 x 2), 44.6 (CH2).  HRMS (FAB): found 477.1503.  





















26 (94 %)  
 
2,4-dimethoxybenzaldehyde (100 mg, 0.60 mmol) was dissolved in DCM (5.0 ml) 
containing acetic acid (100 µl, 2 %).  t-butyl protected glycine (150 mg, 0.78 mmol) was 
added, followed by sodium triacetoxyborohydride (254 mg, 1.20 mmol).  The reaction 
mixture was stirred at room temperature for 1 hour, then neutralised with saturated 
sodium bicarbonate solution (20.0 ml).  The reaction mixture was extracted with DCM (3 
x 20.0 ml), washed with brine (30.0 ml), then dried over MgSO4, filtered and evaporated 
to a yellow oil.  The crude products were purified by column chromatography over silica 
(EtOAc/petroleum ether bp 40-60 oC, 50:50-70:30)  to afford 26 as a clear oil (159 mg, 
0.57 mmol, 94 %).  1H-NMR (250 MHz, CDCl3): δ = 7.05 (1H, d, J = 8.1 Hz CHAr), 6.36 
(1H, s, CHAr), 6.34 (1H, d, J = 2.4 Hz, CHAr), 3.79 (3H, s, OMe), 3.73 (3H, s, OMe), 3.66 
(2H, s, Dmb CH2), 3.21 (2H, s, Cα-H2), 2.05 (1H, bs, NH), 1.38 (9H, s, tBu).  LRMS 
(ESI): found 282.0.  C15H24NO4 [MH]+ requires 282.17.  Spectroscopic data in good 














12a 25 (89 %)
MeOH
0 oC - RT
 
 
Ketone 12a (100 mg, 0.30 mmol) was dissolved in anhydrous MeOH and the reaction 
mixture was cooled to 0 oC.  NaBH4 (13 mg, 0.33 mmol) was added in 4 portions over 1 
hour.  The reaction mixture was stirred for a further 30 minutes at 0 oC, then allowed to 
warm to room temperature and stirring was continued for a further 1 hour.  The reaction 
mixture was concentrated in vacuo, then partitioned between EtOAc (20.0 ml) and H2O 
(20.0 ml) and stirred vigorously for 1 hour, then extracted with EtOAc (3 x 20.0 ml), 
dried over MgSO4 and concentrated in vacuo.  The crude product was purified by column 
chromatography over silica (EtOAc/petroleum ether bp 40-60 oC, 20:80) to afford 25 as a 
clear gummy solid (89 mg, 0.27 mmol, 89 %).  1H-NMR (250 MHz, CDCl3): δ = 7.45 
(1H, d, J = 8.4 Hz, Dmb CHAr), 7.36 (2H, d, J = 6.6 Hz, PMB CHAr x 2), 6.98 (2H, d, J = 
8.7 Hz, PMB CHAr x 2), 6.64 (1H, dd, J1 = 8.4 Hz, J2 = 2.4 Hz, Dmb CHAr), 6.57 (1H, d, J 
= 2.4 Hz, Dmb CHAr), 5.09 (1H, dd, J1 = 8.6 Hz, J2 = 4.0 Hz, Dmb CH), 3.94 (9H, s, OMe 
x 3), 3.80 (2H, s, PMB CH2), 3.01 (1H, d x 2, J = 4.0 Hz), 2.76 (1H, d x 2, J = 8.6 Hz).  

















80 % crude yield  
 
Glycine t-butyl ester (570 mg, 2.98 mmol) and benzophenone imine (0.50 ml, 2.98 ml) 
were dissolved in anhydrous DCM (10.0 ml) under a CaCl2 drying tube and the reaction 
mixture was stirred at room temperature overnight.  The reaction mixture was washed 
with brine (5.0 ml), dried over MgSO4 and evaporated to dryness in vacuo to give the 
crude product 27 as a white solid (703 mg, 80 % crude yield) containing slight impurities 
by 1H NMR and TLC.  The crude product was therefore purified by column 
chromatography over silica (EtOAc/petroleum ether bp 40-60 oC, 0:100-10:90).  27 
appeared to be unstable to chromatography however, as the starting imine was isolated as 
the major product.  Almost all column fractions containing the desired product were also 
contaminated with the starting material.  Chromatographic purification thus afforded only 
17 mg (0.06 mmol, 2 %) of uncontaminated 27 as a white solid.  m.p. 109-111 oC 
(literature 111-112 oC, reference 194).  1H-NMR (250 MHz, CDCl3): δ = 7.58 (2H, dd, J1 
= 7.9 Hz, J2 = 1.3 Hz, CHAr x 2), 7.39 (3H, m, CHAr x 2), 7.26 (3H, m, CHAr x 3), 7.11 
(2H, m, CHAr x 2), 4.04 (2H, s, Cα-H2), 1.38 (9H, s, tBu).  LRMS (ESI): found 296.0.  





















12a: R1 = PMB
12b: R1 = Trt
30a: R1 = PMB, R2 = H (79 %)
30b: R1 = Trt, R2 = H (61 %)
13a: R1 = PMB, R2 = CH2CO2H (77 %)
13b: R1 = Trt, R2 = CH2CO2H (58 %)
13c: R1 = Trt, R2 = CH(CH3)CO2H (55 %)
 
 
Ketone 12a or 12b (0.60 mmol) was dissolved in MeOH (5.0 ml).  DCM (0.5 ml) was 
added to reactions with ketone 12b to aid solubility.  Ammonium acetate or glycine or 
alanine (6.00 mmol) was added, followed by sodium cyanoborohydride (27 mg, 0.42 
mmol).  The reaction mixtures were heated to reflux for 24 – 48 hours (for reaction with 
ammonium acetate) or 48 – 72 hours (for reaction with amino acid) then evaporated to 
dryness.  With the exception of PMB benzylamine 30a, the crude residues were purified 
by column chromatography over silica to give the products as white or yellow solids.   
2-glycine-2-(2,4-dimethoxyphenyl) (S-paramethoxybenzyl) ethanethiol 13a: column 
eluent EtOAc/MeOH, 80:20-60:40 (pale yellow solid, 77 %) m.p 164-166 oC.  IR (nujol) 
νmax  3359, 3043, 1681 cm-1.  1H-NMR (250 MHz, CDCl3): δ = 7.11 (2H, d, J = 8.6 Hz, 
PMB CHAr x 2), 7.03 (1H, d, J = 8.5 Hz, DMB CHAr), 6.76 (2H, d, J = 8.6 Hz, PMB CHAr 
x 2), 6.43 (2H, m, DMB CHAr x 2), 4.13 (1H, m, DMB CH), 3.74 (9H, m, OMe x 3), 3.54 
(2H, s, CH2), 3.12 (2H, s, CH2), 2.90 (2H, m, CH2).  13C-NMR (62.8 MHz, CDCl3): δ = 
172.0, 165.2, 165.0, 161.8, 161.3 (qC x 5), 133.8 (CHAr), 133.0 (CHAr x 2), 132.0 (qC), 
116.9 (CHAr x 2), 108.3, 102.0 (CHAr x 2), 61.1 (Dmb CH), 58.3 (CH3 x 2) 58.0 (CH3), 
 199
50.2, 38.1, 35.5 (CH2 x 3).  HRMS (FAB): found 392.1535.  C20H26NO5S [MH]+  
requires 392.1532. 
2-glycine-2-(2,4-dimethoxyphenyl) (S-trityl) ethanethiol 13b: column eluent 
EtOAc/MeOH, 100:0-60:40 (pale yellow solid, 58 %) m.p. 144-146 oC.  IR (nujol) νmax  
3361, 3044, 1681 cm-1.  1H-NMR (250 MHz, CDCl3): δ = 7.30-7.15 (5H, m, Trt), 7.17-
7.06 (10H, m, Trt), 6.91 (1H, d, J = 8.4 Hz, Dmb CHAr), 6.35 (1H, dd, J1 = 8.4 Hz, J2 = 
2.3 Hz, Dmb CHAr), 6.30 (1H, d, J = 2.3 Hz, Dmb CHAr), 3.51 (3H, s, OMe), 3.59 (3H, s, 
OMe), 3.45 (1H, m, Dmb CH), 3.04-2.88 (2H, m, CH2), 2.86-2.76 (2H, m, CH2).  13C-
NMR (62.8 MHz, CDCl3): δ = 171.1, 161.5, 158.1 (qC x 3), 144.2 (qC x 3), 131.3 
(CHAr), 129.4 (CHAr x 6), 127.9 (CHAr x 6), 126.5 (CHAr x 3), 113.7 (qC), 104.4, 98.8 
(CHAr x 2), 67.0 (qC), 60.3 (CH), 55.3 (CH3 x 2), 47.3, 38.3 (CH2 x 2).  HRMS (FAB): 
found 514.2056.  C31H32NO4S [MH]+ requires 514.2052. 
2-alanine-2-(2,4-dimethoxyphenyl) (S-trityl) ethanethiol 13c: column eluent 
EtOAc/MeOH, 90:10-70:30 (pale yellow solid, 55 %, 3:2 mixture of diastereomers) m.p. 
153-156 oC.  IR (nujol) νmax  3360, 3041, 1685 cm-1.  1H-NMR (250 MHz, CDCl3): δ = 
7.55-7.40 (5H, m, Trt), 7.39-7.20 (10H, m, Trt), 7.00 (0.6H, d, J = 8.5 Hz, Dmb CHAr), 
6.85 (0.4H, d, J = 8.5 Hz, Dmb CHAr), 6.54-6.43 (2H, m, Dmb CHAr x 2), 3.87 (1.8H, s, 
OMe), 3.85 (1.2H, s, OMe), 3.83 (1.2H, s, OMe), 3.74 (1.8H, s, OMe), 3.53 (1H, m, Dmb 
CH), 3.24-2.76 (3H, m, CH2 + Cα-H), 1.29 (1.8H, d, J = 7.1 Hz, Cα-CH3), 1.14 (1.2H, d, 
J = 7.1 Hz, Cα-CH3).  13C-NMR (62.8 MHz, CDCl3): δ = 173.3, 162.0, 158.8, 144.9 (qC x 
4), 113.1, 130.0, 128.4, 127.2, 127.0 (CHAr x 5), 114.1 (qC), 104.7, 99.6 (CHAr x 2), 67.5 
(qC), 60.8 (CH), 55.8 (CH3), 54.9 (CH), 34.3 (CH2), 14.6 (CH3).  HRMS (FAB): found 
528.2209. C32H34NO4S [MH]+ requires 528.2208.  HPLC analysis of diastereomeric 
mixture: 1.0 mg of the compound was dissolved in 1.0 ml of 20 % aqueous MeCN and 25 
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µl of the resulting solution was injected into an analytical Phenomenex C18 Luna reverse-
phase column (4.6 mm x 250 mm).  A gradient of 10 % - 85 % MeCN (containing 0.1 % 
v/v TFA) was applied over 40 mins (flow rate of 0.1 ml/min) with UV detection at 254 
nm (see Figure 53).  The two diastereomers eluted at Rt 35.40 and 36.08 min. with a 






Figure 53: HPLC analysis of diastereomeric mixture for 13c. 
 
2-amino-2-(2,4-dimethoxyphenyl) (S-trityl) ethanethiol 30b: : column eluent 
EtOAc/MeOH, 100:0-70:30 (colourless foam, 61 %).  1H-NMR (250 MHz, CDCl3): δ = 
7.12 (5H, m, Trt), 7.19 (10H, m, Trt), 6.78 (1H, d, J = 9.0 Hz, Dmb CHAr), 6.30 (2H, m, 
Dmb CHAr x 2), 3.69 (3H, s, OMe), 3.64 (3H, s, OMe), 3.55 (1H, t, J = 7.5 Hz, Dmb CH), 
2.74 (2H, m, CH2).  13C-NMR (62.8 MHz, CDCl3): δ = 176.4, 160.9, 157.9 (qC x 3), 
144.3, 129.8 (CHAr), 129.4 (CHAr x 6), 128.6 (CHAr x 6), 126.6 (CHAr x 3), 104.0 (CHAr) 
 201
98.7 (CHAr), 67.0 (qC), 55.2, 55.0 (CH3 x 2), 51.6 (CH), 35.2 (CH2).  LRMS (ESI): found 
455.9.  C29H30NO2S [MH]+ requires 456.20. 
2-amino-2-(2,4-dimethoxyphenyl) (S-paramethoxybenzyl) ethanethiol 30a: upon 
cooling the reaction mixture was acidified to pH ≈ 2 with concentrated HCl and washed 
with Et2O (2 x 5.0 ml) to remove unreacted starting material.  The aqueous fraction was 
then basified to pH ≈ 10 with powdered KOH and extracted with DCM (3 x 10.0 ml).  
The combined DCM extracts were dried over MgSO4 and evaporated to dryness in vacuo 
to afford 30a as a colourless foam (79 %) requiring no further purification.  IR (nujol) 
νmax  3368 cm-1.  1H-NMR (250 MHz, CDCl3): δ = 7.42 (1H, s, Dmb CHAr), 7.37 (2H, d, J 
= 8.5 Hz, PMB CHAr x 2), 6.98 (2H, d, J = 8.5 Hz, PMB CHAr x 2), 6.61 (2H, m, Dmb 
CHAr), 4.40 (1H, m, Dmb CH), 3.94 (9H, m, OMe x 3), 3.78 (2H, 2 x s, PMB CH2), 3.02 
(0.4H, d, J = 4.4 Hz, S-CH2), 2.96 (0.6H, J = 4.4 Hz, S-CH2), 2.78 (0.6H, J = 8.6 Hz, S-
CH2), 2.74 (0.4H, J = 8.6 Hz, S-CH2), 2.00 (2H, bs, NH2).  13C-NMR (62.8 MHz, CDCl3): 
δ = 159.8, 158.4, 157.5, 130.4 (qC x 4), 129.8 (CHAr x 2), 127.4 (CHAr), 124.5 (qC), 
113.6 (CHAr x 2),, 103.8, 98.5 (CHAr x 2), 55.2, 55.1, 55.0 (CH3 x 3), 49.4 (CH), 39.0, 




















-10 oC - RT
34a: R = H (99 %)
34b: R = Me (99 %)
34c: R = (CH2)4NHBoc (100 %)  
The Fmoc-protected amino acid (500 mg) was dissolved in dry DCM (25.0 ml) under 
argon and pyridine (1.1 eq.) was added.  The reaction mixture was cooled to -10 oC and 
cyanuric fluoride (5.0 eq.) was added dropwise.  The reaction mixture was allowed to 
warm to room temperature and stirring was continued for 3 hours.  A further portion of 
DCM (10.0 ml) was added, followed by H2O (5.0 ml).  The reaction mixture was then 
filtered and the organic phase was collected and washed with H2O (2 x 15.0 ml), then 
dried over MgSO4 and evaporated to dryness in vacuo to afford the acid fluorides as 
white solids which were used without further purification. 
N-9-fluorenylmethoxycarbonyl-glycine acid fluoride 34a: 99 %.  m.p. 132-133 oC 
(literature 134-135 oC, reference 199).  IR (nujol) νmax  3334, 1844, 1679 cm-1 (literature 
1850 cm-1, reference 199).   1H-NMR (250 MHz, CDCl3): δ = 7.69 (2H, J = 7.2 Hz, Fmoc 
CHAr x 2), 7.49 (2H, d, J = 7.3 Hz, Fmoc CHAr x 2), 7.33-7.20 (4H, m, Fmoc CHAr x 4), 
5.19 (1H, bs, NH), 4.38 (2H, d,  J = 6.9 Hz, Fmoc CH2), 4.60-4.04 (3H, m, Cα-H2 + Fmoc 
CH).  19F-NMR (235.3 MHz, CDCl3): δ = 30.7.  LRMS (ESI): found 299.9.  C17H15FNO3 
[MH]+ requires 300.10. 
N-9-fluorenylmethoxycarbonyl-alanine acid fluoride 34b: 99 %.  m.p. 106-107 oC 
(literature 108 oC, reference 199).  IR (nujol) νmax  3319, 1846, 1686 cm-1 (literature 1850 
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cm-1, reference 199).  1H-NMR (250 MHz, CDCl3): δ = 7.69 (2H, J = 7.2 Hz, Fmoc CHAr 
x 2), 7.50 (2H, d, J = 6.9 Hz, Fmoc CHAr x 2), 7.38-7.20 (4H, m, Fmoc CHAr x 4), 5.12 
(1H, d, J = 7.6 Hz, NH), 4.51-4.30 (3H, m,  Fmoc CH2 + Cα-H), 4.15 (1H, t, J = 6.6 Hz, 
Fmoc CH) 1.46 (3H, d, J = 7.4 Hz, Cα-CH3).  19F-NMR (235.3 MHz, CDCl3): δ = 26.7.  
LRMS (ESI): found 314.1.  C18H17FNO3 [MH]+ requires 314.12. 
N-9-fluorenylmethoxycarbonyl-lysine(N-tbutoxycarbonyl) acid fluoride 34c: 100 %.  
m.p. 121-122 oC (literature 120-121 oC, reference 199).  IR (nujol) νmax  3354, 1854, 1682 
cm-1 (literature 1850 cm-1, reference 199).  1H-NMR (250 MHz, CDCl3): δ = 7.69 (2H, J 
= 7.3 Hz, Fmoc CHAr x 2), 7.52 (2H, d, J = 7.2 Hz, Fmoc CHAr x 2), 7.37-7.20 (4H, m, 
Fmoc CHAr x 4), 5.53 (1H, d, J = 7.6 Hz, NH), 4.54 (1H, bm, NH), 4.46-4.28 (3H, m,  
Fmoc CH2 + Cα-H), 4.14 (1H, t, J = 6.8 Hz, Fmoc CH), 3.06 (2H, m, CH2), 1.90-1.72 
(2H, m, CH2) 1.44-1.39 (2H, m, CH2), 1.36 (9H, s, Boc tBu).  19F-NMR (235.3 MHz, 











0 oC - RT 36 (86 %)  
 
Potassium hydride (35 % suspension in mineral oil, 268 mg, 2.40 mmol) was washed 
with anhydrous pentane (3 x 5.0 ml), then suspended in anhydrous pentane (5.0 ml) and 
the reaction mixture was cooled to 0 oC.  Triisopropylsilyl thiol (0.50 ml, 2.30 mmol) was 
added dropwise to the suspension and stirring was continued at 0 oC for 2 hours.  The 
reaction mixture was evaporated to dryness in vacuo and recrystallised from toluene to 
 204
afford the potassium triisoproylsilylthiolate salt as a white solid (520 mg, 2.28 mmol, 99 
%) which was then suspended in anhydrous THF under argon.  The suspension was 
cooled to 0 oC and bromoethanol (200 µl, 2.80 mmol) was added dropwise.  Stirring was 
continued for 15 minutes at 0 oC, then for 5 hours at room temperature.  The resulting 
white precipitate was removed by filtration and washed with anhydrous THF (15.0 ml).  
The combined filtrate was concentrated in vacuo and purified by column chromatography 
over silica (EtOAc/petroleum ether bp 40-60 oC, 15:85) to afford 36 as a clear oil (464 
mg, 1.98 mmol, 86 % based on starting triisopropylsilyl thiol).  1H-NMR (250 MHz, 
CDCl3): δ = 3.66 (2H, t, J = 5.9 Hz, CH2), 2.69 (2H, t, J = 6.1 Hz, CH2), 1.74 (1H, bs, 
OH), 1.26-1.11 (3H, m, iPr CH x 3), 1.03 (18H, s, iPr CH3 x 6).  13C-NMR (62.8 MHz, 
CDCl3): δ = 63.8, 29.6 (CH2 x 2), 18.9 (CH3 x 6), 13.1 (CH x 3).  LRMS (ESI): found 
216.9.  C11H25SSi [M-OH]+ requires 217.14.  1H and 13C spectroscopic data in good 





Except where noted, manual peptide synthesis was carried out on a 0.05 mmol scale using 
10 equivalents of Fmoc-amino acid per coupling and HOBt/HBTU coupling reagents.  
The Fmoc amino acid was dissolved in DMF (1.0 ml) and DIPEA (150 µl, 0.85 mmol) 
and 1.0 ml of an HOBt/HBTU solution in DMF (0.5 M concentration for each reagent) 
were added with stirring.  The resulting solution was added to the peptide synthesis tube 
containing the resin and agitated for an average of 4 hours.  Fmoc removal was carried 
out by treatment of the resin with a 20 % v/v solution of piperidine in DMF for 20 
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minutes.  Reaction progress was monitored by the Kaiser ninhydrin test and LC-MS 
analysis.  5 equivalents of auxiliary-amino acid cassettes and coupling reagents were used 
for the final coupling.  Resins were washed exhaustively with DMF and then with DCM 
after each coupling or deprotection step.  All resins, amino acids and coupling reagents 
were purchased from Novabiochem.   
 
Peptides were cleaved from the solid phase with concomitant side-chain deprotection by 
treatment with 95 % TFA v/v, 2.5 % EDT v/v, 2.5 % H2O v/v for 3 hours.  The resin was 
removed by filtration and the crude peptide was precipitated from ice-cold ether and 
collected by centrifugation at 5000 rpm for 15 mins.  The crude peptide was then 
dissolved in the minimum volume of MeCN/H2O (0:100-20:80) and purified by semi-
preparative HPLC.  Fractions containing the product were lyophilized to afford the 
peptides as fluffy white solids. 
 
UV Fmoc analysis was conducted as described in the Novabiochem synthesis notes.  
Approximately 1 µmol of resin with respect to Fmoc was weighed into each of two 10 
mm silica UV cells.  Freshly prepared 20 % v/v piperidine in DMF (3.0 ml) was added to 
each cell and also to a third empty cell.  The resin mixture in each cell was gently agitated 
with a pasteur pipette for 3 minutes.  The UV absorbance of each of the two cells 
containing the resin mixture was measured at 290 nm, using the cell containing only the 
piperidine solution as a reference.  The formula loading = (Abssample - Absref)/(1.65 x mg 
resin) was then used to obtain an estimate of the resin loading (mmol/g). 
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Auxiliary-peptides were synthesized on NovaSyn®TGT resin preloaded with serine 
(loading = 0.22 mmol/g).  Auxiliary-peptides 24a and 31a have the sequence Aux-
GSETVEEELGKIIEGFVTGAEDIISGASRITKS, corresponding to residues 100-132 of 
GlyCAM-1.  Auxiliary-peptides 24b, 24c, 31b and 31c are shorter versions of the same 
sequence as detailed in the text.  Auxiliary-glycopeptide 32 has the sequence Aux-
GSSQLEET(GalNAc(OAc)3)S, corresponding to GlyCAM-1 residues 76-83. 
 
Peptide benzyl thioesters 33a – 33d were synthesized on 4-sulfamylbutyryl-AM resin 
(loading 1.1 mmol/g).  Peptide alkyl thioesters 37a – 37c were synthesized on Rink amide 
AM resin (loading 0.62 mmol/g).  Benzyl thioester 33a was also synthesized on this resin 
as detailed in Scheme 35. 
 
N-4,5,6-trimethoxy-2-(4-methoxybenzylthio)benzyl glycine-(GlyCAM-1 101-132) 
23a: 7 % isolated yield.  m/z (ESI) calculated: 3756.2, observed: 1878.5 [M]2+, 1712.4 
[M-Aux]2+, 1252.4 [M]3+, 1141.6 [M-Aux]3+. 
N-4,5,6-trimethoxy-2-(4-methoxybenzylthio)benzyl glycine-(GlyCAM-1 110-132) 
23b: 10 % isolated yield.  m/z (ESI) calculated: 2782.2, observed: 1392.0 [MH2]2+, 
1225.8 [M-AuxH2]2+. 
N-4,5,6-trimethoxy-2-(4-methoxybenzylthio)benzyl alanine-(GlyCAM-1 116-132) 
23c: 10 % isolated yield.  m/z (ESI) calculated: 2108.4, observed: 2108.2 [M]+, 1776.6 
[M-Aux]+, 1055.0 [MH2]2+, 888.9 [M-AuxH2]2+. 
N-4,5,6-trimethoxy-2-(2-nitrobenzylthio)benzyl glycine-(GlyCAM-1 110-132) 23d: 
m/z (ESI) calculated: 2797.1, observed: 1399.1 [MH2]2+, 1225.8 [M-AuxH2]2+. 
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Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)-glycine-(GlyCAM-1 101-132) 31a: 10 
% isolated yield.  m/z (ESI) calculated: 3620.0, observed: 1810.0 [M]2+, 1712.2 [M-
Aux]2+, 1207.6 [M]3+, 1141.8 [M-AuxH3]3+. 
Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)-glycine-(GlyCAM-1 110-132) 31b: 
11 % isolated yield.  m/z (ESI) calculated: 2646.0, observed: 1323.9 [MH2]2+, 1225.9 [M-
AuxH2]2+, 883.2 [MH3]3+, 817.7 [M-AuxH3]3+. 
Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)-alanine-(GlyCAM-1 116-132) 31c: 
13 % isolated yield.  m/z (ESI) calculated: 1972.2, observed: 1972.5 [M]+, 1776.4 [M-




Typical procedure for PMB deprotection of N-4,5,6-trimethoxy-2-(4-
methoxybenzylthio)benzyl peptides 23a-23c: 
 
The S-PMB protected peptide (1.0 mg) was placed in an eppendorf tube and dissolved in 
10 % v/v acetic acid (0.50 ml) at 0 oC.  Mercury(II)acetate (1.0 mg) was added and the 
reaction mixture was shaken (250 rpm) at room temperature under argon for the times 
shown in the text.  DTT was added to a final concentration of 5 % w/v and the reaction 
mixture was agitated for a further 1 hour.  The thick white precipitate was removed by 
centrifugation at 13000 rpm for 10 mins.  The remaining solution was purified directly by 
semi-preparative HPLC and fractions lyophilized to afford the N-4,5,6-trimethoxy-2-
mercapto-benzyl peptides 24a - 24c as fluffy white solids.  
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N-4,5,6-trimethoxy-2-mercapto-benzyl glycine-(GlyCAM-1 101-132) 24a: 69 % 
isolated yield.  m/z (ESI) calculated: 3636.0, observed: 1818.3 [M]2+, 1712.5[M-
AuxH2]2+, 1212.3 [M]3+, 3425.0 [M-AuxH3]3+. 
N-4,5,6-trimethoxy-2-mercapto-benzyl glycine-(GlyCAM-1 110-132) 24b: 87 % 
isolated yield.  m/z (ESI) calculated: 2662.02, observed: 1331.8 [MH2]2+, 1225.8 [M-
AuxH2]2+, 888.4 [MH3]3+, 817.6 [M-AuxH3]3+. 
N-4,5,6-trimethoxy-2-mercapto-benzyl alanine-(GlyCAM-1 116-132) 24c: 71 % 





Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl) glycine (GlyCAM-1 74-83) 
glycopeptide 32: 
 
S-PMB protected glycopeptide 31d (1.0 mg) was dissolved in a minimum volume (100 
µl) of ice-cold TFA and treated with mercury(II)acetate (1.0 mg).  The reaction mixture 
was allowed to stand under argon at 0 oC for 10 mins then diluted to 10 % v/v TFA (1.0 
ml) with H2O.  DTT was then added to a final concentration of  5 % w/v.  The mixture 
was shaken (250 rpm) at room temperature for 30 minutes and the thick white precipitate 
was removed by centrifugation at 13000 rpm for 10 minutes.  The remaining solution was 
purified directly by semi-preparative HPLC and fractions lyophilized to afford the thiol as 
a fluffy white solid (quantitative yield).  m/z (ESI) calculated: 1462.5, observed: 1462.7 
[M]+, 1266.9 [M-Aux]+, 937.3 [M-Aux-(AcO)3GalNAc]+. 
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Typical procedure for synthesis of benzyl thioesters 33a-33d. 
 
Initial coupling with DIPCDI:  45 mg (0.05 mmol) of 4-sulfamylbutyryl-AM resin 
(loading 1.1 mmol/g) was preswelled in DCM for 1 hour.  The Fmoc-protected C-
terminal amino acid (0.20 mmol) and N-methyl imidazole (16 µl, 0.20 mmol) were 
dissolved in a 4:1 v/v solution of DCM/DMF and DIPCDI (31 µl, 0.20 mmol) was added.  
The reagents were mixed and then added to the resin.  The tube containing the reaction 
mixture was agitated for 18 hours, after which time the tube was drained and the resin 
was washed exhaustively with DMF and DCM.  This coupling step was then repeated as 
above.  Subsequent peptide elongation was carried out exactly as for auxiliary-peptides.  
The N-terminal residue of each peptide was coupled as the Boc-protected amino acid to 
avoid a further Fmoc deprotection step.  The resin was transferred to a glass vial and a 
solution of iodoacetonitrile (90 µl, 1.25 mmol, prefiltered through a plug of basic 
alumina) and DIPEA (95 µl, 0.55 mmol) in NMP (1.0 ml) was added and the reaction 
mixture was agitated in the absence of light for 12-18 hours.  The resin was removed by 
filtration and washed exhaustively with NMP, DCM and THF, then added to a glass vial.  
THF (1.5 ml) was added, followed by benzyl mercaptan (205 µl, 1.75 mmol) and NaSPh 
(3.0 mg, 0.02 mmol) and the reaction mixture was stirred for 18-24 hours.  The resin was 
removed by filtration and washed with DCM (3 x 5.0 ml).  The combined filtrate was 
concentrated in vacuo and then treated with 95 % v/v TFA, 2.5 % v/v EDT, 2.5 % v/v 
H2O for 3 hours.  The crude product was precipitated with ice cold ether and collected by 
centrifugation at 5000 rpm for 15 minutes, then purified by semi-preparative HPLC as for 
auxiliary-peptides. 
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C-terminal alanine benzyl thioester 33a: < 1 % isolated yield.  m/z (ESI) calculated: 
653.7, observed: 654.6 [MH]+, 676.2 [MNa]+, 1307.4 [2M]+. 
C-terminal phenylalanine benzyl thioester 33b: 5 % isolated yield.  m/z (ESI) 
calculated: 729.8, observed: 730.4 [M]+. 
C-terminal lysine benzyl thioester 33c: 7 % isolated yield.  m/z (ESI) calculated: 608.8, 
observed: 609.1 [M]+. 
 
 
Initial coupling with acid fluoride: 90 mg (0.10 mmol) of 4-sulfamylbutyryl-AM resin 
(loading 1.1 mmol/g) was suspended in anhydrous DCM (300 µl) in a glass vial.  DIPEA 
(35 µl, 0.20 mmol) was added, followed by the Fmoc-protected acid fluoride 34a or 34b 
(0.30 mmol), dissolved in anhydrous DCM (1.20 ml).  The vial contents were stirred for 2 
hours, then the resin was removed by filtration and washed exhaustively with DCM.  A 
sample of the resin was subjected to UV Fmoc analysis and a loading of 0.84 mmol/g (76 
%) from the reaction with glycine acid fluoride 34a and 0.81 mmol/g (74 %) from the 
reaction with alanine acid fluoride 34b was observed.  Peptide elongation and the 
activation and cleavage steps were conducted exactly as above to afford alanine thioester 
33a in 2 % yield and glycine thioester 33d. 
C-terminal glycine benzyl thioester 33d: 7 % isolated yield.  m/z (ESI) calculated: 




Double linker resin 35 
 
161 mg (0.10 mmol) of Fmoc-Rink amide AM resin (loading 0.62 mmol/g) was 
preswelled in DCM for 1 hour, then washed with DMF and subjected to standard Fmoc 
deprotection.  Fmoc-protected phenylalanine (194 mg, 0.50 mmol) was coupled using 
standard HOBt/HBTU coupling in the presence of DIPEA with 5 equivalents of coupling 
reagents and Fmoc deprotection was again carried out.  3-carboxypropanesulfonamide 
(50 mg, 0.30 mmol) and HOBt (41 mg, 0.30 mmol) were dissolved in anhydrous DMF 
(2.0 ml) and DIPCDI (47 µl, 0.30 mmol) was added.  These reagents were mixed and 
then added to the resin and agitated for 5 hours.  The C-terminal residue of the target 
thioester was coupled as the acid fluoride (0.30 mmol) in the presence of DIPEA (52 µl, 
0.30 mmol) in DCM (1.5 ml) for 4 hours.  Samples of the resin were then subjected to 
UV Fmoc analysis and loadings of 0.47 mmol/g (76 %) for glycine, 0.33 mmol/g (54 %) 
for alanine and 0.36 mmol/g (58 %) for lysine were observed.  Peptide elongation was 
carried out exactly as before.  The resin bearing the C-terminal alanine peptide was split 
in two and half was subjected to the previously used iodoacetonitrile activation and 
benzyl mercaptan cleavage procedures as discussed in the text.  The remainder of this 
resin was preswelled in the minimum volume of anhydrous THF for 1 hour, then drained 
and washed with THF and placed in a glass vial.  Alcohol 36 (82 mg, 0.35 mmol) and 
PPh3 (92 mg, 0.35 mmol) were dissolved in anhydrous THF and added to the resin and 
the reaction mixture was cooled to 0 oC.  DEAD (71 µl, 0.45 mmol) was added dropwise 
and the reaction mixture was stirred overnight, over which time the temperature was 
allowed to rise to room temperature.  The resin was removed by filtration and washed 
repeatedly with THF, DCM and then with further portions of THF.  If necessary, as 
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determined by LC-MS analysis of a the crude residue obtained by subjection of a sample 
of the resin to TFA cleavage, the Mitsunobu alkylation was repeated as above, otherwise 
the resin was subjected to TIPS deprotection.  A solution of TBAF and AcOH in THF 
was made up by mixing 1M TBAF in THF (0.50 ml) with 0.2 M AcOH in THF (5.0 ml).  
3.0 ml of the resulting solution was added to the resin and stirred for 30 minutes, after 
which time the resin was removed by filtration and washed (THF, DCM, Et2O).  The 
resin was then treated with 95 % v/v TFA, 2.5 % v/v EDT, 2.5 % v/v H2O v/v for 3 hours.  
The resin was removed by filtration and the crude peptide was collected by precipitation 
of the filtrate in ice-cold Et2O/hexane 1:1 v/v and centrifugation and purified by semi-
preparative HPLC as before to afford alkyl thioester peptide 37a.  C-terminal glycine and 
lysine alkyl thioesters 37b and 37c were produced by the same procedure, scaling up as 
appropriate. 
C-terminal alanine alkyl thioester 37a: 11 % isolated yield.  m/z (ESI) calculated: 
903.0, observed: 903.7 (MH]+. 
C-terminal glycine alkyl thioester 37b: 12 % isolated yield.  m/z (ESI) calculated: 
756.9, observed: 757.7 [MH]+. 
C-terminal lysine alkyl thioester 37c: 18 % isolated yield.  m/z (ESI) calculated: 858.1, 
observed: 858.6 [M]+. 
 
 
Typical procedure for thiol-free ligation reactions: 
 
The auxiliary-peptide was dissolved in ligation buffer (6 M guanidine hydrochloride, 200 
mM sodium phosphate, pH = 8.0) to a concentration of 8 mM.  200 µl of this solution 
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was added under a stream of argon to an eppendorf tube containing 200 µl of a similar 8 
mM solution of the thioester peptide in ligation buffer, followed by 8 µl of a 1 M TCEP 
solution (final TCEP concentration 20 mM).  The reaction mixture was shaken under 
argon at room temperature for 48 – 72 hours and monitored by LC-MS.  8.0 mg MESNa 
was added to give a final concentration of 2 % w/v and agitation was continued for a 
further 6 hours, after which the reaction mixture was purified directly by semi-preparative 
reverse phase HPLC (in the initial ligation studies in the presence of thiol, the same 
amount of MESNa was added after the TCEP solution at the start of the ligation). 
Gly-Gly (4,5,6-trimethoxy-2-mercaptobenzyl) ligation product 39a: 54 % isolated 
yield.  m/z (ESI) calculated: 3045.5, observed: 1523.6 [MH2]2+, 1016.1 [MH3]3+. 
Gly-Gly [Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)] ligation product 39b: 67 % 
isolated yield.  m/z (ESI) calculated: 3029.5, observed: 1515.5 [MH2]2+, 1010.9 [MH3]3+. 
Gly-Gly [Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)] glycopeptide ligation 
product 42: 48 % isolated yield.  m/z (ESI) calculated: 1845.9, observed: 1845.9 [M]+,  
1650.1 [M-aux]+, 1517.3 [M-aux-(OAc)3GalNAc]+, 923.8 [MH2]2+. 
Ala-Gly [Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)] ligation product 46: 70 % 
isolated yield.  m/z (ESI) calculated: 3175.5, observed: 1588.7 [MH2]2+, 1059.6 [MH3]3+. 
Lys-Gly [Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)] ligation product 48: 24 % 
isolated yield.  m/z (ESI) calculated: 4103.6, observed: 1369.1 [MH3]3+, 1026.8 [MH4]4+. 
Gly-Ala (4,5,6-trimethoxy-2-mercaptobenzyl) ligation product 50a: 42 % isolated 
yield.  m/z (ESI) calculated: 2371.7, observed: 1186.7 [MH2]2+, 791.6 [MH3]3+. 
Gly-Ala [Nα-(1-(2,4-dimethoxyphenyl)-2-mercaptoethyl)] ligation product 50b: 48 % 
isolated yield.  m/z (ESI) calculated: 2355.7, observed: 1178.8 [MH2]2+, 786.6 [MH3]3+. 
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Typical procedure for auxiliary removal: 
 
The purified ligation products were placed in an eppendorf tube under argon and 
dissolved in 95 % v/v TFA, 2.5 % v/v EDT, 2.5 % v/v H2O v/v and allowed to stand with 
occasional agitation at room temperature for 3 hours.  After this time the bulk of the TFA 
was evaporated under a stream of argon and the crude product was collected by 
precipitation in ice-cold Et2O and centrifugation and purified by semi-preparative HPLC 
as before. 
Gly-Gly ligation product 40: 58 % isolated yield from 39a, 100 % isolated yield from 
39b.  m/z (ESI) calculated: 2833.2, observed: 1417.4 [MH2]2+, 945.6 [MH3]3+. 
Gly-Gly glycopeptide ligation product 43: m/z (ESI) calculated: 1649.7, observed: 
1650.1 [M]+, 1320.9 [M-(OAc)3GalNAc]+,  825.6 [MH2]2+. 
Ala-Gly ligation product 47: 100 % isolated yield from 46.  m/z (ESI) calculated: 
2979.3, observed: 1490.5 [MH2]2+, 994.3 [MH3]3+. 
Lys-Gly ligation product 49: 100 % isolated yield from 48.  m/z (ESI) calculated: 
3907.3, observed: 1954.6 [MH2]2+, 1303.6 [MH3]3+, 977.9 [MH4]4+. 
Gly-Ala ligation product 51: 60 % isolated yield from 50a, 100 % isolated yield from 
50b.  m/z (ESI) calculated: 2159.4, observed: 1080.7 [MH2]2+, 720.9 [MH3]3+. 
 
 
Deprotected Gly-Gly glycopeptide ligation product 44 
 
The purified ligation product 43 was placed in an eppendorf tube under argon and 
dissolved in sodium phosphate buffer pH 8.0 containing 2 % hydrazine hydrate v/v and 
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allowed to stand with occasional agitation at room temperature for 4 hours.  Complete 
reaction was confirmed by LC-MS analysis.  m/z (ESI) calculated: 1523.6, observed: 




This project was a collaborative work and the following practical contributions by Dr 
Derek Macmillan are gratefully acknowledged: preparation of ONB-protected auxiliary-
peptide 23d; preparation of PMB-protected auxiliary-glycopeptide 31d and development 
of deprotection conditions to give 32; preparation of thioesters 33e and 33f; preparation 
of glycopeptide ligation product 42 and deprotection to give 44; and initial ligation 
studies at Leu-Gly and Ser-Gly junctions in the presence of MESNa.   
 
23d was prepared as described for auxiliary-peptides, with use of cassette 11b in the final 
coupling step.  Glycopeptide 31d was prepared as described for auxiliary-peptides, with 
use of the Fmoc-Ser[(OAc)3GalNAc]-OH cassette, prepared and incorporated as 
described in reference 196, and with the use of cassette 13a in the final coupling step.  
Protecting group and auxiliary removal steps were performed as described in the 
experimental section. 
 
In addition to his practical contribution, I would like to thank Dr Derek Macmillan for all 
his support, encouragement, advice and patience as my supervisor.  Thanks also to all 
past and current members of the Macmillan research group and all those in lab 34, and the 
technical support staff in the School of Chemistry, especially Robert Smith in mass 
spectrometry and John Millar in NMR, for their assistance.   
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ABSTRACT
Rapid, facile routes to the TFA-cleavable 4,5,6-trimethoxy-2-mercaptobenzyl and 1-(2,4-dimethoxyphenyl)-2-mercaptoethyl classes of auxilia ries
for cysteine-free native chemical ligation are described. Rapid synthesis, coupled with mild cleavage conditions will undoubtedly broaden the
utility of such auxiliaries, particularly where chemically fragile peptide modifications such as glycosylation are present.
The pioneering research of Kent1 and Tam2 in the develop-
ment of chemoselective peptide ligation strategies has
facilitated the total synthesis of hundreds of proteins.3
However, the requirement for an N-terminal cysteine residue
is considered a limitation of the native chemical ligation
(NCL) methodology, and consequently cleavable thiol aux-
iliaries have been developed.4 Most, however, required
multistep syntheses and/or exposure to harsh conditions such
as HF during synthesis or to facilitate auxiliary removal,
which is not compatible with some posttranslational modi-
fications such as glycosylation. We became interested in
using the TFA-cleavable auxiliaries developed by Offer et
al.4f and Botti et al.4a since, in our recent research, concerning
the application of NCL to the assembly of O-linked glyco-
protein GlyCAM-1, we had observed that a peptide contain-
ing both an N-terminal cysteine residue and an internal
cysteine residue (introduced to facilitate a prior ligation)
failed to give a ligation product until the internal cysteine
was capped.5 We then hoped to devise an alternative strategy
employing a removable auxiliary to circumvent any problem
arising from the presence of the internal thiol while, at the
same time, developing an auxiliary synthesis that was more
compatible with glycopeptide chemistry and that would allow
convenient incorporation of auxiliaries as amino acid “cas-
settes” (Scheme 1) using standard Fmoc solid-phase peptide
synthesis (SPPS). We focused on auxiliary-linked glycine
conjugates since X-Gly4d,g ligation junctions seem most
useful, particularly with the 1-phenyl-2-mercaptoethyl class
of auxiliary,4g and these would adequately permit investiga-
tion of our preferred Leu-Gly and Ser-Gly ligation junctions.
A key aim was to employ suitably labile protecting groups
(R, Scheme 1) for the thiol functionality such asS-p-
methoxybenzyl (PMB),S-o-nitrobenzyl (ONB), andS-trityl
(1) (a) Dawson, P. E.; Muir, T. W.; Clark-Lewis, I.; Kent, S. B.Science
1994, 266, 776.
(2) Liu, C.-F.; Tam, J. P.Proc. Natl. Acad. Sci. U.S.A.1994, 91, 6584.
(3) Dawson, P. E.; Kent, S. B. H.Annu. ReV. Biochem. 2000, 69, 923.
(4) (a) Botti, P.; Carrasco, M. R.; Kent, S. B. H.Tetrahedron Lett. 2001,
42, 1831. (b) Canne, L. E.; Bark, S. J.; Kent, S. B. H.J. Am. Chem. Soc.
1996, 118, 5891. (c) Clive, D. L. J.; Hisaindee, S.; Coltart, D. M.J. Org.
Chem. 2003, 68, 9247. (d) Low, D. W.; Hill, M. G.; Carrasco, M. R.; Kent,
S. B. H.; Botti, P. Proc. Natl. Acad. Sci. U.S.A.2001, 98, 6554. (e) Offer,
J.; Dawson, P. E.Org. Lett. 2000, 2, 23. (f) Offer, J.; Boddy, C. N. C.;
Dawson, P. E.J. Am. Chem. Soc. 2002, 124, 4642. (g) Marinzi, C.; Offer,
J.; Longhi, R.; Dawson, P. E.Bioorg. Med. Chem2004, 12, 2749.
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(Trt) since reaction conditions employed for their removal
have been shown to be compatible with glycopeptide
synthesis.4g,5,6 For the synthesis of glycine-linked 4,5,6-
trimethoxy-2-mercaptobenzyl auxiliary5 (Scheme 2), we
introduced the SPMB-protected thiophenolic moiety using
triflate 1 and PMB-thiol in a single step using the palladium-
catalyzed coupling chemistry developed by Buchwald and
Hartwig.7
Initially, we were disappointed to find that reported
conditions for palladium-catalyzed aryl C-S bond formation
using various substituted aryl triflates8 failed to give ap-
preciable quantities of thioether2 with our substrate (1).
However, this reaction occurred readily upon heating for 20
min at 150°C in a microwave reactor. The commercially
available aryl bromide could also be employed in place of
1, but the yields were consistently lower (24- 4%) under
comparable reaction conditions. ONB-thiol failed to provide
access to ONB-protected thiophenol under our optimized
microwave conditions, and theS-trityl protecting group was
not investigated at this stage as it was unlikely to survive
the subsequent reaction conditions. Following Vilsmeier
formylation,4f aldehyde3 was conjugated directly to glycine
using H-Gly-OtBu (utilizing the tert-butyl ester to ease
purification of the product) via reductive amination employ-
ing sodium triacetoxyborohydride as reductant in excellent
yield.9 The auxiliary-glycine conjugate4 was then prepared
for standard SPPS via TFA-mediated cleavage of thetert-
butyl ester followed by Fmoc protection of the secondary
amine. Synthesis of protected 1-(2,4-dimethoxyphenyl)-2-
mercaptoethyl auxiliaries9 and10 was completed in only
two steps. PMB- and trityl-protected thiol moieties were
introduced by the action of the corresponding thiols on
commercially available bromoacetophenone6 to afford
thioethers7 and 8 in excellent yields. Glycine was then
introduced via reductive amination using sodium cyanoboro-
hydride as a reductant in refluxing methanol.10 This route
was investigated since under identical conditions for the
preparation of4 (H2NCH2CO2tBu, Na(AcO)3BH, AcOH/
DCM), only reduction of the ketone was observed. Further-
more, only the glycine-linked auxiliary4 was amenable to
thetert-butyl deprotection and Fmoc protection cycle (9 was
resistant to Fmoc protection). We reasoned that, if the
increased steric bulk proximal to the amino group of9 was
precluding Fmoc protection, then Fmoc protection might not
be required at all during peptide synthesis. Consequently,5
and9 or 10 were introduced directly (using 3-5 equiv) to
preassembled peptides corresponding to selected GlyCAM-1
protein fragments (Table 1) with no evidence of multiply
coupled species arising from the use of9 in SPPS. Interest-
ingly, auxiliaries11and12of the type commonly employed
in the submonomer approach (through subsequent reaction
with bromoacylated peptides)4 could also be conveniently
prepared under identical reaction conditions employing
ammonium acetate in place of glycine in the reductive
amination. After Fmoc deprotection and cleavage from the
resin of5-linked peptide13 (Table 1), the PMB protecting
group was efficiently removed using excess Hg(OAc)2 in
10% aqueous AcOH followed by the addition of DTT to a
final concentration of 5% w/v.9-linked peptides (14and15)
were more resistant to such treatment, but the SPMB group
was readily cleaved upon exposure to Hg(OAc)2 in neat TFA
for 10 min at 0°C followed by dilution to 10% aqueous(6) (a) Marcaurelle, L. A.; Bertozzi, C. R.J Am. Chem. Soc. 2001, 123,
1587. (b) Nicolaou, K. C.; Watanabe, N.; Li, J.; Pastor, J.; Winssinger, N.
Angew. Chem., Int. Ed.1998, 37, 1559.
(7) (a)Murata, M.; Buchwald, S. L.Tetrahedron2004, 60, 7397. (b)
Wolfe, J. P.; Buchwald, S. L.J. Org. Chem.2000, 65, 1144. (c) Wolfe, J.
P.; Buchwald, S. L.J. Org. Chem.1997, 62, 1264. (d) Marcoux, J.-F.;
Wagaw, S.; Buchwald, S. L.J. Org. Chem.1997, 62, 1568. (e) Mann, G.;
Baranano, D.; Hartwig, J. F.; Rheingold, A. L.; Guzei, I. A.J. Am. Chem.
Soc.1998, 120, 9205.
(8) Zheng, N.; McWilliams, J. C.; Fleitz, F. J.; Armstrong, J. D., III;
Volante, R. P.J. Org. Chem.1998, 63, 9606.
(9) H2N-Ala-OtBu was also introduced under identical conditions in 96%
yield.
(10) Williams, R. E.; Ehrlich, P. P.; Zhai, W.; Hendrix, J.J. Org. Chem.
1987, 52, 2615.
Scheme 1. Strategy for Introduction of Glycine-Linked
4,5,6-Trimethoxy-2-mercaptobenzyl and
1-(2,4-Dimethoxyphenyl)-2-mercaptoethyl Auxiliary Cassettes
Scheme 2. Synthesis of Auxiliary-Linked Glycine Cassettes
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TFA and addition of DTT to a final concentration of 5%
w/v (Figure 1).
With deprotected conjugates13-15 in hand, we aimed
to evaluate their ability to perform native chemical ligation
reactions at our preferred Leu-Gly and Ser-Gly junctions,
thus further probing the generality of the auxiliary-mediated
ligation reaction with scaffolds arising from5 and9. Model
experiments were indeed required since there have been no
published reports of the use of these particular scaffolds in
cysteine-free NCL at Leu-Gly or Ser-Gly junctions.4 For
ligation reactions, AEEEL-SBn and GLRS-SBn thioesters
were prepared so as to model the GlyCAM-1 Leu108-Gly109
and Ser74-Gly75 ligation junctions, respectively, using
established methodology.12
Ligation reactions at peptide concentrations of approxi-
mately 3 mM were conducted in 6 M guanidine hydrochlo-
ride, 200 mM sodium phosphate buffer; pH 8.0, containing
2% w/v mercaptoethanesulfonic acid (MESNA) and 20 mM
tris-carboxyethylphosphine (TCEP). The reactions were
monitored by LC-MS. Initially, minor peaks attributable to
the ligation products between AEEEL-SBn and13 or 14
(PMB removed) were observed; however, these species did
not accumulate over time and so we concluded that they were
likely to be the transthioesterified yet unrearranged starting
materials. A further ligation between fully deprotected
glycopeptide15 and GLRS-SBn thioester was also unsuc-
cessful, as was ligation between unprotected15and a readily
available bacterially derived peptide-thioester (corresponding
to GlyCAM-1 residues 1-77, which also terminates in a serine
thioester). Again only traces of product were observed after
48 h. This bacterially derived peptide-thioester had success-
(11) See Supporting Information for full details of peptide sequences,
experimental procedures, and spectra.
(12) Shin, Y.; Winans, K. A.; Backes, B. J.; Kent, S. B. H.; Ellman, J.
A.; Bertozzi, C. R. J. Am. Chem. Soc.1999, 121, 11684.
Table 1. Synthesis and Ligation Reactions of Auxiliary-Linked GlyCAM-1 Fragments11
protected
peptide-auxiliary

















13c 5-GlyCAM-1 (109-132) 2782.1 2782.2 2662.0 2661.7 AEEEL-SBn 3233.7 -d N
GLRG-SBn 3045.6 3046.0 Y
14 9-GlyCAM-1 (109-132) 2766.1 2766.4 2646.1 2645.0 AEEEL-SBn 2029.6 -d N
15 9-GlyCAM-1 (75-83) 1582.6 1582.9 1462.5 1462.7 GLRS-SBn 1845.9 -d N
GlyCAM-1(1-77S)-SMESNA 9905.2 -d N
GLRG-SBn 1875.9 1876.6 Y
16e 10-GlyCAM-1 (75-83) - - 1462.5 1462.7 - - - -
a After removal of SPMB or STrt protecting groups.b Prepared according to ref 12, and ref 13 for bacterially derived thioester.c Fmoc removed prior to
cleavage from resin.d Only a trace amount of product was observed after 48 h by LC-MS and was not isolated.e TFA-mediated cleavage from the resin
affords the fully unprotected auxiliary-linked glycopeptide, which is identical to deprotected15 and was not tested independently in ligation reactions.
Figure 1. HPLC purification and SPMB deprotection of glyco-
peptide15. (a) TFA-cleaved15eluting at 26.9 min. Slight cleavage
of SPMB under the resin cleavage conditions gives rise to fully
unprotected material at 23.8 min; (b) SPMB cleavage from15 in
10% AcOH, Hg(OAc)2, 0 °C-rt, 5% DTT, 1 h (black trace) and
in neat TFA at 0°C, 10 min (blue trace) shows almost complete
conversion.
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fully participated in several NCL reactions previously with
glycopeptides bearing a cysteine residue at the N-terminus.5,13
These findings were in stark contrast to those obtained when
a GLRG-SBn thioester (the glycine analogue of GLRS-SBn)
was employed in ligation reactions. Reactions between
GLRG-SBn thioester and unprotected13or 15were virtually
complete within 48 h.11 The ligation products were readily
purified by semipreparative reverse-phase HPLC, and the
auxiliaries were removed upon treatment with 95% TFA for
3 h (Figure 2). The acetyl esters employed as protecting
groups for the carbohydrate hydroxyl groups during SPPS
were finally removed with 2% v/v hydrazine hydrate in 10
mM sodium phosphate buffer, which also confirmed the
presence of a stable amide-linked ligation product.
In summary, we have developed particularly rapid and
facile routes to two popular classes of TFA-cleavable acyl
transfer auxiliaries for cysteine-free NCL. In both cases,
deprotection of ap-methoxybenzyl thioether facilitated rapid
liberation of the thiol functionality under conditions compat-
ible with glycopeptide synthesis. Trityl-protected auxiliaries
10 and 12 could also be prepared in only two steps and
incorporated into synthetic glycopeptides, though yields for
the reductive amination of the trityl-protected precursors were
consistently lower than those for the analogous SPMB-
protected compounds. Additionally, we applied a relatively
mild reductive amination protocol for the apparently
problematic4c introduction of the amine functionality of
auxiliaries 9-12. Furthermore, unprotected glycine can
participate in the reductive amination and the auxiliary-
glycine conjugates obtained can be coupled directly to
synthetic peptides without further protecting group manipula-
tions. Auxiliary introduction and cleavage were shown to
be compatible with the presence of glycosidic linkages and
to function in cysteine-free NCL reactions across Gly-Gly
ligation junctions. Unfortunately, both classes of auxiliary
failed to deliver ligation products at Leu-Gly junctions and
the 1-(2,4-dimethoxyphenyl)-2-mercaptoethyl auxiliary failed
to deliver a ligation product at Ser-Gly junctions, which
may limit their use in our studies unless amino acid
substitutions in the GlyCAM-1 protein backbone are toler-
ated. We believe, however, that the rapid synthesis, coupled
with mild cleavage conditions will undoubtedly broaden the
utility of such auxiliaries in favorable cases, particularly
where sensitive peptide modifications such as glycosylation
are present.
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Figure 2. Cleavage of auxiliaries after Gly-Gly native glycopep-
tide ligation reactions. (a) LC-MS trace for purified ligated
glycopeptide product after auxiliary removal. (b) MS of glycopep-
tide product (calcd mass) 1649.4 Da, showing characteristic
fragmentation). (c) Treatment with hydrazine hydrate (2% v/v, 4
h) removes acetate esters on monosaccharide (calcd mass for
deacetylated glycopeptide) 1524.4 Da).
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